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Given the limited genetic coding capacity of HIV-1, it is reasonable to expect that
the virus must interact with an extensive set of cellular factors and their
complexes to complete its passage through the cell. Indeed, it is remarkable that
the viral genome, comprising only about 0.0003% of the entire genetic capacity
of the cell, commandeers the cellular environment to its own advantage.
However, to date, only a small group of cellular proteins have been shown to be
required for viral propagation. In an effort to recover and identify those host
proteins that interact in complex with the viral machinery, we have developed a
systematic genetic method to select derivatives that can encode a small, but
potent, foreign epitope tag yet remain fully replication-competent in culture. In
conjunction with a novel cryogenic methodology to capture and preserve viralhost interactions usually lost when more conventional isolation techniques are
employed, we have recovered host complexes that interact specifically with each
of three independently tagged HIV-1 proteins during progressive infection. Thus,
the quantitative purification of the tagged viral proteins has allowed the
identification of both described factors already known to interact with each of the

targeted viral proteins and as well, unanticipated sets of new host proteins in
complex with the virus and previously obscured from investigation. Identification
and characterization of protein-protein interactions between the host and the
virus will provide insight into the cellular processes expropriated by the virus to
complete its life cycle.
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Chapter 1: Introduction to the Interaction of HIV-1
with Host Factors
Human immunodeficiency virus type 1 (HIV-1) is the causative agent of acquired
immunodeficiency syndrome (AIDS) in human. Given the limited genetic capacity
(104 bp) of HIV-1 and the complex molecular events occurring during infection, it
is likely that the virus interacts with an extensive variety of cellular factors to
complete its passage through the cell. To date, a handful of virus-assisting host
proteins have been identified and well characterized for their mechanism of
action, but many questions remain unanswered (Goff, 2007). Here we endeavor
to identify the factors that interact directly with the HIV-1 machinery during viral
replication using a system in which viruses have been molecularly engineered to
incorporate an extremely potent immunologic peptide tag into the targeted HIV-1
proteins for investigation. As these engineered viruses were generated through a
selective process based on replication competence in culture, each of the tagged
viral proteins is likely to undergo the same interactions encountered by the wild
type virus. We believe that this system affords us a more authentic view of both
the transient and stable molecular interactions encountered during the natural
course of HIV infection and therefore can be used for recovery of the tagged viral
proteins from the infected culture. Indeed, using this set of independently tagged
replication-competent derivatives we have recovered host proteins previously
unknown to be in complex with any viral protein. Success of this work rests upon
a novel methodology that preserves protein-protein interactions during cellular
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disruption and lysis that allows immunoaffinity purification of the tagged viral
protein and access to its associated host factors. Elucidation of the interplay
between the virus and host during HIV-1 infection would be a great asset not only
for detailed insights into basic strategies employed by the virus for its
propagation and survival but also to provide the rationale for the intervention of
host pathways usurped by the virus as it passes through the infected cell.

1.1 HIV-1 Genome and Replication Cycle
HIV-1 belongs to a large and diverse family of enveloped diploid RNA viruses,
the retroviridae, that can reverse transcribe their virion RNA into linear double
stranded DNA and subsequently integrate into the host genome. Retroviruses
are further subdivided into seven groups defined by evolutionary relatedness
(Coffin, 1992). HIV-1 is a representative example of the lentiviruses genus, the
name of which is derived from the Latin (lenti-, slow) characterized by a long
incubation period and their chronic, persistent infections that can cause disease
by killing or inducing function loss of specific cells and tissues. HIV-1 virions are
about 110 nm in diameter (Darlix et al., 1995). The mature viral particle is
composed of an inner core surrounded by an outer envelope formed of a lipid
bilayer with cellular origin incorporating and displaying viral glycoproteins. The
inner core is formed by an outer shell of capsid protein molecules (CA protein)
surrounding the dimeric RNA genome in close association with about 2000
molecules of nucleocapsid protein (NC protein), each virion containing about 100
molecules of reverse transcriptase (RT) and integrase (IN) (Figure 1.1A).
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HIV-1 has two copies of a single stranded, positive-sense 9.2 kilobase (kb) RNA
genome. It encodes nine open reading frames, capable of producing fifteen
proteins after proteolytic cleavage of the Gag, Gag-Pol and Env polyproteins
(Figure 1.1B). The gag, pol and env open reading frames are common to all
retroviruses. Gag (55 kDa) is processed into the mature matrix (MA, p17), capsid
(CA, p24), nucleocapsid (NC, p9) and p6. They are the structural components of
the internal virion core. The three Pol proteins, protease (PR, p10) for proteolytic
cleavage, reverse transcriptase (RT, p66/51) containing both DNA polymerase
and RNase H activity and integrase (IN) mediating integration into the host
genome, all have enzymatic functions. The surface glycoprotein (SU, gp120) and
the transmembrane subunit (TM, gp41) encoded by env form a complex that
interacts with its specific cellular receptors and ultimately leads to fusion and
entry of the virus into the cell. In addition to these conserved genes products,
HIV-1 encodes six unique accessory proteins. Among them, Vif, Vpr and Nef are
virion associated and modulate infectivity, Tat and Rev regulate viral gene
expression and Vpu participates in viral assembly.
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Figure 1.1 HIV-1 structure and genetic organization. Schematic representations
of (A) cross section of HIV-1 particle, [modified from (Coffin et al., 1997)], and (B)
the HIV-1 genome. Different reading frames are indicated by vertical
displacement of the coding region.
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The HIV-1 life cycle follows the general pattern of retroviral infection, but is
endowed with some unique features. It can be considered as a sequence of
discrete steps as outlined in Figure 1.2 (Freed, 1998). The viral surface envelope
glycoprotein binds to its receptor CD4 and provides a contact surface for direct
interactions with one of its associated co-receptors, either CCR5 or CXCR4. The
receptor/co-receptor engagement triggers viral-host membrane fusion between
the lipid bilayer of the virion and the host cell plasma membrane, releasing the
viral core into the cytoplasm. Although this step is very much uncharacterized,
viral uncoating is thought to occur next releasing an organized subviral
composite, operationally defined as the reverse transcriptase complex (RTC) or
preintegration complex (PIC), into the cytoplasm. The RTC/PIC is a highmolecular-weight assembly of several viral, and possibly cellular proteins, in
combination with the two strands of nucleic acids that comprise the diploid viral
RNA genome. It is in the context of the RTC/PIC that the viral RNAs are copied
and converted by the activity of reverse transcriptase (RT) into a full-length linear
DNA copy, the genetic information now a mosaic of that originally encoded by
each of the viral genomic RNAs. Following an additional catalytic step (3’
processing) in which 2 nucleotides at both ends of the viral cDNA are “trimmed”
by the action of the viral integrase protein (IN) yielding recessed 3’ ends, the PIC
(or a subset of its original components) is transported across the nuclear
membrane. In the nucleus, the viral DNA, already “pre-activated” by the trimming
reaction for insertion into the host chromosome, is then recombined into cellular
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DNA by another catalytic step, the strand-transfer reaction, also performed by the
IN protein. The gaps left after the ligation of 3'-ends of the viral DNA to the 5'ends of the staggered cleavage in cellular DNA are then repaired, the
recombinant joint restored to its original state by the DNA repair activities of the
host. Host cell mediated circularization of viral DNA leads to the formation of 1LTR and 2-LTR circles, this event also coordinated by host enzymatic functions.
The integrated viral DNA, also known as provirus, is now competent for
transcription, generating the various sub-genomic RNA transcripts encoding the
viral regulatory and structural gene products as well as the full-length viral RNA
that is either translated to produce the large Gag-Pol polyprotein or directly
packaged into the budding virion. The cellular plasma membrane is the site of
virion formation and release. Here, the heavily glycosylated viral envelope protein
and other structural gene products are targeted for virion incorporation along with
the two new copies of viral genomic RNA. Finally, and soon after encapsidation
and budding, an increase in the local concentration of the viral protease (PR)
promotes its dimerization and activates PR for proteolysis. The reactive PR now
cleaves the Gag-Pol polyprotein into its constituent processed products to
generate the mature virion reinstating the infectious cycle.
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Figure 1.2 General features of the HIV-1 replication cycle. The early phase (left
portion of the diagram) begins with CD4 recognition and involves events up to
and including integration of the proviral DNA, and the late phase includes all
events from transcription of the integrated DNA to virus budding and maturation.
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As shown above, HIV-1 has a relatively small complement of viral proteins. Thus,
to pass through each step of the viral life cycle, it is likely that the virus depends
heavily upon the host cell for additional factors for the completion of the various
molecular events required for sustained infection. In addition to the receptors and
cellular transcription factors that are required for retroviral replication, it has been
hypothesized that viral proteins must interact with many other cell components,
making extensive use of the available host cellular machinery (Coffin et al.,
1997). Moreover, it is a reasonable assumption that each of the viral proteins
must perform multiple functions at several discrete points within the viral life
cycle, each precisely tuned to encompass their multifunctional roles in the very
limited space of the HIV-1 proteome. Discoveries like this have provided an initial
glimpse into the molecular complexity at the viral-host interface. However, while
most of this work has relied on the detection of direct interactions between one
viral protein and its immediate cellular binding partner, the isolation and
identification of the set of host factors comprising multi-component protein
complexes and recruited for specific viral functions has remained elusive.

1.2 Methods for the Study of Virus-Host Interactions
Cellular co-factors for viral replication and pathogenesis have been subjects of
intense investigation. Several genetic and biochemical methodologies have been
employed to identify cellular genes or gene products essential to viral infection.
Chemical mutagenesis has been used to induce frameshift mutations in cellular
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coding regions. Mutant cell lines resistant to viral replication can be easily
recovered and subsequently analyzed for interrupted gene functions (Bruce et
al., 2005; Gao and Goff, 1999). Chemical mutagenesis is a simple and
straightforward approach to select cell lines resistant to viral infection. However,
because of the nature of chemical mutagenesis, the altered gene(s) cannot be
readily identified. This fact, coupled with the possibility of altering several genes
in parallel, makes it extremely difficult to identify the mutant gene(s) responsible
for the associated phenotype. Another approach, insertional mutagenesis, uses
retroviral integration as an insertional mutagen to randomly inactivate host genes
(Joyner et al., 1989; Zheng and Hughes, 1999). This method has the advantage
that the identity of the gene can be determined and the creation of a large library
of independent insertional events can be readily obtained. However, this
approach inactivates only one homologue and therefore can identify only those
genes whose corresponding gene products are amenable to trans-dominant
interference or can be detected by their functional haplo-insufficiency. A third
method that has had success is transduction of a gene required for infection from
a cell line sensitive to infection to cells that are refractory to infection. As the
opposite of the insertional mutagenesis, this approach adds back positive factors
of infection. For example, this technique has been very successful to recover
cellular genes encoding restriction factors, host receptors or co-receptors
required for viral entry (Evans et al., 2007). Transduction of a resistant genotype
can also be used, especially for the study of restriction factors for viral infection
(Sheehy et al., 2002; Stremlau et al., 2004). Typically, a cDNA library is prepared
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from cells that are resistant to viral infection. Closely related sensitive cells are
then transduced with a retroviral vector library and used to recover cells now
refractory to productive infection. The cells resistant to infection can be recovered
by their selected survival after an infection challenge with a virus that results in
cell death, a subset of surviving cells harboring the transduced gene conferring
resistance. Fluorescent screening methods have also been used (Stremlau et al.,
2004). However, in addition to the difficulty of making a representative
complementary DNA (cDNA) library for factors limiting in the population, these
approaches will succeed only when one gene product is required for its positive
or negative effects on viral infection.

Antisense library approaches and rescue methods have been developed to
quickly identify antisense cDNAs responsible for a given phenotype (Deiss and
Kimchi, 1991; Hannon et al., 1999). Interfering RNA (RNAi) libraries have also
been used. For example, double stranded RNA, termed small interfering RNA
(siRNA), homologous to a cellular gene can mediate sequence-specific
degradation of the cognate mRNA upon its introduction into cells, leading to
epigenetic gene inactivation (Elbashir et al., 2001). In recent years, it is clear that
the use of siRNA libraries is much more efficient than antisense RNAs in
knocking down gene expression and not surprisingly, this methodology has
attracted a great deal of attention as a powerful tool for functional identification of
genes (Vanhecke and Janitz, 2005). However, there are still some drawbacks.
Studies has shown that sequence identities of as few as 11 to 12 nucleotides
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between an interfering RNA and an unrelated messenger RNA (mRNA) may be
sufficient for interference to occur (Jackson et al., 2003). If this is true, crossreactivity, referred to as the ‘off-target effect’, could be a substantial problem (Ma
et al., 2006). Although RNA interference targeting is more efficient than the
antisense RNA approach, it is clear—as in the case of worms or flies—that the
expression of different genes in mammalian cells are diminished with a wide
range of efficiencies. The potential for a non-specific interferon response to
siRNA expression in mammalian cells might also be problematic using some
genetic screens (Scacheri et al., 2004).

A commonly used biochemical approach to identify co-factors for viral infection
and/or replication is based on the macromolecular interactions between an
ectopically expressed viral protein and its reactive host cell protein(s). In these
studies, a vector is engineered to express an affinity tag fused to the N- or Cterminus of a viral protein of interest (VPOI). Upon high-level expression of the
VPOI, any proteins associated with it intracellularly can be affinity purified using
the fused tag and identified by techniques such as mass spectrometry or
immunoblotting. Many cellular factors have been identified for various VPOI by
this means (Cherepanov et al., 2003; Mulder et al., 2002; Schrofelbauer et al.,
2007). However, since the targeted protein is highly expressed, this conventional
and straightforward method might not necessarily represent the physiological
conditions occurring during infection and may not suitable for studying the
dynamics of the virus-host protein interaction.
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In addition to the above methods, host proteins that directly interact with viral
gene products have been identified using the yeast two-hybrid system (Kalpana
et al., 1994; VerPlank et al., 2001). However, this approach requires tight
interactions that take place in the yeast fungi nucleus, and is notorious for
producing false positives. Moreover, this approach is not optimized for the study
of most viral proteins in their natural mammalian intracellular environments.

1.3 The Interaction of HIV-1 with Host Factors
Much effort has been focused on understanding the interactions between HIV-1
and its host cells. Identification and characterization of the different cellular
partners utilized by each viral protein would be invaluable in efforts to gain an
intimate understanding the biology of the virus and by extension, and to expand
the potential for the discovery of new antiviral targets. To date, various
biochemical and molecular techniques have been used to reveal the identity of
many cellular factors required for sustained propagation of HIV-1 in target cells.
Furthermore, research on HIV-1 as well as many other retroviruses has shown
that both viral and cellular factors regulate the progression of the viral life cycle. A
list of cellular co-factors for HIV-1 characterized over the past few years and the
methods used to identify them are summarized in Table 1.
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Table 1. Examples of host factors that interact with HIV-1.
Viral
Protein
MA

Host Protein

Methods
of Function
Identification
AP3
Yeast two hybrid
Gag trafficking, virion
assembly
HO3
Yeast two hybrid
Increasing infectivity
CA
Cyclophilin A
Yeast two hybrid,
Uncoating, RT initiation
in vitro binding
Gene transduction Restriction factor,
TRIM5α
degradation of CA?
Uncoating?
NC (p12)
APOBEC3G
Co-IP
Hypermutation, genome
degradation
p6
Tsg101
Yeast two-hybrid
Budding (ESCORT
recruiting)
AIP1/ALIX
Isolation in virus
Budding (ESCORTIII
like particle (VLP)
recruiting)
Gag
HP68
Co-IP
Assembly
LysRS (KARS) Co-IP, in vitro
tRNA packaging
reaction
AP-2
Affinity purification Viral budding and release
Staufen
Co-IP
RNA packaging
RHA
Co-IP
Particle production, RT
IN
INI1
Yeast two-hybrid
Viral assembly, nuclear
import
LEDGF
Co-IP
Viral DNA integration,
chromatin tethering
Rad18
Co-IP
DNA repair in integration
Ku80, DNA-PK, PIC purification
DNA repair, anti-apoptosis
Ku70
EED
Yeast two-hybrid
Import, PIC targeting
HSP60
Affinity purification Catalytic
Importin 7
In vivo co-IP
Nuclear import
p300
Co-IP
IN acetylation
BAF
Co-IP
Chromatin targeting
SU (gp120) CD4
Neutralization
Receptor for viral binding
TM (gp41) CXCR4, CCR5 Gene transduction Co-receptors, membrane
fusion
Vif
APOBEC3G
Gene transHypermutation, genome
duction, Co-IP
degradation
Cul5, Elongins IP/MS during
APOBEC3G degradation
B and C, Rbx1 infection
Vpr
RIP/VpvBP
Co-IP
Cytoplasmic retention of
Vpr
DDB1
Co-IP
G2 arrest

13

Rev

Yeast two hybrid

vRNA nuclear export

Tat

Crm1,
Rab/hRIP
p32
Cyclin T1, cdk9

Yeast two hybrid
Co-IP

Nef

ASK1
P13K

In vitro affinity
binding
Co-IP

PACS-1

Antisense

Post-transcriptional block
Transcriptional
transactivation
Signaling intermediate in
apoptosis pathway
blocks HIV induced
apoptosis
MHC I down-regulating
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Integrase (IN) is an essential viral protein that performs multiple tasks including
its cooperation in reverse transcription (Wu et al., 1999), nuclear import of the
PIC (Maertens et al., 2004), HIV-1 particle production (Bouyac-Bertoia et al.,
2001; Gallay et al., 1997), and as indicated by its name, integration of the viral
DNA into the host genome (LaFemina et al., 1992; Wiskerchen and Muesing,
1995a). In order to mediate these diverse processes, integrase is believed to
associate with a number of cellular factors to exploit their functions. Among the
binding partners, the integrase interactor 1 INI1/hSNF5 is a component of the
chromatin remodeling SNF-SWI complex and has been found to activate IN
DNA-joining activity in vitro (Kalpana et al., 1994). However, there is no strong
evidence for involvement of INI1 during the in vivo integration process. INI1’s
binding seems to be required for late events in the viral life cycle via an unknown
mechanism(s) (Yung et al., 2001). Given the timing of its activity, INI1 may
interact with IN within the context of the Gag-Pol polyprotein. Alternatively, given
the observed cellular relocalization of INI1 during HIV-1 infection, INI1 might play
a role for virus-associated INI1 and/or cellular INI1 during the early steps of HIV1 infection, such as PIC nuclear import (Turelli et al., 2001). Although INI1 has
been hypothesized to play a part in integration-site selection or HIV-1
transcription, no experimental evidence has been produced to support this
notion. On the other hand, the human lens epithelium-derived growth
factor/transcription co-activator p75 (LEDGF/p75) has been identified as a new
IN binding partner by co-immunoprecipitation (Cherepanov et al., 2003) and
confirmed by yeast two-hybrid system (Emiliani et al., 2005). Current studies

15

suggest a role of LEDGF for various processes including the nuclear entry of the
PIC, tethering IN to chromatin or a function in the integration reaction itself
(Emiliani et al., 2005; Llano et al., 2006; Llano et al., 2004). Both INI1 and
LEDGF specifically interact with lentiviral IN, not with integrases from the
distantly related oncoretroviral family. This may suggest that their functional
significance is restricted to lentiviral replication (Llano et al., 2004; Yung et al.,
2004). Components of the DNA damage response system including DNA-PK,
ATM and Ku80, have also been reported to interact with IN (Li et al., 2001).
These proteins have been shown to be indirectly involved in the integration
reaction, but might be required to induce the post-integration DNA repair systems
that are responsible for filling in the gaps and sealing the nicks that are left after
integration at the sites of viral integration (Ariumi et al., 2005; Goff, 2007; Smith
and Daniel, 2006).

A notable example of exploring a cellular factor that involved in viral life cycle is
the elegant study on the viral accessory gene vif. The vif open reading frame is
present in all lentiviruses except equine infectious anemia virus and is required
for viral replication and pathogenicity in vivo (Simon et al., 1998). In the absence
of Vif, HIV-1 virions that are produced from non-permissive primary T
lymphocytes and certain T cell lines, are defective, and cannot initiate productive
infection. HIV-1 Vif is essential for viral evasion of the host antiviral factor
APOBEC3G, which is present in Vif-nonpermissive cells and has been identified
as a potent mediator of anti-HIV-1 activity (Sheehy et al., 2002). APOBEC3G
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belongs to a family of proteins that have cytidine deaminase activity and when
packaged into HIV-1 virions, induce modification of newly synthesized minusstrand viral DNA from cytosines to uracils. The hypermutation damages the
genomic integrity and results in defective particles (Zhang et al., 2003). Vif
protects the viral genome by binding to APOBEC3G and inducing its
ubiquitination and degradation by a Vif-Cul5-Skp1-cullin-F-Box (SCF)-like
complex, thereby blocking incorporation of APOBEC3G into the viral particles
(Yu et al., 2003).

Another example of the involvement of an essential host protein pertains to the
export of RNAs of HIV-1. The HIV-1 Rev protein binds to the structured Rev
response element (RRE) on unspliced and singly spliced viral mRNAs and
targets the mRNA to the cytoplasm using the host RNA export pathway for Rev.
Rev has been shown to interact with Crm1, a host cellular protein and a main
member of the nucleo-cytoplasmic transport factors absolutely required to export
the viral structural mRNA transcripts from the nucleus into the cytoplasm (Neville
et al., 1997).

As outlined above, a number of host proteins have been found to be involved in
different aspects of HIV-1 replication including viral entry, host restriction,
intracellular trafficking, mRNA export and assembly. Cellular functions that are
anticipated but not yet defined will include factors ranging from chromatin
remodeling to chemokine receptor-mediated signal transduction. It is certain that
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the scope of the host machinery usurped by the virus is unknown and several
new approaches will be necessary to find those interactions acting at the
molecular interface between the virus and its host cell.

1.4 Proteomic Approach for the Study of Host Proteins that
Interact with HIV-1
In our proteomic approach, we endeavor to identify factors that interact directly
with the HIV-1 machinery during natural viral replication using a system in which
viruses have been molecularly engineered to incorporate a potent immunological
or biochemical tag. A genetic procedure has been developed for the systematic
and comprehensive mutagenesis of individual HIV-1 gene segments (in, vif and
env) in an attempt to introduce a unique restriction endonuclease site (a five
amino acid in-frame open reading frame) into a viral gene without deleterious
effect to the function of the associated gene product in the context of cycling viral
replication. Transposon mutagenesis was used as a method to produce
insertional libraries within specific HIV-1 gene segments. This protocol relies on
the random introduction of a small DNA fragment encoding an efficiently
recognized tag throughout a viral protein-coding segment of HIV-1. This step
creates a large collection of uniquely marked bacterial DNA clones, each of
which contain a small number of extra codons at different positions. The plasmid
DNA from the library can be used to create a diverse viral stock and that is
subsequently used to initiate HIV-1 infection of susceptible cells. Following a
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stringent step for replication competency in vivo, viral DNA persisting after
several rounds of viral replication and represented by low molecular weight
extrachromosomal circular DNAs can be reintroduced back into E. coli, where
they can be clonally purified and amplified. In turn, homogeneous viral stocks
prepared from the plasmid DNA clones can be used to generate a panel of
viruses each uniquely tagged with respect to the location of the insertion.
Because of the rigorous step of biological selection, viruses that survive through
multiple passages can accommodate a tag within a specific location within the
HIV proteome without loss of biological “fitness” as revealed by their robust
replication.

The ability to introduce a small peptide into a viral protein without obvious effect
can be used as a mapping tool to locate a site(s) within the secondary, tertiary
and quaternary structure of the protein that can accommodate foreign amino
acids. Segments of protein sequence located at the surface of the threedimensional structure or in connector regions frequently tolerate insertions of a
few amino acids and remain functional, while segments that are buried, or part of
an active site, are generally intolerant of such insertions (Goff and Prasad, 1991).
In principle (and in practice), selected sites within proteins are usually amenable
to the incorporation of even larger numbers of amino acids yet have the ability to
remain functional. Here, DNA that codes for an efficient epitope or affinity tag is
subsequently introduced into the HIV-1 genome within the viral gene
corresponding to the preferred site of insertion.
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Following confirmation of replication competency, the epitope-tagged virus can
be utilized for the quantitative recovery of the viral protein. The modified viral
proteins expressed in infected cells are expected to form the same physiological
complexes as their natural counterparts and because of the high affinity epitope
tag, each modified protein can be purified, often associated with its binding
partner(s) or complex(es) that it relies on to performs its functions during viral
replication through the cell. Importantly, since binding is strong, potentially
transient complexes can be purified over a short period of time. A particular viral
protein tagged independently at different positions will allow corroboration of any
cellular binding partners identified using this procedure. The recovered proteins
that are associated with each tagged viral protein can be identified using
standard mass-spectrometry methods. This scheme should allow identification of
the binding partner(s) for each viral protein at various times throughout the viral
life cycle.

Large-scale studies of protein complexes have been carried out in yeast, in
which individual proteins are tagged and used to recover associated proteins
(Gavin et al., Ho et al., 2002). In those studies, hundreds of different proteins
were tagged with a fragment of protein A or an epitope FLAG tag to create ‘bait’
proteins. DNAs encoding the bait proteins were then stably introduced into yeast
cells. Importantly, the modified proteins form physiologically relevant complexes
with other proteins that are in association with the bait protein in the context of
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the living cell and thus provide a strategy to recover and identify true binding
partners. Adapting this approach to HIV-1 will provide a dynamic picture of virushost interactions not currently appreciated and contribute to the basic biological
strategy employed by HIV-1 to gain control of the host cell.

Thus, the method described herein will provide a powerful tool to identify cellular
proteins that associate with a given viral protein during the viral life cycle, a
subset of which may be absolutely required by the virus for its livelihood but in
part dispensable or compensated by the host cell. Research in this area has the
potential to provide many new targets for small molecule intervention, particularly
if the host factor is required for viral growth but dispensable for normal cell
function. For example, individuals with a 32 base-pair deletion in the CCR5
cellular co-receptor gene are refractory to HIV-1 transmission, yet are not
seemingly compromised for overall health. Consequently, small molecule
inhibitors have been screened and identified against this cellular target (Strizki et
al., 2001). Cellular proteins are emerging as potential targets for new
antiretroviral drugs since they do not mutate as frequently as the virus and viral
replication might be blocked because there are no alternative pathways. Coupled
with the development of RNAi therapeutics, antiviral drugs that target cellular
proteins may play major roles in combating HIV resistance.
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Chapter 2: Materials and Methods

2.1 Generation of Replication-Competent HIV-1 that Incorporates
a Potent Antigenic Tag
2.1.1 Random Insertion of a Unique Restriction Site (PmeI) into
Proviral DNA by a Transposition Methodology
For cloning purposes, the HXb2-derived HIV-1 proviral clone, R7/3, was
engineered to contain a pair of unique restriction endonuclease sites immediately
flanking each of the targeted gene segments. This allows for the precise insertion
of the targeted gene without disruption of the remainder of the proviral genome or
plasmid backbone. The proviral clone was modified to create or eliminate certain
restriction sites using overlap-PCR site-directed mutagenesis. The locations of
the new restriction sites with respect to the corresponding amino acid (aa) within
the viral proteins studied here are as follows in Table 2.
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Table 2. The location of restriction sites with respect to their corresponding
amino acid within the viral protein.
Viral Protein
Segment

5’ Site

N-terminal
amino acid*

3’ Site

C-terminal
amino acid*

Complete
Integrase (IN)

XbaI

4

MluI

288 / 288

Integrase
C-Terminus
(IN-CTD)

PstI

215

MluI

288 / 288

Vif

SacII

51

BstEII

185 / 192

Env (V1-V3)

NdeI

62

NheI

345 / 856

*The location of the first and last codons within the viral protein-coding segment
that can be mutagenized without interruption of the adjacent restriction enzyme
recognition sequence. The total number of amino acids of the complete protein is
indicated in the right column after the slash. None of the mutagenic alterations
that introduce a new restriction site alter the identity of the corresponding amino
acid in the target viral protein.
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To generate a library of transposon-mediated insertions in the individual viral
gene segments, the regions of interest were subcloned into the ampicillin
resistant pBluescript II (pBS) KS(-) plasmid (Stratagene) to generate pBS-KS-in,
pBS-KS-in(ctd), pBS-KS-env(v1-v3) and pBS-KS-vif. These pBS-KS(-) subclones
served as substrates for the in vitro transposition reaction using the Tn7-derived,
GPS-LS linker scanning system according to the manufacturer’s instructions
(New England Biolabs). The transposition reactions were used to create plasmid
libraries – pBS-KS-in/Tn, pBS-KS-in(ctd)/Tn, pBS-KS-env(v1-v3)/Tn and pBSKS-vif/Tn, each containing a large number of random 1.7 kb Kanr transposition
insertion within the targeted viral gene. Greater than 106 recombinants were
selected based on ampicillin/kanamycin double resistant phenotype they confer
upon the host bacterial cell. To recover only those transpositional events that
occur within the targeted gene segment, plasmid DNA from reach plasmid library
was combined and the pooled DNA preparation (QIAgen) digested with the
corresponding restriction enzymes, XbaI/Mlu for pBS-KS-in/Tn, PstI/MluI for pBSKS-in(ctd)/Tn, NdeI/NheI for pBS-KS-env(v1-v3)/Tn and SacII/BstEII for pBS-KSvif/Tn. Viral gene segments that received a transposon were purified from those
gene segments that did not contain a transposon based on their inherent mobility
difference on agarose gels (i.e., the transposon-containing-fragments were 1.7
kb larger in size). The transposon-targeted fragments were isolated [QIAquick
Gel Extraction Kit (QIAgen)] and then ligated into the appropriately restrictionsite-modified R7/3 proviral vector clone. To recover proviral plasmids containing
a transposon within the targeted gene segment, bacterial transformants were
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selected based on their combined resistant phenotype (Ampr-Kanr) and the
plasmid DNA from each of double resistant R7/3 library pooled and digested with
PmeI. The PmeI restriction site does not appear in the parental plasmid R7/3, but
flanks the ends of the inserted transposon in the Ampr-Kanr transformants in
such a way that digestion with PmeI removes the element from the plasmid.
Therefore, the PmeI-restricted, linear DNA from each of the R7/3/Tn libraries was
purified, ligated to itself, retransformed back into bacteria and the number of
colonies from each library determined. Each library now contains a 15-nucleotide
insertion randomly and uniquely placed throughout the target viral coding region
(in, in-ctd, env or vif). To confirm this supposition and to map the distribution and
randomness of our mutagenesis, each plasmid library was digested with PmeI
and a restriction enzyme lying outside and stationary with respect to the
endpoints of the targeted viral gene. Plasmid DNA was again a prepared,
individual library pooled and used to prepare the heterogeneously tagged viral
stocks.

2.1.2 Viral Production and Infection
Human embryonic kidney (HEK) 293T cell lines were passaged at 37°C in the
presence of 5% CO2 in culture medium containing Dulbecco's modified Eagle's
medium (DMEM) supplemented with penicillin and streptomycin (Pen/Strep) plus
10% fetal bovine serum (FBS). To produce virus, 3 µg pooled DNA from the
R7/3-PmeI libraries (in, in-ctd or env) was used to transfect subconfluent
monolayers (30%) of HEK 293T cells grown in T-25 culture flasks using 25 µg
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polyethylenimine (PEI) (Polysciences Inc.). For the R7/3-PmeI vif library, viral
stock was made by transfecting 293-APOBEC3G-HA. This cell line is derived
from HEK293 cells and stably transfected with a pcDNA expression vector for
human APOBEC3G tagged with HA (Yu et al., 2003).

Following DNA transfection, the flasks were incubated at 37oC for 18 hours, the
transfection medium removed and replaced with 10 mL of fresh medium added
back to each transfection, and the supernatant recovered and aliquoted. Viral
supernatants were collected 20-24 hours later (38-42 hours post-transfection) by
centrifugation at 1,000 rpm for 5 min. Viral production was determined by p24
ELISA performed using the HIV-1 p24 Antigen EIA kit (Beckman Coulter).
Viruses with 10 ng of p24 produced from in or env libraries were used to initiate
infection in 1 x 106 CEM cells, and MT2 cells were used for infection by viruses
produced from vif proviral library. All infected cultures were propagated in T-25
flasks at 37 °C in RPMI-1640 supplemented with 10% FBS. Progress of the
advancing infection was monitored visually by syncytia formation, the cell density
maintained at approximately 1 x 106 cells per mL with 1:3 passage when
necessary. For sample collection, 1 mL of the infected culture was pelleted down
at 1,000 rpm for 5 minutes. Cell pellets were collected once a day over the
course of 7 days post-infection, washed in phosphate buffer saline (PBS) and
stored at -80oC until further processing.
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2.1.3 Purification of Circular Viral DNAs from CEM Infections—
Recovery of Replication-Competent, PmeI-Tagged HIV-1 Clones
The Hirt extraction procedure (Hirt, 1967) was used to recovery low molecular
weight viral DNAs, among these DNAs, covalently closed 1- or 2-LTR viral DNA
circles produced in infected cells were collected each day from each infected
culture. Briefly, the cell pellets from infections were washed once with PBS and
then resuspended in 500 µL of 10 mM Tris-HCl/10 mM EDTA. After adding 50 µL
of 10% SDS and incubation for 10 min at room temperature, 140 µL of 5 M NaCl
was added, the mixture was gently mixed and the insoluble fractions allowed to
precipitate overnight at 4oC. The supernatant was collected after centrifugation at
14,000 rpm for 30 min. The DNA was isolated by ethanol precipitation using
0.25% linear acrylamide as carrier and resuspended in 20 µL of a 10 mM TrisHCl (8.0) buffered solution.

Five microliters of each DNA sample prepared by the Hirt extraction method were
used as template for PCR. The viral coding regions (in, env, or vif) harboring
unique PmeI insertions were amplified by 25 cycles of PCR using the appropriate
primer pairs for each gene and the resulting PCR-amplified DNA fragments
purified using QIAgen Gel Extraction Columns (QIAgen) and eluted in 30 µL 10
mM Tris-HCl/EDTA buffer. To determine if viral recombination had occurred via
reverse transcription during any part of expansion and led to the emergence of
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wild type viral DNA sequence within the targeted gene sequence, 5 µL of each
PCR product was cleaved with PmeI. The percent of viral DNA that had retained
or lost the PmeI site during infection was determined using 0.8% agarose gel
electrophoresis. For selected samples, the purified PCR-amplified DNA was
digested with the two unique restriction enzymes that flank each viral reading
frame, namely, XbaI-SacII for in, PstI-MluI for the integrase C-terminal domain,
NdeI-NheI for env [gp120 (v1-v3)] and SacII-BstEII for vif. Resulting fragments
were ligated into its corresponding pBS-KS(-) vector to generate libraries with the
PmeI-tagged insertion in the viral gene of interest. Since only those plasmids
containing a PmeI site were linearized after PmeI digestion, the linear DNA
resulting from this cleavage reaction was purified away from supercoiled DNA by
electrophoresis over 6% polyacrylamide and electroelution of the linear DNA
(supercoiled DNA does not enter this type of gel). Following self-ligation and
bacterial transformation, plasmid DNAs with PmeI insertions were prepared from
each of 10-30 individual clones and the targeted viral gene segment of each
completely sequenced to determine the location of the PmeI tag. Tagged viral
genes were recloned back into proviral R7/3 and individual viral stocks prepared
and tested for replication competency (syncytia formation). Positive, infectious
clones represent mutant HIV-1s that can tolerate a 15 bp PmeI insertion yet
remain viable and as such are excellent candidates for further modifications
including the addition of a 3xFLAG epitope tag at the unique PmeI site within the
IN, Env and Vif proteins.
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2.1.4 Construction of Replication-Competent 3xFLAG-Tagged HIV
Three commercially-prepared (IDT) synthetic oligonucleotide complimentary
pairs encoding all three reading frames of the 3xFLAG epitope (NH2GGSADYKDHDGDYKDHDIDYKDDDDKASGG-COOH) were phosphorylated at
their 5’ ends, annealed and the appropriate oligonucleotide pair cloned into the
PmeI site of their respective replication competent PmeI-proviral clone. To
prevent multiple 3xFLAG oligonucleotide insertions, the resulting plasmids were
cut with BlpI. BlpI is a restriction site specified by all oligonucleotide pairs but
absent from the rest of the plasmid. In addition, since BlpI recognizes an
abbreviated palindromic sequence (5’…GC/TNAGC…3’), only ligation events
regenerating the complete 3xFLAG DNA sequence are possible. Oligonucleotide
pairs encoding several other tags such as 1xFLAG (GGSADYKDDDDKASGG),
an amino acid sequence capable of biotin addition we designate, SNAGG
(GGSASSLRQILDSQKMEWRSNAGGSGGV) and a biotin mimicking Strep tag
(GGSAWAHPQFEKASGG) were also constructed. Proviral clones with these
tags were generated using the same methodology described above. Thus, while
the methods described herein focus on the 3xFLAG tagged clones, in principle,
this strategy can be applied to any other tag.

The resulting tagged proviral clones were transfected individually into 293T or
293-APOBEC3G (in the case of the vif tagged clone) cells using PEI as
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described above to produce viral stocks with a 3xFLAG in the in, env or vif
reading frames. Viral production was quantified by p24 ELISA, and viruses
corresponding to 10 ng of p24 used to infect 1 x 105 CEM or MT2 cells (Viftagged viruses) in 6-well plates. Cell counts were maintained at 1 x 106 cells per
mL by splitting 1:3 on passage. Replication-competent clones with in-frame
3xFLAG tag insertions that resulted in a progressive and robust syncytia
formation after their infection of CEM cells were used for further experimentation.

2.1.5 Concentrating Viral Particles
Viral supernatants (0.7 mL) from each 3xFLAG tagged virus were collected 7
days post-infection and filtered using 0.45 µm filters (Millipore). Viruses in cellfree media were carefully layered onto the top of 0.3 mL cushions of 20%
sucrose in PBS in 1.5 mL minicentrifuge tubes. Virus was pelleted at 14,000 rpm
at 4oC for 3 hours. Supernatant were removed by aspiration and trace amounts
of liquid removed by pipetting. Viral particles remaining at the bottom of each
tube were resuspended and inactivated in 20 µL of 1% Epigen in PBS at room
temperature for 30 min.

2.1.6 Immunoblotting Analysis of Viral Proteins
Infected cell pellets were washed twice with PBS and suspended in RIPA buffer
(50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate
and 0.1% SDS) containing mixed protease inhibitors (Roche). Samples were
incubated with rotation at 4oC for 30 min, sonicated three times at a 10% setting
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for 10 sec and then cleared by centrifugation at 14,000 rpm for 10 min at 4oC.
Virion pellets and soluble portions of cellular lysates were mixed with LDS
sample buffer (Invitrogen) and 10mM DTT, heated for 5 min at 95oC. Proteins
were resolved by electrophoresis on 10% or 4-12% Bis-Tris polyacrylamide
NuPAGE gels (Invitrogen), and the gel’s contents transferred to polyvinylidene
difluoride (PVDF) membranes (Millipore). Molecular weight estimates for
experimental bands on immunoblots were obtained by comparison with the
mobilities of New Precision Plus Protein All Blue Standard (Bio-Rad) or the
SeeBlue Plus 2 pre-stained standard (Invitrogen).

Membranes were subjected to immunoblot analysis by incubating with primary
antibody at 4oC overnight or 1 hr at room temperature. Primary antibodies were
as follows: 1 µg/mL α-FLAG mouse mAb M2 (Sigma) for 3xFLAG tagged viral
protein expression; 1:1,000 6G5 integrase monoclonal antibody (Nilsen et al.,
1996); 1:1,000 monoclonal α-Vif (Simon et al., 1995) or human polyclonal IgG
purified from the serum of an HIV-1 positive individual (LSS) classified as a longterm nonprogressor (Cao et al., 1995). After washing the blot three times with
0.1% Tween in PBS, the membranes were incubated with secondary antibody at
1:10,000 for 1 hr at room temperature. Sheep anti-mouse horseradish
peroxidase-conjugated antibody (Amersham Biosciences) was used as the
secondary antibody if a murine monoclonal was used as the primary antibody.
Anti-rabbit IgG was used for polyclonal primary antibodies and human sera was
followed by peroxidase-conjugated anti-human antibody incubation. Proteins
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were detected with the ECL Plus Chemiluminescence System (Amersham
Biosciences)

or

Immobilon

Western

HRP

Chemiluminescent

Substrate

(Millipore).

2.2 Characterization of the Replication-Competent Tagged
Viruses
2.2.1 Viral Growth Curves
To assess the growth kinetics of the R7/3-IN-3xFLAG and R7/3-Env-3xFLAG
viruses, these tagged viruses as well as the unmodified, control wild type, R7/3,
were produced in transfected 293T cells as described earlier. 1x106 CEM cells in
T25 flasks were infected with viral supernatants normalized for p24 levels (10
ng). Input virus was removed after overnight incubation by washing cells twice
with PBS, and infected cells maintained in fresh RPMI medium. Culture
supernatants (200 µL) were collected starting at the day of infection daily for 7
days. The rate of viral growth was quantified by measuring the concentration of
p24 in the culture supernatants, as determined by an HIV-1 p24 antigen EIA kit
(Beckman Coulter). Infection in MT2 cells with R7/3-Vif-3xFLAG or wild type R7/3
produced from 293-APOBEC3G were similarly performed.

2.2.2 Production of VSV-G Pseudotype Viruses
Pseudotyped HIV-1 particles carrying the vesicular stomatitis virus G protein
(VSV-G) were used in this study (Naldini et al., 1996; Reiser et al., 1996). The
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NdeI site in the env gene was restricted with NdeI and Klenow polymerase used
to blunt-end the site. In the complete proviral DNA, this procedure results in a
frame-shift in the env reading frame (envminus) and loss of functional Env protein.
Pseudotyped viruses were generated by DNA co-transfection of 293T cells with
0.5 µg of a pVSV-G expression vector (pCI-VSV-G) DNA and 0.5 µg of the
envminus proviral plasmid derivative per well in 6-well plate format containing 2 mL
of DMEM complete media. In addition, 8 µg/mL polybrene was added to each
transfection. The medium was changed after 12 hr. Then, 48 hr after transfection,
the medium was removed and filtered through 0.45 µm Millex-HA filter (Millipore).
Virus stocks were aliquoted and stored at -80°C. Extracellular p24 levels were
measured as described above.

2.2.3 One-Step Infectivity Assays
Three indicator cell lines were employed to assess viral infectivity. (1) P4R5 cells,
a HeLa-CD4/LTR-lacZ indicator line expressing both CXCR4 and CCR5. In this
cell line, the ß-galactosidase reporter gene is expressed only in infected cells
(Charneau et al., 1994). (2) The GFP reporter-containing human osteosarcoma
cells (HOS)-derived indicator cells, GHOST(3)/X4/R5 containing the HIV coreceptor molecules, CCR5, CXCR4 (Morner et al., 1999) and R3 and stably
transfected with a Tat-dependent reporter construct consisting of the HIV-1 long
terminal repeat (LTR) enhancer-promoter directing the expression of a
humanized allele of the green fluorescent protein (GFP). (3) A CEMx174
derivative cell line, LuSIV, modified by stable transfection of a luciferase reporter
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gene (Roos et al., 2000) activated only upon infection.

For the adherent cell lines, HeLa-P4R5 or GHOST(3)X4R5, confluent
monolayers were maintained on 10-cm dishes and split 1:10 into 6-well plates
the day before infection. For suspension cells, LuSIV, 1x105 cells were plated
into each well of a 6-well plate. 1 ng of virus was used for infection in the
presence of polybrene at 8 µg/mL. Plates were incubated at 37oC for 12 hours,
after which cells were washed three times with PBS and the unattached viruses
removed. LuSIV infections were incubated for an additional 2 days at 37oC. The
cells were resuspended in 2 mL of media. 100 µL of the infected culture
transferred to a 96-well plate compatible with the MLX 96 Well Plate
Luminometer (Dynex). 100 µL of Bright-Glo Buffer with Bright-Glo substrate
(Promega) was added to each well and mixed with the cells by pipetting. After
incubation at room temperature for 2 minutes, samples were processed for
luminescence. The output data was analyzed using the Revelation software
platform. Infectivity of various tagged viruses is expressed as percentages
relative to the wild type R7/3 infectivity quotient.

A genetic assay was employed to measure the integration frequency of the
viruses with tagged insertions. The nef region of the WT and its derivative
proviral clones with PmeI, 1xFLAG or 3xFLAG insertions within the integrase
gene was replaced with the dominant selectable marker, the blastocidin D gene
(bsd). All integrase clones with insertions also incorporate inactivating frameshift
mutations in the vpr and env genes. Vesicular stomatitis virus (VSV)-G
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pseudotyped viral stocks were prepared by co-transfecting the R7/3 BSD vprminus
envminus proviral vectors with pCI-VSV-G into 293T cells. Viral production was
measured by p24 determination. HeLa P4R5 cells were plated in 12-well format
at approximately 30% confluence and infected with 2, 20 or 200 ng of p24 in
duplicate in 0.5 mL culture media for 8 hrs. The medium was then changed and
cells incubated for an additional 36 hrs before being trypsinized and serially
diluted in complete medium supplemented with 5 µg/mL Blasticidin-S HCl
(Invitrogen). Cells were cultured for an additional 6 days before staining with a
fixing solution containing crystal violet. Colonies were counted to ascertain
relative integration frequencies.

2.2.4 Neutralization Assay
Neutralization assays were employed on the Env-3xFLAG tagged virus to
determine the effects of 3xFLAG insertion on the ability of a known V3-directed
neutralizing antibody, 447-52D (Gorny et al., 1992), and the ability of the M2 αFLAG mAb to neutralize Env-tagged infections. Neutralization was calculated as
reductions in luciferase or EGFP reporter gene expression after multiple rounds
of virus replication in the dual reporter suspension cell line, 5.25.EGFP.Luc.M7
(gift from Dr. N.R. Landau, New York University School of Medicine, New York).
The cell line is a genetically engineered clone of CEMx174, a fusion of 721.174
cells to the human T cell line CEM, and expresses multiple entry receptors: CD4,
CXCR4, GPR15/Bob and CCR5 (Brandt et al., 2002). It also possesses Tatresponsive reporter genes for both luciferase and the green fluorescent protein
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(GFP). These cells were maintained in growth medium containing puromycin (0.5
µg/mL), G418 (300 µg/mL) and hygromycin (200 µg/mL) to preserve the CCR5
and reporter-gene segments.

For neutralizing assays, 10 ng and 100 ng p24 of cell free R7/3 WT and the
infectious clone with 3xFLAG tag insertion in the V2 region (R7/3-Env-3xFLAG)
were incubated with different dilutions of the M2 α-FLAG (0.4-100 µg/mL) or a
conventional HIV-1 neutralizing antibody, 447-52D (0.1-25 µg/mL) for 1 hr at
37oC in a 24-well plate. A 100 µL suspension of susceptible cells (5x105
cells/mL) was then added to each well. The virus-antibody complexes were
adsorbed to 5.25 M7 cells for 12 hrs at 37oC. Unbound viruses and antibodies
were removed by centrifugation and washing with PBS. One well received cells
plus virus in the absence of antibody as a viral control for productive infection.
Another set only received cells and was used as the background control. The
reverse transcriptase inhibitor, AZT (10 µM) was added to one well of the
infections with no antibody as an additional control. Plates were incubated for 3
days or until approximately 10% of the cells in the virus control wells were
positive for GFP expression as determined by fluorescence microscopy. At that
time, 100 µL of cell suspension was transferred to a 96-well white solid plate
(Costar) for measurement of luminescence by use of Bright-Glo substrate
solution (Promega), in accordance with the manufacturer’s instructions.
Neutralization titers were considered positive when relative luminescence units
(RLUs) were reduced by either 50% compared with the viral control wells without

36

added antibody and subtracted for the background signal.

2.2.5 Flow Cytometry
To investigate the effect of neutralizing antibodies on the 3xFLAG insertion into
Env, 20 ng p24 of either R7/3 WT or Env-3xFLAG were incubated with different
dilutions of M2 α-FLAG (2-100 µg/mL) or neutralizing antibody 447-52D (0.5-25
µg/mL). After incubation for 1 hr at 37oC, the virus-antibody mixtures were added
to semi-confluent GHOST(3)X4R5 cells in 24-well plates, and spinoculated at
2100 rpm for 1 hour. After incubation for an additional 4 hrs at 37oC, unbound
viruses and antibodies were aspirated and the cells washed with PBS. One well
received cells plus virus in the absence of antibody as a positive control for viral
infection. Another set only received cells and was used as the background
control. Cells were rinsed with PBS and harvested 2 days post infection by
treating with trypsin-EDTA for 30 sec, and fixed in 4% para-formaldehyde before
analysis by flow cytometry (GFP fluorescence). A FACS Calibare (BectonDickinson) was used for analysis coupled with CellQuest software (BectonDickinson). Control staining was performed using uninfected cells. Results are
plotted as a frequency versus the log fluorescence of the signal or its geometric
mean.

2.2.6 Immunofluorescent Microscopy and Image Deconvolution
Hela P4R5 or GHOST(3)X4R5 cells were plated on glass coverslips with poly Llysine treatment (0.01% solution, Sigma) at 20% confluency in 24 well plates.
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Cells were infected on the second day with 10 ng of tagged or wild type viruses
and incubated for an additional 48 hours. Alternatively, cells were plated to 30%
confluency and analyzed over time. For the time course study, cells were
infected with 10 ng of tagged or wild type virus at 9-hour intervals until 36 hours
post-infection. Cells were then fixed for 30 minutes on ice with freshly made 3%
formaldehyde/PBS (Tousimis), and permeablized with 3% formaldehyde, 0.2%
Triton in PBS for 15 minutes on ice. After blocking with 1% goat serum/PBS for
15 minutes, cells were incubated for one hour at room temperature with
monoclonal M2 FLAG antibody (4.8 µg/µL, Sigma) at 1:2,000 dilution in PBS
containing 1% goat serum. Following the primary antibody incubation, cells were
washed with PBS/0.1% Tween and incubated for an hour at room temperature
with the fluorescein-conjugated secondary antibody, Alexa 594 Fluoro-coupled
goat α-mouse antibody (Molecular Probes), at 1:500 dilution in PBS/1% goat
serum. After three washes in PBS/0.1% Tween, cell-coated coverslips were
removed from the plate and left to air dry briefly. One drop of Vecta-Shield
mounting media containing 4,6-diamino-2-phenylindole (DAPI) for nuclear
staining (Vector Laboratories, Burlingame, CA) was added to each microscope
slide. Alternatively, nuclei were stained with 0.8 µM bis-benzimide (Sigma,
Hoechst No. 33258) in PBS. The coverslips were then placed on slides, cell side
facing down on top of the mounting media and sealed with nail polish.

An inverted DeltaVision optical sectioning microscope (Applied Precision) was
used to collect between 10 and 20 images spaced at 0.2 µM through the slide
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using standard FITC, Cy5 and rhodamine filters. Images were acquired with a
60x oil immersion objective. The images were deconvolved through 15 iterations
using the DeltaVision deconvolution software (Applied Precision). 3D volume
reconstructions and sections were obtained by compiling the deconvolved
sections with the Softworx software (Applied Precision).

2.2.7 Pilot Immunoisolation Experiments
A small-scale Immunoprecipitation experiment was performed to investigate the
efficiency of isolating 3xFLAG tagged viral proteins. Viruses were produced as
described above. Infection was initiated in 1x106 CEM cells in T25 flasks with
viruses tagged with the 3xFLAG tag in integrase or envelope gp120 (R7/3-IN3xFLAG or R7/3-Env-3xFLAG, respectively) equivalent to 10 µg p24. Cells were
harvested by centrifugation at 1000 rpm for 5 min six days post infection or when
most of the cells in the culture were involved in syncytia formation. After washing
twice with PBS, cell pellets were resuspended in 500 µL modified RIPA buffer (50
mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate and
0.1% SDS) in the presence of CompleteTM protease inhibitor (Roche). After 30
min incubation at 4oC, lysates were sonicated with a Sonic Dismembrator 500
(Fisher Scientific) and cleared by 10 min of centrifugation at 14,000 rpm at 4oC.
Cell lysates were incubated with 0.2-0.5 mg of Epoxy 270 Dynabeads
(Invitrogen) conjugated with M2 α-FLAG (Sigma) for 1 hr at 4oC with gentle
rotation. After 6 washes with modified RIPA buffer, proteins were eluted with 20
µL of 1x LDS sample buffer (Invitrogen). For western blot analysis, eluted
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proteins as well as equal percentages of the total lysate and flow through were
separated by electrophoresis on Novex polyacrylamide gels (Invitrogen), and
then

transferred

to

polyvinylidene

difluoride

membranes

(Amersham

Biosciences). The membranes were incubated with 1 µg/mL M2 α-FLAG mAb for
3xFLAG-tagged

viral

protein

detection.

A

sheep

α-mouse

horseradish

peroxidase-conjugated antibody (Amersham Biosciences) was utilized as
secondary antibody and the reactive proteins visualized using the ECL-Plus
Chemiluminescence System (Amersham).

2.3 Identification of Cellular Proteins Interacting with Tagged
Viral Proteins During Infection
2.3.1 Virus Production
For the integrase or Env gp120 3xFLAG tagged viruses, viral stocks were
produced by transfecting HEK293T cells in T75 flasks with 8 µg proviral DNA
using 70 µg PEI. After changing media with 12 mL fresh RPMI 18 hrs later,
supernatants were harvested 40 hours post transfection at 1,000 rpm for 5 min,
aliquoted and frozen at –70oC. Viral production was quantified by p24 ELISA as
described above. For virus with 3xFLAG tag in Vif, viral stock was generated by
transfecting 293-APOBEC3G-HA under the same conditions.
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2.3.2 Infection and Culture Expansion
Human T-cell lines, CEM (Vif-permissive) and MT2 or HuT78 (both Vif-restricted
cell types), were maintained in RPMI 1640 medium (Invitrogen) supplemented
with 10% FBS and Pen/Strep. For 3xFLAG tagged IN or Env viruses, CEM cells
from 40 ml of logarithmically growing culture were concentrated by spinning at
1,000 rpm for 5 min. Viral supernatants of 5 µg of p24 were added to cell pellets
and additional RPMI were added to give 10 mL of total volume. The virus-cell
mixture was spinoculated at 2,300 rpm at 20oC for 1 hour. An additional 30 mL of
fresh RPMI was added to the culture and incubated at 37oC. Input virus was
removed by washing the cells three times with PBS 18 hours post-infection.
Infected cells were resuspended in 120 mL of fresh RPMI in T175 flasks.
Infections were expanded 1:3 every other day in T175 flasks. An additional 5x107
uninfected CEM cells were added to each flask when they were “blossoming”
with microscopic syncytia formation. Infected cells were harvested six days post
infection. In each infection, there was approximately 1 L of suspension culture
collected. For the Vif 3xFLAG tagged viruses, human T-cell lymphoma HuT78
and MT2 cells were used as host cells for infection. The rest of the steps for
these cell types were similar to the procedure outlined above for CEM cells.

2.3.3 Conjugation of Magnetic Beads with Antibody
A suitable amount (20-60 mg) of M-270 Epoxy Dynabeads (Invitrogen) were
washed three times with 1 ml of 0.1 M sodium phosphate buffer, pH 7.4. During
the second wash, the beads were incubated with shaking for 10 min at room
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temperature. After the third wash, cells were resuspended with M2 α-FLAG mAb
(Sigma) at the ratio of 10-20 µg of antibody per mg of beads. Sodium phosphate
buffer (0.1 M) was added to bring the total volume to 13.3 µL/mg of beads. After
gentle mixing, 6.7 µL/mg beads of 3 M ammonium sulfate was added to give a
total volume of 20 µL/mg of beads. The mixture was incubated at 30 °C overnight
with gentle rotation. Following conjugation, the solution was removed after
applying a magnetic field. 0.1 M sodium phosphate buffer was immediately
added to the beads. Subsequently, the coupled magnetic beads were washed in
the following order: 100 mM glycine-HCl pH 2.5, 10 mM Tris pH 8.8, freshly
prepared 100 mM triethylamine solution, four washes with PBS, one 15-min
wash with 0.5% Triton X-100 in PBS and one final wash with PBS. Beads were
stored in PBS/0.02% NaN3 at 0.1 mg beads/µL at 4 °C up to a month.

2.3.4 Cell Disruption and Cell Lysis
Approximately 1 L of CEM cells infected with R7/3 with 3xFLAG insertion in
either IN or Env, and HuT78 infected with viruses 3xFLAG tagged in Vif were
harvested six days post infection by centrifugation at 1,000 rpm. In addition, viral
particles from 1 mL of the cell-free supernatant were concentrated following the
procedures described above. Cells were disrupted and lysed based on the
successful development of a cryogenic method (Cristea et al., 2006; Cristea et
al., 2005). After washing the cell pellets twice with PBS, the cell pellets were
weighed and resuspended at the ratio of 300 µL/g of cells in 20mM HEPES, pH
7.5, 1.2% (w/v) polyvinyl-pyrrolidone (PVP, Sigma) with a protease inhibitor
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cocktail (Roche) and integrase inhibitor Merck-0812 at 2 µM (Merck). The cell
mixture was dripped into liquid nitrogen by careful pipetting and then snap frozen
to form small pellets of uniform size. Lysis buffer was formed into frozen pellets
as well. Lysis buffer is 20mM K-HEPES, pH 7.4, 110mM KOAc, 2mM MgCl2,
0.1% Triton, 0.5% deoxycholate, 300mM NaCl, 25 units /mL DNase I (Roche)
supplemented with protease inhibitor (Roche) and HIV-1 integrase inhibitor.
Snap-frozen pellets were also made by pipetting the complete lysis buffer into
liquid nitrogen. Pellets from each viral infection was combined with lysis pellets
formed from 2 mL lysis buffer and loaded into a 25 mL metal grinding jar and
topped with a 20 mm tungsten carbide grinding ball. Cells were disrupted by
cryogenic grinding using Retsch MM 301 Mixer Mill (Retsch). The grinding was
completed in 6 cycles at 30 Hz for 3 min. The jars were recooled in liquid
nitrogen between cycles to prevent sample thawing. After grinding, the jars were
kept closed on ice until the grounded cells and lysis buffer thawed and mixed in
the liquid phase. After a brief spin of the contents of the jar in a preparative
centrifuge, the lysates were carefully collected. Additional lysis buffer was added
to give 6 mL lysis buffer in total per g of pelleted infected cells and used to rinse
the jar of any trace amount of lysate. Cell lysates were slowly rotated at 4°C for
15 min, vortexed vigorously three times for 30s followed by another incubation
with rotation for 10 min followed by an additional vortex. Cell lysates were then
centrifuged for 10 min at 3600 rpm at 4°C. The supernatant fraction was
transferred to a new tube and used for the affinity purification experiments. To
test extraction efficiency, the pellet formed after centrifugation was resuspended
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in 1 mL 1x LDS sample buffer and sonicated with a Sonic Dismembrator 500
(Fisher Scientific), heated at 90oC for 10 min and cleared by 10 min
centrifugation at 14,000 rpm.

2.3.5 Immunoaffinity Purification
Suitable amounts of α-FLAG conjugated magnetic beads (7 mg beads per gram
of infected cells) were washed three times with 1 mL lysis buffer. After the last
wash, the beads were divided into 200 µL aliquots in lysis buffer and added to
the soluble fraction of cell lysate from each infection. Cell lysate and beads were
incubated with gentle rotation at 4 °C for 1 hour. The magnetic beads were
concentrated by applying a magnet field. The column flow-through was collected
to test the efficiency of protein recovery. The beads were then washed six times
with 1 mL lysis buffer. The isolated protein complexes were eluted from the
beads by shaking gently for 20 min at room temperature with 500 µL of a fresh
0.5 N NH4OH, 0.5 mM EDTA solution. Samples were frozen on dry ice and dried
in a speed vacuum overnight. The lyophilized elutants were resuspended in 30
µL 1x LDS-PAGE sample buffer with reducing agent (Invitrogen). After heating at
70oC for 10 min with agitation, 100 mM iodoacetamide was added to the samples
and incubated at room temperature in the dark for 30 min to alkylate the reduced
cysteines.

Ten percent of each LDS sample buffer elutant was saved for Western Blot
analysis. The rest of the samples were separated on a 4–12% NuPAGE Novex
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Bis-Tris precast electrophoresis gel (Invitrogen). The gel was fixed with 16%
methanol and 10% acetic acid in water for 10 min and stained with Gel-Code
Blue Stain reagent (Pierce) according to the manufacturer’s fast staining
protocol. Briefly, the gel was rinsed four times and heated in a microwave twice.
Staining solution was added to cover the gel and heated until boiling, followed by
incubation at room temperature for 30 min with gentle shaking. Another staining
was performed to enhance the signals of protein bands. The gel was destained
by several rinses in double distilled water (ddH2O) and shaking for 20 min in
ddH2O. The destained gel was stored in ddH2O at 4oC until processing.

2.3.6 Mass Spectrometry
To identify the proteins in the gel, each lane of elution was cut from the gel and
excised into 24-26 1 mm wide slices. Two or three adjacent slices were
combined and then diced into 1mm3 cubes. They were destained in a solution of
50 mM ammonium bicarbonate and 50% acetonitrile with agitation at 4oC. After
discarding the solution, the gel pieces were dehydrated in acetonitrile, and in-geldigested with 12.5 ng/µL sequencing grade modified trypsin (Promega) overnight
at 37oC. The resulting peptides were extracted overnight at 4oC using reverse
phase resin POROS 20 R2 (Applied Biosystems) at the concentration of
approximately 1.25 g resin/L. After several washes in 0.1% (v/v) trifluoroacetic
acid (TFA), proteins were co-crystallized with 50% saturated α-cyano-4hydroxycinnamic acid (4-HCCA) in 70% (v/v) acetonitrile and 0.1% (v/v) TFA,
and subjected to mass spectrometry (MS) analysis.
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A matrix-assisted laser desorption ionization (MALDI) Orthogonal Time of Flight
(TOF) Mass Spectrometer (prOTOF 2000, PerkinElmer) was used for peptide
fingerprinting (MS). An in-house built MALDI interface coupled to an ion trap
(Krutchinsky et al., 2001) (LCQDECAXPPLUS, Finnigan) and a vacuum-MALDI ion
trap (vMALDI LTQ, Finnigan) were used for amino acid sequence analysis
(MS/MS). External calibration was performed using a standard peptide mixture.
Computer algorithms, such as XProteo (http://www.xproteo.com) were used to
correlate peptide mass fingerprint data obtained from MS analysis.

2.3.7 Immunoblot Analysis
Cell lysates and viral particles were prepared as described above. For Western
blot analysis, 0.1% of the total lysate, flow through, insoluble pellet and 1% of
each elution as well as the beads after elution were loaded on the gel. Samples
were treated as described above. After transfer, the membrane was probed with
1 µg/mL primary antibody M2 α-FLAG mAb for 3xFLAG-tagged viral protein
detection. A sheep anti-mouse horseradish peroxidase-conjugated antibody at
1:10,000 was used as the secondary antibody. Proteins were detected as
described above.
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2.4 Identification of Host Proteins that Interact with HIV-1
Integrase Fusions—IN Interacts With RNA Helicase A
2.4.1 Plasmid Construction
To identify cellular proteins that interact with integrase in the cytoplasm and/or
the nucleus, an expression construct of integrase fused to the C-terminal of
EGFP (EGFP-IN) was constructed by cloning a modified integrase (mod
integrase gene, see below) into the vector, pEGFP-C1 (Clonetech). An
expression vector for the fusion protein EGFP-MBP-IN(SH3) was built by
inserting the maltose binding protein gene into pEGFP-C1 to make pEGFP-MBP
and then cloning the C-terminal Src homology-3 (SH3) domain of integrase
[residues 220-270 (Eijkelenboom et al., 1995)] at the C-terminal end of pEGFPMBP. As controls, an IN(SH3) NLS mutant with a triple Lys to Ala mutant
IN(SH3K(262/3/6)A) (Muesing, unpublished) and an unrelated SH3 DNA binding
protein, from the archaebacteria Sulfolobus solfataricus, Sso7d (Baumann et al.,
1994), were each constructed into pEGFP-MBP. In addition, IN(SH3),
IN(SH3K(262/3/6)A) and Sso7d were inserted into the bacterial expression vector,
pMAL (New England Biolabs), down-stream from the malE gene that encodes
MBP (di Guan et al., 1988) to make constructs, pMAL-MBP-IN(SH3), MBPIN(SH3K(262/3/6)A) and MBP-Sso7d.

The expression vector pcDNA-FLAG-His-RHA (Zhou et al., 2003) was kindly
provided by Dr. Chee-Gun Lee (University of Medicine and Dentistry of New
Jersey). The FLAG-His region was removed and replaced with a triple
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hemagglutinin (3xHA) tag to generate pcDNA-3xHA-RHA by PCR and molecular
cloning. For immunofluorescent studies, 3xHA at the N-terminal end of RHA was
replaced with 3xFLAG. An expression construct of HIV-1 integrase with 3xFLAG
insertion at residue 280 (pcDNA3.1-IN-3xFLAG) was generated by first
subcloning the XbaI/SacII integrase fragment of the R7/3-(XbaI/SacII)-IN3xFLAG proviral clone into the pcDNA3.1(+) vector. The majority of the integrase
gene upstream of the 3xFLAG insertion was then replaced by the corresponding
part of a synthetic integrase gene (mod) that destroys the inherent RNA
secondary structure of the native integrase gene while maintaining its amino acid
sequence. It has been designed to circumvent the lack of expression of the
native integrase gene and to obtain high level of IN expression – (Genbank
AF422697, Muesing, 2002) and (Cherepanov et al., 2000).

2.4.2 Immunoprecipitation of IN-3xFLAG, EGPF-IN or EGPF-MBPIN(SH3) Fusion Proteins and Associated Cellular Factors
HEK 293T cells in a P150 plate were transfected with 15 µg of the expression
construct, IN-3xFLAG, using PEI as described above. Transfection of
pcDNA3.1(+) DNA was used as control. After incubation for 40 hours, cells were
washed twice with PBS and lysed in a modified RIPA buffer (50 mM Tris-HCl, pH
7.4; 150 mM NaCl, 0.5% sodium deoxycholate, 1% NP-40 and 0.1% SDS)
containing protease inhibitors (Roche) at a concentration of 5 mL buffer per gram
of cells. After a 30-min incubation at 4 °C, lysates were sonicated with a Sonic
Dismembrator 500 (Fisher Scientific) and cleared by 10 min of centrifugation at
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20,000 relative centrifugal force at 4 °C. To isolate IN-3xFLAG as well as any
associated protein complexes, the cleared cell lysate was incubated with α-FLAG
conjugated Dynabeads at 4 °C for 1.5 hr and eluted in 30 µL 1xLDS sample
buffer (Invitrogen).

pEGFP-MBP-IN(SH3), pEGFP-MBP-IN(SH3K(262/3/6)A) and pEGFP-MBP-Sso7d
were expressed and similarly lysed. The efficiency of transfection was assessed
by the expression of green fluorescence. Approximately 0.9 g cells were
collected and cryogenically grinded as described above. The ground powder was
transferred to a 50 mL tube and 6 mL/g cells of lysis buffer of 20 mM HEPES, pH
7.4, 110 mM KOAc, 2 mM MgCl2, 0.1% Tween 20, 1% Triton X-100, 0.5%
sodium deoxycholate, 0.5 M NaCl, 25 U/mL DNase I and protease inhibitor
cocktail was added. The resulting lysate was homogenized for 10 sec with a PT
10-35 Polytron (Kinematica) and slowly rotated at 4°C for 15 min. After
centrifugation for 10 min at 3600 rpm at 4°C, the supernatant fraction was used
for the affinity purification experiments. Immunoaffinity purifications were
performed as described (Cristea et al., 2005) using 1 hour incubation with M-270
Epoxy Dynabeads (Invitrogen) coupled with α-GFP antibodies (in-house
prepared and as described above).

The MBP-IN(SH3), MBP or MBP-IN(SH3K(262/3/6)A) fusion proteins were
expressed in E. coli and 1 mL of crude extract in column buffer (20 mM Tris-HCl
pH 7.4, 0.2 M NaCl, 10 mM DTT, 1 mM EDTA) was lysed with a Sonic
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Dismembrator 500 (Fisher Scientific). After centrifugation, the supernatant was
incubated with 200 µL of amylose magnetic resin according to the manufacturer’s
protocol (New England Biolabs). After washing three times with 1 mL column
buffer, MBP fusion protein bound on amylose resin was divided into two. Each
half was incubated with the cytoplasmic or nuclear extracts of CEM cells
prepared using NE-PER isolation buffers according to manufacturer’s instructions
(Pierce). After several washes with column buffer, proteins bound to amylose
beads were eluted by adding 50 µL of 10 mM maltose.

Elutions were resolved on 10% or 4-12% Bis-Tris NuPAGE gels. Each gel was
fixed with 10% methanol and 7% acetic acid in water for 20 min and stained with
Gel-Code Blue Stain reagent (Pierce) according to the manufacturer’s staining
protocol. Bands of interest in IN-3xFLAG immunoisolations were processed as
described earlier and analyzed by DE-STR MALDI-TOF mass spectrometer. For
EGFP-IN, EGFP-MBP-IN(SH3) and MBP-IN(SH3) immunoaffinity isolations,
entire lanes on the gel were cut into 1-2 mm pieces and protein digested with
trypsin and analyzed by mass spectrometry using MALDI QqTOF MS.

2.4.3 Immunoprecipitation and Western Blots
Semi-confluent 293T cells on a 10-cm dish were transfected with 3 µg of
pcDNA3.1-IN-3xFLAG and 3 µg of pcDNA-3xHA-RHA using PEI. As control,
pcDNA3.1-IN-3xFLAG DNA or pcDNA3.1-3xHA-RHA was transfected with the
empty vector pcDNA3.1. 36 hours after transfection, cells were lysed and
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immunoprecipitated with 1 mg α-FLAG conjugated Dynabeads. Antibody-protein
complexes were eluted in 1x LDS sample buffer. Immunoblotting of the elutions
was performed using 1 µg/mL α-HA mAb (Covance) as primary antibody.
Reciprocal immunoprecipitation was also performed using α-HA conjugated
Dynabeads, and probed with 1 µg/mL M2 FLAG monoclonal antibody (Sigma).

2.4.4 Immunofluorescent Staining
For subcellular localization studies of RHA, 293T cells were plated on glycine
coated coverslips in 24-well plate format and co-transfected with p3xFLAG-RHA
and pEGFP-IN. After 36 hours of incubation, cells were probed for the presence
of 3xFLAG-tagged RHA with 2 µg/mL M2 FLAG (Sigma) mouse monoclonal
antibody. The staining and imaging using DeltaVision deconvolution microscopy
was performed according to protocol described above.

2.5

Investigation

of

HIV-1

Integrase

Post

Translational

Modifications
2.5.1 Characterization of HIV-1 Integrase Acetylation Mutants
The acetylation sites in HIV-1 integrase of R7/3 at lysine residues 264, 266 and
273 were mutated to arginine [K(264/266/273)R or 3R] by overlap PCR
mutagenesis and verified by DNA sequence analysis. A 1xFLAG tag at the
extreme C-terminus of integrase was inserted into the WT or 3R version of R7/3.
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To be consistent with the original finding (Cereseto et al., 2005), the 3R mutation
also was also constructed in the Bru IN background using overlap PCR
mutagenesis. Viral stocks were prepared by transfecting 1 µg of each proviral
DNA into 293T cells using 8 µg/mL PEI in 6-well plate format. 10 ng p24 of each
viral supernatant was used to infect 1.0 x 106 CEM-SS cells. 18 hours after
infection, cells were spun down to remove residual virus. After washing once with
PBS, cells were resuspended in 8 mL fresh media. 100 µL of the infected culture
was collected daily. Infection cultures were split 1:4 every 3 days. Viral titers
were determined by use of an exogenous reverse transcriptase (RT) assay
(Potts, 1990). The radioactive products of the RT reactions were spotted onto
DE81 paper, detected by phospho-imaging and quantified using ImageQuant 5.2
software. Independent viral growth curves were generated after infection of CEM
cells and monitored over a ten-day period using the accumulation of viral capsid
(p24) as an indication of viral propagation. Infection in HeLa P4R5 cells was
studied using 10 ng p24 of WT and 3R mutants in either R7/3 or R7/3 Bru IN.
Two days post-infection, cells were processed as described above.

Other single- or double-substitution mutants at IN residues 264, 266, and/or 273
were constructed into an otherwise isogenic background (R7/3) except using the
Bru IN sequence in place of the R7/3 IN. To investigate the possible co-receptor
dependency of the mutant phenotypes, WT and 3R mutants in R7/3- (CXCR4
usage), and R7/3 YU-2-derivatives (CCR5 usage) were constructed by replacing
the envelope coding sequence at gp120. EGFP-derivatives were constructed by
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replacing the first 250 base-pairs of the nef region of these clones so that the
successful infection could be monitored by the green fluorescence. In a 12-well
plate, HeLa P4R5 cells were infected with 10 ng of EGFP-R7/3, EGFP-YU-2 and
their corresponding 3R mutants to compare their dependence on CCR5 or
CXCR4 entry.

A genetic assay was employed to measure the respective integration frequencies
between the WT and mutant viruses. The WT and 3R mutant proviral clones
were recombined in such a manner to replace the nef gene with a dominant
selectable marker, the blastocidin D gene (bsd), which also incorporated
inactivating frameshift mutations in the genes, vpr and env. Vesicular stomatitis
virus (VSV)-G pseudotyped viral stocks were prepared by co-transfecting R7/3
BSD expression vectors with pCI-VSV-G into 293T cells. HeLa P4R5 cells were
plated in 24-well dishes at approximately 30% confluence and infected with 5 ng
p24 in 0.5 mL for 8 hrs. The medium was changed and the cells incubated for an
additional 36 hrs before being trypsinized and serially diluted into medium
supplemented with 5 µg/mL Blasticidin-S HCl (Invitrogen). Cells were cultured for
an additional week before staining with crystal violet. Colonies were scored to
determine relative integration frequencies.

For immunoprecipitations, semi-confluent 293T cells in 10-cm plate format were
transfected with 3xFLAG tagged IN or co-transfected with C-terminal HA tagged
p300 and pIN-3xFLAG. p300 with a 33 amino acid deletion in combination with a
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catalytic point mutant in HAT domain was obtained from Dr. Richard Eckner
(University of Medicine and Dentistry of New Jersey). As control, cells were
either transfected with pcDNA3.1 or pHA-p300. Cell pellets were lysed in 2 mL of
modified RIPA buffer (see above) with 10 mM sodium butyrate (a non-specific
inhibitor of all HAT enzymes) and a protease inhibitor cocktail. α-FLAG
conjugated magnetic beads were incubated at 4°C with cell extracts for 2 hours.
After incubation, the immunocomplexes were analyzed by Western blotting using
1

µg/mL

α-p300

(Abcam)

or

1

µg/mL

α-HA

(Covance).

Reciprocal

immunoprecipitations were performed using cells co-transfected with pHA-300
and pIN-3xFLAG using either α-p300 or α-HA conjugated magnetic beads
according to the protocol described here.

2.5.2 Integrase Phosphorylation by CKII in vitro
Expression plasmid pINSD-HisSol (Jenkins et al., 1995) encoding a 20 amino
acid histidine (His) tag (MGSSHHHHHSSGLVPRGSH-) at the N-terminus of
integrase with a single substitution of lysine for phenylalanine at position 185
(F185K) was obtained from Dr. Robert Craigie (NIH). This sequence also
contains a thrombin cleavage site LVPRGSH to allow removal of His tag after
purification. Proteins were expressed according to protocol (Jenkins et al., 1995).
In brief, plasmids encoding the recombinant IN and site-directed IN mutants were
expressed in E. coli BL21(DE3). Protein expression was induced by 1 mM IPTG.
Cells were harvested from 100 mL of LB broth containing 100 µg/mL Ampicillin
and lysed in 25 mM Hepes pH 7.5, 500 mM NaCl, 2 mM β-mercaptoethanol, 5
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mM imidazole and 0.3 mg/mL lyzozyme. The samples were incubated at 4oC for
30 min, the cells were sonicated three times at 1 min intervals. After
centrifugation at 14,000 rpm for 10 min, the supernatant was recovered and
applied to a 0.5 x 8 cm chelating Sepharose Ni-affinity column (Pharmacia). After
extensive washing with 20 mM and 60 mM imidazole in elution buffer of 25 mM
Hepes pH 7.5, 0.5 M NaCl, 2 mM β-mercaptoethanol, 10% glycerol, proteins
were eluted with a 1 M imidazole in elution buffer. The His tag was removed by
cleavage with thrombin (Pharmacia). Optional additional purification using
Heparin column chromatography (Pharmacia) was performed according to the
manufacturer’s protocol. Protein concentrations were measured by (BioRad).
Resulting proteins were stored in 30% glycerol at –30oC. Similarly, GST fusion IN
proteins were produced by replacing the His tag with GST. Proteins were purified
using Glutathione Sepharose 4B Microspin Columns according to the
manufacturer’s directions (Pharmacia). All potential phosphorylation mutants and
truncated forms of IN were constructed by restriction digestion and cloning.

The in vitro CKII assay was performed according to the following protocol (New
England Biolabs). One µg of the purified recombinant IN proteins and various
mutants were incubated with 5 U/mL CKII in CKII reaction buffer of 20 mM TrisHCl pH 7.5, 50 mM KCl, 10 mM MgCl2 in the presence of 200 µL rGTP and γlabeled

32

P ATP to a final activity of 200 µCi/umol at 30oC. The reaction products

were loaded onto a 4-12% NuPAGE gel and stained with Coomassie Blue and
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exposed overnight at –30oC. In a titration experiment, the amount of CKII was
serial diluted 1:3 starting from 50 U/mL.

Mutations of potential phosphorylation sites (S283A, T66A, T66A/S283A,
T95A/S283A, S195A/S283A and T95A/S195A/S283A) were incorporated in R7/3
proviral clone by restriction digestion and molecular cloning. Viral stocks were
produced and scored for syncytia formation in CEM cells as described above.
Viral growth was followed for 10 days post-infection.

For the immunoprecipitation studies, N-terminal 1xFLAG tagged IN was cotransfected with Myc-CKIIβ and HA-CKIIα or α’ subunits in 6 well plate format as
described above. 40 hours post transfection, cells were lysed in 200 µL/well lysis
buffer [50 mM Tris-HCl, pH 7.3, 150 mM NaCl, 5 mM EDTA, 0.2% Triton X-100,
and CompleteTM protease inhibitors (Roche)]. After a 30 min incubation on ice,
lysates were sonicated with a Sonic Dismembrator 500 and cleared by 10 min of
centrifugation at 14,000 rpm at 4 °C. For co-immunoprecipitation, cleared cell
lysates were incubated with the following antibodies: 1 µg/ml anti-HIV-1 integrase
mouse mAb12, 1 µg/ml α-FLAG mouse mAb M2 (Sigma), 1 µg/mL α-HA or αMyc at 4 °C for 1.5 hrs. Antibody-protein complexes were precipitated with
protein A-Sepharose (Amersham Biosciences) and resolved on a 10%
polyacrylamide gel. Immunoblotting was then performed as described above,
using appropriate primary antibodies.
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2.5.3 HIV-1 Integrase Ubiquitination (Ub)
The 3xFLAG-tag at IN residue 280 (IN-MOD) was recombined in such a way as
to express either a stable and unstable integrase protein (M-IN-3xFLAG vs. F-IN3xFLAG). These constructs specify either a methionine (M) or phenylalanine (F)
residue at the N-terminus of IN, dictating the inherent intracellular stability of the
produced IN protein (Mulder and Muesing, 2000). In accordance with the N-end
rule of Varshavsky, the intracellular half-life of M-IN is greater than 24 hours
while F-IN is less that 30 minutes (Mulder and Muesing, 2000). The mutant
pcDNA3-HA-Ub set (5 constructs) contain four tandem repeats of HA-Ub—each
mutant construct conservatively substituted with arginine in at all but one lysine
residue (K6, K11, K29, K48, or K63). The converse constructs were also
reconstructed. In this set, only one lysine is substituted with arginine. These
constructs are designated K6R, K11R, K29R, K48R, or K63R (Nishikawa et al.,
2004) and were kindly provided by Dr. Tomohiko Ohta (St. Marianna University
School of Medicine, Japan).

To test IN ubiquitination, 293T cells were transfected with 5 µg of Ub-(F)IN3xFLAG in 10-cm plate. As a control for FLAG immunoprecipitation, Ub-(F)IN
was transfected alone. Cells were lysed 30 hrs post transfection in RIPA buffer
and immunoaffinity isolated as described above. Magnetic bead elutions were
evaluated using Western blot analysis with either 1 µg/mL M2 α−FLAG MAb or a
1:1000 dilution of a polyclonal antibody.
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IN the definitive experiments, HEK 293T cells were co-transfected with 0.5 µg of
pUb-(M)IN-3xFLAG or pUb-(F)IN-3xFLAG with each set of the ubiquitin
expression constructs in 6-well plate format. Cell lysates were prepared with a
modified RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% SDS, 0.5%
deoxycholate and 1% NP-40) that included a cocktail of protease inhibitors
(Roche) and incubated for 30 min at 4oC. The lysates were then sonicated for
three times at 10 sec intervals, and the lysates clarified by centrifugation at
14,000 rpm for 10 min at 4oC. Dynal magnetic beads conjugated with M2

α−FLAG antibody were incubated with the supernatant for 1 hr at 4 °C as
described earlier. After 6 washes with lysis buffer, samples were eluted in 20 µL
1xLDS sample buffer (Invitrogen). After electrophoresis, proteins were analyzed
by immunoblotting using the α-FLAG monoclonal antibody.

For mass spectrometry analysis, 293T cells were transfected with the pcDNAUb-F-IN-3xFLAG and the Ub expression clone with single lysine at residue 29
(pcDNA3-HA-Ub29K) on P150 plates and cultured for 2 days. Pilot experiments
determined that when 29K is expressed with Ub-F-IN (all of the other reactive
lysines residues are substituted with arginine in this construct), mono-Ubsubstituted IN was greatly enhanced. Cells were removed from the plates by
scraping and washed once with PBS. Approximately 150 mg of cells were lysed
and sonicated as described above. After centrifugation, the cleared lysate was
immunoprecipitated with 6 mg of Dynabeads conjugated with α-FLAG
monoclonal antibody and separated on SDS-PAGE gel. The gel was fractionated
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and the slices corresponding to the 36 kDa (IN-3xFLAG) and 44 kDa (IN3xFLAG-Ub) were cut from the Coomassie-stained gel and subjected to tryptic
digestion. Sequence analysis of the digested fragments was performed by DESTAR MALDI-TOF mass spectrometry (Applied Biosystems) and MS/MS
analysis was performed on QSTAR XL tandem mass spectrometry with the
hybrid quadrupole time of flight configuration (Applied Biosystems). Data was
analyzed using Analyst QS software from the manufacturer.
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Chapter 3: Generation of Replication-Competent
HIV-1 that Can Accommodate a Potent Antigenic
Tag

3.1 Introduction
To identify cellular proteins that interact with a particular viral protein by high
affinity immunoprecipitation, the first step is the generation of replicationcompetent viruses with small but recognizable tags. Potent epitopes such as
FLAG or 3xFLAG provide high-affinity and specific binding to antibody and have
been very popular for immunoprecipitation and protein-protein interaction studies
(Prickett et al., 1989). Therefore, the 3xFLAG tag was chosen as the primary tag
for our studies. As described above, replication competent viruses were
recovered through a stringent biological selection from libraries of viruses that
had randomly incorporated a small insertion (PmeI) at a unique location within a
specific viral coding region. These ‘linker-scanned’ insertional libraries were
created using a Tn7-based transposon system that produces a unique PmeI
restriction site insertion (the ‘linker’) placed randomly throughout the target DNA
(Biery et al., 2000). This transposon-based mutagenic strategy was adopted
because of its ability above all other systems to provide random insertion into the
target DNA and to as well rapidly generate many independent clones. Linker
scanning mutagenesis is a genetic method that has been used to study protein
structure in efforts to identify and analyze functional domains or genes (Barany,
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1985; Goff and Prasad, 1991; Stone et al., 1984). It has been previously been
used rapidly identify essential and nonessential in herpes viral genes (Brune et
al., 1999), the env gene of moloney murine leukemia virus (Rothenberg et al.,
2001) and the HIV-1 genome by genetic footprinting (Laurent et al., 2000).
Recently, viable Hepatitis C viral (HCV) clones have been generated using a
random linker insertion mutagenic approach into insert the gene for the green
fluorescent protein (GFP) into the HCV nonstructural protein 5A (Moradpour et
al., 2004) as well as the Sindbis (SINV) E2. In the latter case, an insertion of a 19
residue

transposon

or

GFP

was

recovered

(Atasheva

et

al.,

2007;

Navaratnarajah and Kuhn, 2007). Indeed, these studies have led to the
characterization of viruses that are capable of accommodating an exogenous
insertion and in these cases could be used for viral protein visualization or their
facile purification.

Independently, we have created transposon-based linker insertion libraries in
three of the nine HIV-1 viral genes: integrase (in), envelope gp120 V1-V3 region
(herein env) and the viral infectivity factor (vif). IN is an essential, multi-functional
viral protein and has been our main research interest. Vif function was unknown
at the time when this study was initiated. The Env V1 to V3 loop is highly variable
and we suspected that it would be likely to tolerate insertions. These transposon
libraries and the tagged-yet-infectious HIV-1 particles derived from them are the
first examples of applying this strategy to HIV-1. A TnsABC transposase-based
system was adopted to allow random and unique insertion of a Tn7 based
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transposon, a transposable element, into a plasmid of interest in vitro (Biery et
al., 2000; Craig, 1996; Stellwagen and Craig, 1997). Importantly, Tn7 is very
nonspecific with respect to site of transposition and is almost completely random
with respect to insertion within AT-rich sequences, such as the HIV-1 genome. In
addition, immunity is established after the completion of the first transpositional
reaction ensuring only one insertional event into all but less than 1% of the target
DNA molecules.

Briefly, a library of plasmids with random insertions was selected based on a
drug resistant marker gene encoded by the transposed DNA segment.
Subsequently, the transposon, flanked by restriction sites (PmeI) and absent in
the original plasmid, was excised by PmeI digestion. This results in a library of
plasmids with insertion of a 15 base-pair (bp) segment specifying a unique and
blunt-ended PmeI site randomly throughout the targeted viral gene DNA. Using
this methodology, we have constructed libraries of tagged HIV-1 proviral DNA
each containing a unique PmeI site within HIV-1 integrase (in), its C-terminal
domain (in-ctd), env and vif genes.

Infection of susceptible T-cell lines with a population of viruses prepared from the
PmeI insert-bearing library provides a stringent step of biological selection for
viruses capable of both robust survival in culture and capable of accommodating
a five amino acid foreign peptide segment (the 15 bp insertion that includes the
unique PmeI site in the sequence of its cognate DNA). To recover viral DNA of
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replication-competent clones, small circular viral DNA was isolated and amplified
from infected cells after selection in culture over several rounds of viral
replication. For all retroviruses, proviral DNA must be integrated within the host
chromosomal DNA in order to serve as an active template for the expression of
retroviral genome. However, typical of all retroviruses including HIV-1 is the
appearance of extrachromosomal, covalently closed circular viral DNA (vCCC
DNA) in the nucleus of the infected host (Gianni et al., 1975; Roth et al., 1990).
Their structures are consistent with their formation by either their homologous
recombination across the LTRs of a linear pre-proviral DNA precursor, the 1-LTR
circle, or by host-mediated ligation of the LTRs of the linear precursor (2-LTR
circle). Although the circular viral DNAs are transcriptionally silent remnants of
failed attempts during retroviral integration, they are exact but circular copies of
the linear integrated provirus (Jurriaans et al., 1992). The circular viral DNA is
stable and persists in the nucleus for the lifetime of the infected cell (Cunningham
and Muesing, unpublished results). This feature allows for the recovery of the
extrachromosomal DNAs from infected cells using standard isolation procedures
(Hirt, 1967). The low-molecular weight DNA obtained by Hirt extraction is an
enriched source of viral cDNA. We have been able to recover 1- and 2-LTR viral
DNAs prepared from infected mammalian cell cultures and then to subsequently
PCR amplify the viral coding region containing specific PmeI insertions from
replication-competent viral mutants.

In the end, we used transposon-mediated mutagenesis to identify sites in the
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HIV-1 pol(in), env and vif genes where a 15 bp insertion could be incorporated
with minimal effect on viral growth. At the sites of PmeI insertion, a larger tag
such as 3xFLAG was subsequently inserted. Viable viruses harboring a 3xFLAG
in the C-terminal domain of integrase (CTD), the base of the V2 loop of gp120
and in a unique internal region of the Vif protein were all recovered. Stable
maintenance and recovery of these tagged viruses have been accomplished in
human T-cells.

3.2 Results
3.2.1 Generation of Proviral Plasmid Libraries with PmeI Insertion
Libraries of proviral DNA with random transposon-generated insertions have
been created in vitro. Since the transposed DNA segment (transprimer) encodes
a drug resistant marker (specifying either kanamycin or chloroamphenicol
resistance), recovery of plasmids with an insertion is accomplished by bacterial
growth in the appropriate antibiotic. Because the transposon is unable to
replicate on its own (orinegative), only those target DNA molecules containing a
transprimer insertion are recovered. Most of the transposon can be excised to
leave behind a 15 bp segment specifying a unique and blunt-ended PmeI
restriction site placed randomly throughout the target DNA. In four out of six
reading frames, insertion leads to the addition of five foreign codons, the precise
sequence depending on the identity of the target site residues duplicated upon
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transposition (Figure 3.1), thereby ensuring a high probability for productive inframe insertions.
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Transposon (Tn7)

PmeI

TGTTTAAACACAAT..
ACAAATTTGTGTTA..

PmeI

..ATTGTGTTTAAACA
..TAACACAAATTTGT

Kanr

Target DNA
5’…TGAGGGGTGCCCACACTAATGAT…
…ACTCCCCACGGGTGTGATTACTA…5’
Transposition Reaction
5’…GCCCA TGTTTAAACACAAT..
r..ATTGTGTTTAAACA
…CGGGT ACAAATTTGTGTTA..Kan ..TAACACAAATTTGT

GCCCA…
CGGGT…5’

PmeI Digestion & Religation
5’…GGTGCCCA TGTTTAAACA
...CCACGGGT ACAAATTTGT

GCCCACAC…
CGGGTGTG…5’

10 bp PmeI insertion

5 bp Duplication

Reading Frames
+ strand

- strand

TGT TTA AAC AGC CCA
Cys Leu Asn Ser Pro

TGT TTA AAC ATG GGC
Cys Leu Asn Thr Gly

CAT GTT TAA ACA GCC
His Val STOP

GCT GTT TAA ACA TGG
Ala Val STOP

ATG TTT AAA CAG CCC
Met Phe Lys Aln Pro

CTG TTT AAA CAT GGG
Leu Phe Lys His Asn

Figure 3.1 Generation of 5 amino acid insertions by a transpositional
methodology, (modified from Biery, Stewart et al. 2000). For illustrative purposes,
the target DNA sequence shown was selected randomly from the DNA sequence
of the HIV-1 integrase.
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There were several generations of libraries produced along the way for each viral
gene of interest. The viral gene fragments (in, in-ctd, env gp120 v1-v3 and vif)
from the transpositional libraries were first subcloned into pBS-KS(-), a much
smaller plasmid (3 kb) than the original proviral clone (16.4 kb) to maximize the
number of insertional events occurring within the selected viral coding regions.
The first set of libraries pBS-KS-in (or in-ctd, env, vif)/Tn was generated after in
vitro transposition and resulted in the random insertion of the transposon carrying
a Kanamycin resistant (Kanr) gene throughout the pBS-KS plasmid. To identify
those plasmids with insertions specifically in the viral coding region, a second
generation of libraries, R7/3-in (or in-ctd, env, vif)/Tn was created after reintroducing each transposed viral gene into a proviral vector (R7/3). This was
done by restriction digestion to release a population of fragments with random
Kanr transposon sites within the particular viral gene of interest generated in the
first set of libraries. Since the fragments harboring a Kanamycin resistant
transposon are 1.7 kb larger than the ones without insertions, they can be
separated and purified by their mobility difference from the wild type viral gene by
cleaving with an appropriate pair of restriction enzymes followed by agarose gel
electrophoresis. The viral DNA fragments containing transpositional insertions
were then cloned into proviral R7/3 clone to create a proviral library with random
transposon insertions within the target gene. Plasmids containing the transposon
were selected by plating on LB plates containing both Kanamycin and Ampicillin
to ensure that the new R7/3 library contained an insertion within the targeted
gene. Finally, PmeI digestion of the second transposon library eliminated the
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Kanr gene and generated the third libraries, R7/3-in (or env, vif)/PmeI, which
contain a random 15 bp insertion within each of the viral genes originally
targeted. Libraries with random 15 bp insertions were recovered on LB Ampr
plates. The scheme for generation of proviral libraries with random15 bp insertion
is shown in Figure 3.2.

The number of colonies (each arising from an independent transpositional event)
was determined for the second and third set of libraries. They ranged from 4x104
for the env v1-v3 library to 7x104 for vif. The number of clones required to assure
insertion after every base pair depends on the size of the target, the desired
interval between linker insertion sites and possible inclusion of the regions of the
plasmid required for its maintenance (i.e. the origin of replication and the
selectable marker) in the target. The number of clones that mathematically
guarantees insertion after every base pair along the target viral gene was
calculated based on the Poisson distribution (Pfeiffer and Schum, 1973). Here,
according

to

the

Poisson

distribution

calculation

http://hyperphysics.phy-astr.gsu.edu/hbase/math/poifcn.html),

each

(Website:
library

contained enough diversity to assure 99% probabilistic insertion of the tag after
every base in each of the targeted viral gene.
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R7/3

integrase

XbaI

PBS-KS(-)
~3 kb

864 bp

MluI

Cloning

PBS-KS-in

Ampr
MCS

integrase

ori
Tn7 transposase ( Δ )

Transposition
Reaction

+

Kanr

Δ

Δ
Ori- transprimer

MluI
Ampr
[pBS-KS-in]/Tn
Library

MluI

or
Kanr

XbaI

XbaI
Restriction
Digestion

Kanr
or

(Continued on next page)
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(Continued from previous page)

XbaI

MluI
Kan

R7/3-in/Tn Library

r

Cloning

+
Kanr

R7/3

PmeI

PmeI
Digestion &
Self Ligation

Random insertion of PmeI (5
amino acids) within specific
viral coding region

R7/3-in/PmeI Library

Figure 3.2 Scheme used to generate a proviral library with random and unique
PmeI restriction site insertion. For illustration, the outline of the strategy
employed to generate the proviral library with 15 bp PmeI insertions in the HIV-1
integrase gene.
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Restriction digestion was employed to give a qualitative assessment of the
randomness and uniqueness of the libraries with 15 bp PmeI insertion. DNA from
the PmeI proviral plasmid library was cleaved with PmeI and the unique,
stationary enzyme, BamHI. BamHI is unique within R7/3 and its restriction site
lands in a non-targeted portion of the clone. Using the mixed population of
transposed Pme I sites within the XbaI-in-MluI library as an example (illustrated
in Figure 3.3A), if the PmeI insertion is unique and random within the integrase
coding region, digestion will result in bands with sizes ranging from BamHI-MluI
(3.3 kb) to BamHI-XbaI (4.2 kb). A visual representation of the large diversity
generated in the PmeI-modified libraries is shown in Figure 3.3B. The smears on
agarose gel were observed in R7/3-in/PmeI and R7/3-vif/PmeI, as well as the
other proviral libraries R7/3-in-ctd/PmeI and R7/3-env(v1-v3)/PmeI. At least at
this level of resolution, this result indicated the unique and random distribution of
the transposed PmeI insertion throughout the entire targeted viral gene segment
in the tagged proviral libraries.
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A.

B.
IN Vif Marker (bp)

8454
XbaI
BamHI

MluI

4324
3675

PmeI

2323

Figure 3.3 Illustration of the random distribution of the PmeI site throughout the
targeted viral gene as determined by digestion with PmeI and a unique stationary
site (BamHI) outside of the targeted region. (A) A schematic representation of the
restriction digestion. Digestion is predicted to result in bands with sizes ranging
from 3.3 kb (BamHI-MluI) to 4.2 kb (BamHI-XbaI) for the R7/3-in/PmeI library,
and 2.9 kb to 3.3 kb for R7/3-vif/PmeI library. (B) Distribution of Pme I sites within
the R7/3-in/PmeI or R7/3-vif/PmeI library. DNAs from the R7/3-in/PmeI and R7/3vif/PmeI libraries were cleaved with PmeI and BamHI. Brackets indicate range of
the smears.
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3.2.2 Stringent Biological Selection for Replication-Competent HIV-1
with PmeI Insertion
As outlined in Figure 3.4, a population of HIV-1 particles with a 5 amino acid
insertion at random locations within a specific target viral gene were produced by
DNA transfection from each of the proviral plasmid libraries, the DNA pooled
together from each library before transfection. Given that each virus is distinct
from the other members in the library by the location of the insertion within the
specific viral protein, insertions that are in incorrect reading frames or disturb
critical positions in the viral proteins will not be able to pass through the next step
of biological selection (viral replication). Thus, infection of susceptible T-cell lines
was initiated with the heterogeneous viral stocks prepared from each of the PmeI
insert-bearing libraries and followed over several days. Sustained viral
propagation in tissue culture was visualized microscopically by the formation of
multinucleated syncytia, which is created by the fusion of infected T cells with
others via gp120 and CD4 interactions between cells in culture. A population of
viruses that could survive this stringent biological selection was subsequently
established during multiple rounds of viral passage. Diverse circular viral DNAs
(1-LTR or 2-LTR circles) generated during this selective process were then
recovered by Hirt extraction. The targeted viral DNAs within the recovered
circular viral DNAs were amplified by PCR and characterized with respect to tag
location in the viral gene by either restriction enzyme digestion and/or DNA
sequencing.
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+
293T cells

Transfection

R7/3 library with PmeI (5
a.a.) within specific viral
coding region

+
T cells
Infection
Several Passages
Survival of ReplicationCompetent Viruses

Hirt Extraction for vCCC DNA
Viral Circles of ReplicationCompetent Viruses with PmeI
PCR & Cloning

Recovery and Amplification of
Individual Proviral Clones

Test for Maintenance of
Replication Competency

Figure 3.4 Scheme for the selection and recovery of insert-bearing replication
competent viruses.
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In this way, viruses that were able to accommodate insertions within the
integrase C-terminal domain, Vif, and Envelope V1 to V3 region have been
recovered. DNA fragments containing novel PmeI insertions were amplified by
PCR of the covalently closed circular (CCC) viral DNA using oligonucleotide
primers flanking the viral gene of interest. Figure 3.5 shows the PCR analysis of
viral DNA recovered from viruses with PmeI insertion in the C-terminal domain of
integrase (in-ctd). If there is insertion within this region, PmeI digestion of the
PCR product will result in two fragments. Alternatively, if an intact fragment is
observed after PmeI cleavage, this indicates that the PmeI insertion was
eliminated. The significant amount of the intact, uncleaved PCR fragment
indicates that intragenic recombination had occurred within the in-ctd in infected
culture. Similar results were observed for other proviral libraries. As shown in
Figure 3.5, the wild-type virus emerged fairly early during infection of R7/3-inctd/PmeI library. Although the wild-type virus persists, it does not dominate the
infection. Interestingly, some clonally marked viral species were detected five
days after infection and were able to out-compete with the wild type recombinant
for the remainder of the culture period. This ‘battle’ was evident as demonstrated
by PmeI digestion of PCR products obtained from viral CCC DNA at various
times after infection. The increasing intensity of the bands corresponding to the
PmeI inserted clone indicates the ability of some of the PmeI-inserted
recombinant viruses to strongly compete against the wild-type over time.
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days post-infection
mw
9

3

4

5

7

Figure 3.5 Time course of the appearance of competing viral species during
selection for replication. vCCC DNA was recovered at various times after
infection of CEM cells with the R7/3-in-ctd/PmeI proviral library (dpi, days postinfection). Two PmeI digested PCR fragments are expected for viruses harboring
a unique PmeI site. An early PmeI-viral clone that appears at days 3 and 4 (white
arrows) is replaced with another viral clone after day 5 (black arrows). The single
uncleaved product is observed for the wild-type recombinant virus (star) and
emerges and persists after day 3.
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The purified PCR fragments from both 2 days- and 7 days-post-infection were
cloned into the R7/3 proviral vector and individual colonies selected for DNA
purification. The existence of a PmeI site was verified by restriction digestion in
the individual clones. For samples collected 2 days post infection, 10-40% of the
colonies examined had PmeI insertion. However, by day 7, most of the colonies
isolated were wild type except for the PmeI-bearing clone from the R7/3-inctd/PmeI library. In order to determine the exact location of the PmeI insertions,
all R7/3 plasmids with PmeI insertions were sequenced with primers flanking the
specific coding region. For each viral gene in the study, approximately 10 clones
were sequenced. Many clones selected from one library were observed to have
identical or nearby points of insertion within the gene segment.

After reconstruction of each insertion into proviral clones, homogenous viral
stocks were produced by DNA transfection and subsequently used to infect
human T-cells in culture to confirm their replication competency. In this way, two
proviral clones with the PmeI site within the in-ctd were studied further: an inframe insertion at residue 280 and another added at residue 281 that resulted in
translational termination of the integrase reading frame at this position. For env:
two in-frame clones flanking the gp120 V2 loop region at residues 140 and 191,
and for vif: two clones with in-frame PmeI insertions at residues 150 and 161. All
of these PmeI viruses were confirmed as replication-competent by progressive
infection over time as observed by the assessment of syncytia formation. Visual
presentations of the locations of the insertions are shown in Figure 3.6.
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Integrase
1

288
280, 281

Env gp120 (V1-V3)
1

293
140

Vif
1

191

193
150 161

Figure 3.6 Schematic representation of the location of the PmeI site and its
corresponding 5 amino acid insertion (solid lines) or the one translational stop
codon insertion (dash line) within the proviral DNA. All are replication-competent.
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3.2.3 Insertion of 3xFLAG Tags at the Various PmeI Sites Result in
Replication-Competent Viral Clones
Each of the viable proviral clones originally selected through biological
competition was linearized by PmeI restriction digestion. The linear DNA was
then ligated to a 93 bp oligonucleotide pair that encodes a 3xFLAG tag at the
PmeI site. The 3xFLAG tag was chosen because of its relatively small size and
its extremely high antigenic reactivity with its respective, commercially available,
monoclonal antibodies. The 3xFLAG oligonucleotide pair was designed so that it
fused a short peptide reading frame when inserted properly but contained
translational stops in all of the other five reading frames. The viral-tag junctions
were designed to encode flexible amino acid adapter sequences comprised of
serine and glycine codons. To eliminate the possibility of incorporating multiple
monomeric units of the 3xFLAG tag into proviral DNA, a unique restriction site
(BlpI) was added to the 3xFLAG tag. This site does not appear within R7/3 or
with any of the R7/3-PmeI libraries. Therefore, any ligation event that result in
multiple additions to the ends of the vector DNA can be “cut back” with BlpI
digestion to eliminate replicate units of the tag. In addition, since BlpI recognizes
a non-abbreviated palindromic sequence, re-circularization of the vector can only
occur to recreate the original 3xFLAG sequence, preventing the occurrence of
clones that do not. Thus after ligation, the DNA was cut with BlpI, the linear
proviral DNA purified, recircularized by self-ligation and proviral clones with a
single 3xFLAG insertion created (Figure 3.7).
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Replication-competent
Proviral Clone

PmeI
Linearization

Ligation
3xFLAG
oligos
BlpI

BlpI

BlpI

Recircularization
by Ligation

Proviral clone with in-frame FLAG-tag
Figure 3.7 Scheme of the addition of a single 3xFLAG tag to a viable PmeI
proviral clone.
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R7/3 plasmids with 3xFLAG insertions were sequenced to verify the locations
and sequences of the insertions. Other tags such as 1xFLAG, a biotin acceptor
tag and Strep tag were also incorporated into proviral clones. Clones verified for
the correct in-frame tag insertion were used to produce homogenous viral stocks
and subsequently used to infect human T-cells in culture to test their respective
viral replication competencies. In the end, 3xFLAG insertion at IN residue 280,
Env V1-V3 191 and Vif 161 were all able to produce viable clones. They are
designated R7/3-IN-3xFLAG, Env-3xFLAG and Vif-3xFLAG. The rates of
syncytia formation are summarized in Table 3.
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Table 3. Qualitative rates of syncytia formation in tagged viral infections.
PmeI

3xFLAG

FLAG

SNAGG

IN (at 280)

++

+

++

+++

IN (STOP at 281)

++

NA

NA

NA

Env (at 140)

++

-

-

NA

Env (at 191)

++

++

++

+

Vif* (at 150)

++

-

+

NA

Vif* (at 161)

+++

++

++

NA

WT

+++

* Tests performed in the Vif-restricted T-cell types, MT2 or HUT78.
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3.2.4 Some 3xFLAG Insertions Produce Noninfectious Particles
As shown in Table 3, not all replication-competent PmeI viruses with 5 amino
acid insertions tolerate further addition of a tag sequence. For example, no
syncytia were observed when the 3xFLAG tag was inserted at residue 140 of
gp120. This suggests that this 3xFLAG insertion produced a defective virus
although PmeI (5 amino acid) insertion at the same site is a viable mutant.
Meanwhile, to confirm that the defective virions were produced after DNA
transfection, though noninfectious, virions generated by transfection of cells with
the defective proviral 3xFLAG-tagged DNAs were concentrated and examined by
Western blot. To investigate the extent of virion production and the fidelity of viral
Gag and Gag/Pol processing, virus produced from each clone was probed for
expression of the 1x or 3xFLAG tag (monoclonal M2 FLAG antibody) and probed
with a highly reactive serum from an infected individual (LSS) to ascertain the
overall status of the fully mature native viral epitopes. These results were
compared to that of the untagged wild-type R7/3 to determine if any defects
could be detected. As shown in Figure 3.8A, immunoblot analysis reveals that
the Env gp120 with 3xFLAG tag at residue 140 had low levels of 3xFLAG
expression, the disruption in expression probably related to the characteristics of
insertion at that particular location. Probing with patient serum LSS also indicated
a reduction of processed viral Gag proteins relative to the wild type virus. Similar
results were observed in a proviral clone with a 3xFLAG insertion at Vif residue
151.
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Figure 3.8 Immunoblotting of viral particles with 3xFLAG tag located within Env
gp120 from producer cells. Lane 1: wild type, lane 2: 3xFLAG insertion at Env
V1-V3 residue 140, lane 3: insertion at Env V1-V3 at residue 191. Probed with
(A) M2 monoclonal FLAG antibody or (B) LSS.
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3.2.5 The Expression of 3xFLAG Tagged Viral Protein is Stable and
Maintained over the Course of Long-Term Infection
Western Blot analysis of infected cultures or precipitated viral particles of R7/3IN-3xFLAG, Env-3xFLAG and Vif-3xFLAG collected up to 10 days post infection
were performed to investigate whether the 3xFLAG fusion proteins were stably
maintained during several cycles of infection. As shown in Figure 3.9, a band of
the expected molecular weight of approximately 36 kDa, corresponding to the IN3xFLAG fusion protein, was detected in viral particles concentrated from CEM
cells infected with R7/3-IN-3xFLAG by both the M2 monoclonal FLAG antibody
and a monoclonal integrase antibody 6G5 (Nilsen et al., 1996) that recognizes an
amino-terminal epitope common to both the tagged and untagged integrase.
Thus, comparison of the reactivity of the two monoclonal antibodies is a measure
of the relative stability of tagged integrase over time. Meanwhile, correctly
processed polyprotein of the expected molecular weight of 55 kDa and 24 kDa
was detected by Western blot using the LSS human antisera. These results
demonstrate that the 3xFLAG moiety is retained during infection and does not
interfere with viral polyprotein processing. In addition, as shown in Figure 3.9,
there was no reduction in the size of the band corresponding to IN FLAG or
3xFLAG fusion proteins 7-10 days post-infection when probed with a monoclonal
antibody against native integrase. Importantly, these results indicate that the
3xFLAG fusion proteins do not revert to wild type IN and are expressed stably
during progressive and extended infection. Similar findings were obtained for the
Vif 3xFLAG and Env tagged viruses (Figure 3.9).
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Figure 3.9 Immunoblotting of HIV-1 with 3xFLAG insertion 7 days post-infection.
Viral particles were probed with either (A) the M2 monoclonal FLAG antibody, (B)
human antisera LSS, or (C) a monoclonal antibody against integrase (6G5) or Vif
(#809, NIH AIDS Research and Reference Reagent Program).
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3.3 Discussion
Many studies have focused on understanding the interaction between HIV-1 and
the host cell (Turlure et al., 2004; Van Maele et al., 2006). Knowledge of the
different cellular partners of viral proteins would be invaluable for understanding
the biology of the virus with the potential for designing interaction-specific
antiviral agents. Recovery of replication-competent tagged viruses with insertions
through biological selection coupled with high affinity immunoprecipitation is one
approach to identify cellular proteins (and their complexes) that interact with a
particular viral protein. Here I describe the generation of replication-competent
HIV-1 specifying the potent 3xFLAG tag insertion in the coding regions of the
integrase (IN), envelope (Env) gp120 V1-V3 region and Vif proteins. An essential
component to this effort is the identification of a site or sites within the targeted
viral gene that can accommodate a small foreign insert. Toward this goal, we
used Tn7-mediated in vitro transposition to create a pool of random insertions
within each of the targeted viral coding regions. Each member in the library
differs from the others in the location of the insertion. Only proviral clones with
insertions that do not significantly disrupt the function of the essential viral protein
can complete multiple replication cycles in culture—a most stringent step of
biological selection. Permissive sites (within the IN-CTD, the gp120 V2 loop and
an internal region within Vif were identified using this approach, only to be
subsequently utilized as a blueprint for the insertion of larger peptide elements
(i.e., 3xFLAG) that could be accommodated without loss of replication potential.
Most of the epitope tagged viruses that were generated in this fashion are robust
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for viral spread or moderately impaired for replication. The IN (32 kDa) and Vif
(23 kDa) proteins are increased in size by more than 10% with the addition of the
3xFLAG tag (3.3 kDa). Indeed, it is quite remarkable that even small insertions
are tolerated, given that each viral protein must be required to act in concert with
both other viral proteins and a potential multitude of host factors to affect their
many independent functions during cycles of productive infection. One aspect of
the tag design that may facilitate the 3xFLAG being tolerated internally is the fact
that the tags have flexible adaptor Gly-Ser adaptor amino acids flanking both
ends of the peptide; in a position, perhaps, to be less likely to disrupt the
structure of surrounding domains. Regardless of the reason(s), these
experiments indicate that even given the constraints that are uniquely imposed
on the primary, secondary, tertiary and quaternary structure of the “multi-tasking”
viral proteins, some flexibility must remain for the incorporation of insertion
without overt loss of protein function(s).

The goal of these studies is to obtain identity profiles of host protein complexes
that interact with specific viral proteins at specific times during the HIV-1 life
cycle. To this end, we have used a genetic approach to select viruses that can
stably incorporate an efficient epitope tag within an essential viral protein yet
remain capable of robust replication competency. The random insertion approach
has been very important to our success, especially valuable to those viral
proteins whose structure and function are poorly understood. Instead of a
hypothesis-driven-protocol used to predict locations within the viral protein most
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amenable for tagging, we have employed a powerful biological selective tool
(viability) that does not rely on preconceived notions of tag placement. Thus,
recovery of replication competent viruses that are able to tolerate an insertion
within essential viral gene products is without bias. Using this approach, this
strategy has allowed us to obtain potent antigenic tags in infectious viral particles
in an effort to define HIV-1-host interactions. To date, we have created
transposon-based tagged libraries in three essential viral gene products:
integrase, envelope and the viral infectivity factor, Vif.

Transposon-based mutagenesis coupled with a selection based on viability is a
rapid way to ascertain those regions in a viral proteome that be modified without
cost to propagation. Here, based on the complexity of the libraries obtained, the
mathematical prediction is that transposition occurs at every base pair within the
target gene segment. Ideally, Tn7 transpositional mutagenesis is random.
However, the possibility still exists for some regions to exhibit a higher incidence
of insertion. Indeed, Tn7 transposase has an unbiased affinity for AT-rich regions
but exhibits a low efficiency of transposition into more GC-rich sequences
(Kumar et al., 2004). Evidence of target skewing of the Tn7 transposase is
shown in Figure 3.3. Here, signals corresponding to uniform-sized fragments are
detectable through the background smear of random insertional events.

Many viral proteins have multiple roles in HIV-1 life cycle. For example, HIV-1 IN,
originally defined by its role in viral DNA integration (Van Maele et al., 2006), has
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been implicated in the efficiency of reverse transcription (Wu et al., 1999), viral
nuclear import (Hearps and Jans, 2006) and DNA repair (Mulder et al., 2002). In
addition, at least the enzymatic features ascribed to IN seems to rely on the
ability of the protein to adopt various multimeric configurations. Therefore, it is
not expected that functional integrase can tolerate any appreciable insertional
modification (especially the size of a 30 amino acid peptide, 3xFLAG tag).
Although fusion of an eight amino acid segment (1xFLAG) to the C-terminus of
IN has been explored previously (Petit et al., 1999), a larger epitope (3xFLAG)
within the body of IN has not been described in the context of a replication
competent viral clone. The proximity of our 3xFLAG tag to the C-terminus of IN
(at the 280th residue of the 288 amino acid protein) is in accordance with both
structural and antibody data of the native protein that support the notion that
residues 270-288 are highly flexible, certain conditions favorable for the adoption
of an alternate configuration (Asante-Appiah and Skalka, 1997). Failure of both
NMR and X-ray studies to provide structural details of this region is also
consistent with this region exhibiting dynamic properties (Chen et al., 2000). If
pushed further, we believe that even more infectious clones can be recovered
from our saturated insertional library of the IN 270-288 region. Interestingly,
although a viable C-terminal 1xFLAG proviral clone has been previously obtained
(Arhel et al., 2006; Cereseto et al., 2005; Petit et al., 1999), there have been no
reports of successfully using this particular virus for the identification of cellular
proteins interacting with IN during infection. In the context of the complexes that
IN encounters during its infectious cycle through the cell (i.e., RTC, PIC, nuclear),

90

it is possible that the three-dimensional space occupied the relatively concise
1xFLAG-tag is not readily accessible to antibody under conditions that favor the
recovery of its potential binding partners. To support this notion, our own
immunoisolation experiments using virus with 1xFLAG insertion in integrase have
shown that the smaller 1xFLAG tag was not efficient for immunoprecipitation.

Envelope gp120 is remarkably diverse (Wyatt et al., 1998) and is by far the least
conserved protein of HIV-1. However, HIV-1 Env must conserve determinants
that mediate CD4/co-receptor binding (Zhou et al., 2007) and although
substantial structural rearrangements of the gp120 glycoprotein occurs upon
receptor binding, fusion and entry of the virus into the cell is rarely subject to
antibody-mediated neutralization (Rits-Volloch et al., 2006). In our study, the V1
to V3 variable loop region (Env amino acids 126-338) was initially chosen for
targeting (amino acids 62-345, see Chapter 2) because of its diversity in
sequence (Siwka et al., 1994), including amino acid deletions and insertions and
the most likely of all viral proteins to tolerate modification. Indeed, many escape
mutants to neutralizing antibodies against HIV-1 have been mapped to the V2
region (Shibata et al., 2007). Interestingly, both 5 amino acid insertions identified
in our initial random screen for viable PmeI-tagged viral mutants are located on
opposite sides of the base of the V2 loop (at residues 140 and 191). However,
when 3xFLAG was subsequently inserted into each of the clones, one of the two
viral clones (insertion at residue 140) was replication defective and resulted in
dramatically reduced 3xFLAG tagged Env expression (Figure 3.8). The
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replication-defective phenotype of this ENV-3xFLAG tagged mutant was
independently verified by the lack of observable syncytia or cell death in T-cells
over time in culture (Table 3). There are several possible reasons for the
intolerance of the 3xFLAG tag at position 140. The placement of a relatively large
acidic epitope tag might disrupt proper protein folding and stability. It is also
possible that steric hindrance has played a role in the intolerance of the 3xFLAG
tag at this particular site of insertion. For example, insertions into the V2 loop
might disrupt the overall flexibility of Env, resulting in inability for a predicted
conformational shift during receptor binding. Also, the V2 140 mutant virus might
not have survived concentration of virions during centrifugation, or perhaps the
number of defective virions produced was significantly less than the wild type.
This result indicates that the biochemical properties of identical amino acids
inserted into seemingly structurally related positions may have completely
different consequences for a given protein, further insertion tolerated at one
location but not another.

The interaction between HIV-1 Vif (192 amino acids) and cellular factors have
been extensively studied in recent years (Ehrlich and Yu, 2006; Schrofelbauer et
al., 2004; Sheehy et al., 2002; Xiao et al., 2006). Two PmeI insertion mutants
survived selection in Vif-restricted cells, one at residue 150, another at position
161. Significantly, the PmeI clone at position 161 was recovered from selections
from two independent transposed Vif libraries. Insertion of the 3xFLAG at this site
produced a replication competent virus capable of robust propagation in Vif-
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restricted cell types. Interestingly, this insertion is located near a Vif zinc binding
domain documented to be involved in direct binding of the Cul5 E3 ubiquitin
ligase and required for Vif activity (Xiao et al., 2006). In addition, point mutational
analysis has shown that both Leu 163 and Leu 169 are critical for the functional
integrity of Vif (Yu et al., 2004). The unique location of the Vif-161-3xFLAG clone
identified here might confirm and reveal additional information about Vif-cellular
protein interactions. An infectious HIV-1 clone in which the end of Vif carried a
hemagglutinin (HA) tag has been rationally constructed in an effort to
immunoprecipitate Vif from HIV-1 infected cells. This strategy subsequently
identified cellular proteins that interact with Vif (Yu et al., 2003). In this study, an
antibody against HA immunoprecipitated HA-tagged Vif from the lysates of HAtagged virus infected cells but not untagged Vif from the wild type control
samples. Three cellular proteins co-precipitated with Vif-HA but were absent from
the wild type control. They were identified by mass spectrometry as Cullin 5,
elongins B and C. It will be interesting to see if different host proteins can be
isolated during infection with viruses tagged at different locations.

Initially, a transposon insertional library was constructed for the whole HIV-1
genome to insert a FLAG tag. However, wild type virus quickly overtook the
culture and the FLAG insertion was quickly eliminated during an early cycle of
infection. Although Western blot analysis using α-FLAG revealed the presence of
the FLAG tag in the producer cells transfected with the pooled whole genomic
FLAG library, the signal disappeared at some point during subsequent rounds of
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viral passage. A similar phenomenon is observed in Figure 3.5, where the PmeI
site was almost entirely eliminated in the recovered viral DNA. We suspect that
intravirion recombination is responsible for the elimination of tagged viral genes.
Since HIV-1 has two copies of RNA as its genetic information, recombination can
occur during reverse transcription when reverse transcriptase “stitches” together
viral DNA from both single-stranded RNA templates, the final DNA product, is a
composite of the original genomic RNAs. If the two RNA templates contain
insertions at different genomic locations, a cross over event occurring at different
points between the two can restore the wild type, untagged viral genome. This
created a significant problem in our study. Because of the way the viral stocks
were generated (DNA transfection of a heterogeneously-tagged pooled library), it
is of high probability that two viral genomic RNAs, each specifying a tag in a
different location, could be copackaged into the same virion. As a result, the
genesis of the wild type virus could rapidly overtake a culture especially in
cultures where the tagged viral clones are only moderately compromised for viral
growth (i.e., the likely case when there is an exogenous insertion). In order to
reduce this problem, insertional libraries were constructed in individual viral
coding regions or domains ranging from 300 bp (in-ctd) to 800 bp (Env v1-v3),
instead of the whole HIV-1 genome (10 kb). Since recombinational events occur
with less frequency between closely spaced sequences, this strategy greatly
reduces the chances for the appearance of the wild type virus.

We started with libraries in which a small insertion (5 amino acids) was first
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constructed in the hope that less alteration to the natural viral protein would
correspondingly produce a larger subset of tagged, replication competent mutant
viruses capable of competing with the wild type virus over extended periods in
culture. Moreover, the viral supernatant was serially collected over several days,
monitored by PCR and PmeI digestion to ascertain the level of wild type
contamination at each time point (see Chapter 2). The appropriate samples then
processed for recovery of the tagged viral sequence.

There are several advantages using an exogenous tag instead of antibody raised
directly against HIV-1 viral proteins. First, although numerous antibodies have
been generated against HIV-1 viral proteins, for example integrase (BizubBender et al., 1994; Nilsen et al., 1996), the use of these monoclonal antibodies
for in vivo immunoprecipitation or immunocytochemistry has not been successful.
Second, some of the antibodies generated exhibit inhibitory effects on the in vitro
activities of integrase (Nilsen et al., 1996; Yi et al., 2000). It is possible that the
epitopes of these antibodies are in the critical regions of the viral protein are
required for functionality or for proper protein binding and, therefore might not be
accessible for the specific monoclonal antibody binding during infection. A third
advantage of using our approach is that sites identified within particular a
particular viral protein that can tolerate the addition of an exogenous tag can be
used for other applications such as real-time visualization by inserting a different
tag such as tetracysteine or GFP.
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Epitope tagging has become a powerful tool for the detection and purification of
expressed proteins. This methodology has been used in studies such as proteinprotein interaction, protein localization and immunoprecipitation. Among the most
popular tag systems is the FLAG system (Sigma) that relies on the FLAG
octapeptide (DYKDDDDK) fusion tag, a hydrophilic and immunogenic purification
tag specifically and rationally designed for antibody-mediated identification and
purification of recombinant proteins (Hopp et al., 1988). FLAG system can be
used with one of three monoclonal antibodies, M1, M2 and M5, each recognizing
and binding to the FLAG epitope with different specificities that depend on the
position of the FLAG peptide in the fusion protein. M2 α-FLAG reacts with the
fusion proteins with the internal FLAG epitope, or the N- or C-terminal FLAG tag
and prefers the sequence Asp-Tyr-Lys-Xxx-Xxx-Asp-Xxx-Xxx (Slootstra et al.,
1997). In a flow cytometry assay, the monovalent dissociation or affinity constant
Kd of the M2/FLAG interaction was determined to be about 8.0 nM (Buranda et
al., 2001). Placing multiple FLAG epitopes in tandem (i.e. the 3xFLAG tag) has
been designed for intracellular expression with increased sensitivity of detection.
The presence of three FLAG epitopes in series greatly increases the detection
limit. In addition, the M2 antibody is also capable of reacting with an alternate
epitope embedded within the 3xFLAG sequence. Thus, the 3xFLAG system
allows for increased sensitivity and detection of the FLAG epitope tagging system
while retaining the benefits of 1xFLAG expression. These benefits include the
hydrophilic nature of the tag and its small size. Detection of 3xFLAG using the
M2 α-FLAG is at least 20-200 times more sensitive than any other commonly
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used tag, and 10-20 times more sensitive than the 1xFLAG tag (Hernan et al.,
2000). Therefore, it was an obvious choice for our studies here.

One of the major obstacles to the visualization and characterization of HIV-1
proteins is the absence of strongly reactive antibodies to the native viral proteins.
The 3xFLAG tag is an extremely potent tag and the 3xFLAG tagged viruses
described here therefore represent an attractive system for proteomic studies.
Such studies have been successfully initiated and will allow us to gain a dynamic
view of the requisite host factors and their complexes involved in HIV replication.
Moreover, the strategy we describe here will greatly facilitate the visualization of
functional viral proteins in living cells at various points during viral life cycle.

We used the linker scanning mutagenesis to generate comprehensive libraries of
clones each bearing a single oligonucleotide insertion at a random position in the
gene of interest. The selection of replication competent clones from these
libraries can also be investigated by genetic footprinting (Singh et al., 1997). This
methodology has the ability to analyze in parallel a large set of molecularly
defined mutations that can be subjected to a specific functional selection. This
technique is generally applicable for saturation mutagenesis and high-resolution
functional mapping of cloned DNA sequences. In our case, the HIV-1 1- or 2-LTR
viral DNAs can be isolated from a saturated library with 15 bp insertions before
and after infection of target T cells. Alternatively, viral genomic RNAs can be
recovered from viral particles and the viral coding region of interest amplified by
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RT-PCR. The mutations represented in each sample can be analyzed by PCR
using one primer specific to a site in a mutagenically static region and a second
primer corresponding to the inserted oligonucleotide (i.e., 3xFLAG). As the result,
an insertion at a particular location gives rise to an electrophoretic band of
discrete mobility. For each mutation, a PCR product of unique length will be
generated, depending only on the position of the inserted oligonucleotide in the
gene. For the whole library, this results in a ladder of bands, each representing a
specific insertion. Mutants in which the inserted sequence disrupts a feature
required for the viral replication would fail the selection and no band would
appear at the position. The corresponding bands are therefore absent from the
ladder of PCR products obtained from the library after infection, giving rise to a
genetic footprint representing features of the gene in primary amino acid
sequence that are essential for infection. Because the sequence of the inserted
oligonucleotide is known, and its position can be inferred precisely from the
electrophoretic mobility of the corresponding band, the precise location of
insertions that disrupt gene function can be determined without isolating or
sequencing individual clones.

In summary, the keys to the successes of our approach include the random
introduction of a small insertion into a limited region of the HIV-1 genome and a
step of stringent biological selection to obtain those tagged viruses that remain
stoutly infectious in culture. In turn, these viruses can be readily utilized as
templates for the further modification of the viral genome allowing the
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introduction of a variety of powerful antigenic and biochemical tags depending on
the nature of downstream applications.
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Chapter

4:

Characterization

of

Replication-

Competent Tagged Viruses

4.1 Introduction
Using a transposon-based approach, we have generated HIV-1 proviral libraries
with a 5 amino acid insertion randomly and uniquely placed throughout the
integrase (IN), envelope gp120 v1-v3 loop (Env) and the viral infectivity factor,
Vif. By selection of viable insertion expressing variants, we have identified
positions within these viral proteins suitable for insertion of a much larger
peptide, such as the 3xFLAG-tag, without a strong negative effect on virus
replication. Viable viral clones with 3xFLAG tag insertions were used for the
affinity purification of virus-host protein complexes that associate specifically with
the tagged protein in HIV-1 infected cells. This strategy is sensible only if the tags
do not interfere with the protein’s normal activities during the viral replication
cycle. Additionally, valuable structure-function information was obtained for each
of the three viral proteins. Since the number of independent clones for each gene
greatly exceeded the number of nucleotides for each gene segment, the
location(s) of the sites amenable for insertion providing a mapping tool for
exposed surfaces or subdomains within the specific viral protein. The virological
and biochemical properties of these tagged clones are characterized herein. We
also demonstrate that all three viruses with 3xFLAG tags can be quantitatively
immunoisolated from infected cultures.
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The 5 amino acid insertions and 3xFLAG insertion selected from integrase library
is located near the end of the IN-CTD (residues 220-288). The IN-CTD
contributes to DNA binding and the oligomerization necessary for the completion
of integration (Coffin et al., 1997) and is linked to the catalytic core by residues
195-220, an extension of the final helix of the core domain. Crystal structures of
the IN core and CTD shows that residues 271-288 are not clearly defined in
density maps (Chen et al., 2000). This indicates the highly dynamic and
disordered nature of this region precisely where the 5 amino acid or 3xFLAG tag
insertions were allowed.

The gp120 variable regions are surface exposed and exhibit natural variation.
The Env library was constructed to capitalize upon the highly variable V1-V3
variable loops where the insertion of an artificial tag might easily be tolerated
without loss of function. In the end, a 3xFLAG insertion in the V2 loop region
resulted in a replication competent viral clone. Previous studies have
demonstrated that changes in the V1/V2 variable loop affect envelope
glycoprotein receptor binding and virus entry (Fung et al., 1992; Kolchinsky et al.,
2001). Here, we investigate the consequence of an artificial 3xFLAG insertion in
the V2 region, and whether an antibody directed against the inserted sequence
can neutralize the clone.
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Since the virus with a foreign epitope like the 3xFLAG tag in the V2 region is
replication competent, it is likely that this insertion did not result in significant
effect on viral entry. Neutralizing antibodies often recognize regions of viral
envelope glycoproteins that play pivotal roles in receptor binding or other aspects
of viral entry. A simple neutralization assay can be employed to investigate
whether or not the exogenously added epitope is accessible to its cognate
antibody on the assembled Env trimer and also to probe if normal gp120
structure or function is maintained as revealed by the kinetics of infection. Herein,
we investigate the neutralization of the modified mutant virus by a known
neutralizing antibody against HIV-1 Env, as well as neutralization by an antibody
directed against the artificial epitope tag.

We have constructed an infectious HIV-1 clone with a 3xFLAG tag inserted into
the Vif region at residue 184. The vif open reading frame is present in most
lentiviruses and is required for viral replication and pathogenicity in vivo (Simon
et al., 1998). HIV-1 Vif is essential for viral evasion of host antiviral factor
APOBEC3G (Sheehy et al., 2002). The ability of Vif to suppress antiviral activity
of APOBEC3G is specifically dependent on Cul5-Skp1-cullin-F-Box (SCF)-like
complex (Yu et al., 2003). The site for 3xFLAG insertion is in proximity to the
identified binding region of the SCF machinery. Verification of the known and
unknown host factors involved in Vif activities during infection may provide further
insights into understanding the functions of this important viral gene product.
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4.2 Results
4.2.1 Viability of HIV-1 Virions Harboring Tag Insertions in IN, Env
and Vif
As described in the previous chapter, when compared with the wild-type virus by
microscopic examination, the tagged viruses were as rapid or nearly as rapid for
syncytia formation during infection. A panel of independent assays investigated
the effect of the insertions on viral replication quantitatively. Viral growth curves
were generated for R7/3-IN-3xFLAG and R7/3-Env-3xFLAG by measuring daily
the concentration of the viral p24 core antigen accumulation in the culture
supernatant up to 11 days post-infection. Viral loads from wild type virus were
used as control. As shown in Figure 4.1A, the viral growth curve indicated that
both HIV-IN-3xFLAG and HIV-Env-3xFLAG replicated almost as efficiently as the
parental clone R7/3 in CEM cells, with slight delay in growth. They exhibited
growth kinetics of less than one log when compared to that that of wild type R7/3.
Growth curves for the Vif 3xFLAG tagged virus shows that it was as infectious as
the wild type control in the Vif-restricted cell type, MT2 (Figure 4.1B). These
results indicate that the relatively large tag in these viral proteins do not disrupt
the normal functions of the proteins during infection of these cell types.
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Figure 4.1 Viral growth curves of (A) HIV-IN-3xFLAG, HIV-Env-3xFLAG and wild
type R7/3 virus in CEM cells. (B) R7/3-Vif-3xFLAG and wild type R7/3 virus in
MT2 cells, a Vif-restricted cell type.
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The growth properties of viral clones with insertions were further verified by onestep growth analysis. In a single-step assay to determine the relative infectivity,
an expression vector for the vesicular stomatitis virus (VSV)-G protein was cotransfected with the parental wild type viral DNA and those corresponding to,
R7/3-IN-PmeI, 1xFLAG, 3xFLAG, or the biotin-acceptor tagged viruses SNAGG.
The viral constructs are also defective for HIV-1 envelope expression to allow the
efficient pseudotyping with the VSV-G envelope. The relative infectivity quotient
of the VSV-G pseudotyped viruses was investigated in the LuSIV (SIV LTRLuciferase) indicator cell line. Viruses with various tags in integrase were found
to be nearly infectious, or as infectious as the wild type virus, as shown in Figure
4.2. The results show that the viable mutants are capable of infection, some
exhibiting levels of infection the same as the wild type. As a rule, viruses with
smaller inserts (PmeI insertion or 1xFLAG insertions) are more infectious than
ones specifying larger tags (3xFLAG). In addition, the one step infectivity assay
for R7/3-IN-3xFLAG correlates well with the replication properties as measured in
the multiple-cycle growth curves experiments described above.
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Figure 4.2 Viruses tagged in integrase are infectious in a single step assay.
LuSIV (SIV:LTR-Luciferase) CEM cells were infected over a three log range of
viral stock input normalized for identical amounts of p24 CA, incubated for 60
hours and then assayed for luciferase activity. The respective antigenic tag
added to the integrase gene at the corresponding IN-PmeI site is indicated. The
results are expressed as percent infectivity (wild-type = 100%) and are an
average of two determinations within the linear range.
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The integration frequency of viruses with PmeI, FLAG or 3xFLAG insertions
within IN were also measured using a genetic assay based on the blastocidin D
(bsd) gene carried in a single-cycle, VSV-G the pseudotyped virus. Integration
frequencies of greater than 15 to 20% of that of the wild type are considered a
requirement for sustained viral replication through several cycles in CEM T cell
cultures (Wiskerchen and Muesing, 1995b). As shown in Figure 4.3, the R7/3-INPmeI, R7/3-IN-1xFLAG virus have an integration frequency of more than 50%
that of the WT; the integration frequency of a virus with 3xFLAG tag was about
30% of the WT in this assay. Infections in other cell types such as
GHOST(3)X4R5 and M7 5.25 were also studied. Results from these infections
are consistent with the data described above.
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Figure 4.3 A genetic assay to evaluate the integration frequency of the various
IN-tagged viruses. Data are an average of three readings.
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4.2.2 Effect of V2 Insertion on Viral Neutralization Properties
We investigated the effect of foreign epitope insertion (i.e., the V2-3xFLAG
modified Env) on the neutralization properties using a well-characterized
monoclonal antibody active against most clade B strains of HIV-1. Since many of
the monoclonal antibodies known to neutralize clade-specific HIV-1 species map
to one of the variable loop regions, we asked whether insertional modification of
the V2 region could still be presented as a neutralization target or whether this
alteration disrupted the interaction of the antibody with its natural target. For
example, insertion into the V2 loop region might alter the accessibility of a
surface-exposed site such that the V2 loop or another loop-directed neutralizing
antibody was no longer capable of binding gp120. To determine potential effects
on neutralization, assays were performed with the known neutralizing mAb (44752D) whose antigenic target is in the V3 loop (Conley et al., 1994). Neutralization
assays of the wild type or 3xFLAG tagged Env were performed in
5.25.EGFP.Luc.M7 report cells, in which the infection could be monitored by the
activity of either of GFP or firefly luciferase. As shown in Figure 4.4, mAb 44752D effectively neutralized both the wild type and the V2-3xFLAG viruses. This
indicates that at least at this approximation, the addition of 3xFLAG tag at the
base of the V2 loop maintained the overall structure of gp120 and in particular,
the structure of V3 loop itself. Not surprisingly, although the 3xFLAG-tagged Env
virus is susceptible to anti-FLAG mAb neutralization, the wild type virus is not.
Similar neutralization results were obtained when GHOST(3)X4R5 cells were
used as the cellular target for neutralization and assayed by flow cytometry.
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Thus, the insertion of the 3xFLAG sequence into the gp120 V2 region exerted no
significant effects on the general neutralization sensitivity of the modified
envelope glycoprotein, and by extension, indicates the possible neutralization of
this specific recombinant virus by the activity of an α-FLAG mAb (M2).

However and interestingly, as shown in Figure 4.4B, the M2 antibody only
partially neutralized this virus. In this experiment, a portion of the 3xFLAG tagged
virus remained infectious despite incubation with high concentrations of the M2
antibody. Further increases in M2 concentration led to less specific virus
inhibition, as evidenced by some effects of the FLAG antibody at higher
concentration on viruses with the native wild type envelope glycoprotein (Figure
4.4B). It is therefore difficult to determine whether this residual fraction of
infectious virus can be neutralized at the higher doses of M2 antibody without
considering its inherent non-specific effects. Indeed, it is surprising that given the
avidity of the M2 antibody for its target epitope, 3xFLAG, that the recombinant
Env is not exquisitely sensitive to neutralization. It is possible that the M2
antibody does in fact bind to the 3xFLAG-V2 epitope in the context of the virionassociated Env trimer structure on the surface of the mature HIV-1 virion but the
interaction does not lead to inactivation of the virus. On the other hand, the
foreign epitope might be buried within the secondary, tertiary or quaternary
structure of the mature envelope and inaccessible by antibody. Finally, since the
modified 3xFLAG-tagged Env of this virus is quantitatively recovered from
infected cells under native conditions, it is possible that the extensive post-
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translational glycosylation of the viral envelope encountered during its
progression from the endoplasmic reticulum to the surface of the infected cell
and into the virion particle somehow occludes interaction with M2. It is perhaps
significant that purification of this recombinant envelope from infected cells under
standard immunoprecipitation conditions only recovers the gp160 preprocessed
precursor protein (see below). Whether or not this protein is extensively
glycosylated in the context of the foreign tag is currently unknown but serves as
the basis for further investigation.
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Figure 4.4 Neutralization assays using (A) 447-52D and (B) M2 α-FLAG. A mock
infection with no viral addition and an infection with the RT inhibitor, AZT, serve
as negative controls. A positive control was included in which neither antibody
was added.
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4.2.3 Visualization of 3xFLAG Tagged Viral Proteins During Infection
As an alternative but important utility, viruses with 3xFLAG insertions can be
used to examine the subcellular localization of the tagged viral molecules during
infection. HeLa P4R5 cells or GHOST(3)X4R5 cells were infected with different
3xFLAG tagged viruses and then probed with the M2 mAb and the complex
visualized with the use of a fluorescein-conjugated secondary antibody. The cells
were examined by fluorescence microscopy after 24-36 hours. As shown in
Figure 4.5, all three 3xFLAG tagged viral proteins could be easily detected and
visualized during infection (the heterogeneity in the signal intensity of individual
stained cells being perhaps the reflection of positional effects on the specific
location of the integrated proviral DNA). In cells infected with wild type virus, only
very minimum background fluorescence was detected. For cells infected with the
IN-3xFLAG virus, the majority of the signal was found in the cytoplasm as brightly
fluorescing dots. The staining of the integrase-tagged protein (or the Gag-Pol
polyprotein, of which integrase is a component) shows a reticular staining pattern
surrounding the nucleus and extending throughout the cytoplasm. Its
accumulation is also easily observed near the cell boundaries or plasma
membrane (Figure 4.5 A).

Surprisingly, there was no obvious plasma membrane staining observed for virus
with the 3xFLAG tag within envelope (Figure 4.5B). Instead, the tagged envelope
protein was detected in the cytoplasm, concentrated near the nucleus. As
discussed in the previous section, it is possible that only a subset of the 3xFLAG-
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tagged Env protein is detectable by α-FLAG, perhaps reflecting either its state of
post-translational modification or alternative structural configurations of the
protein itself.

The staining of Vif-3xFLAG in the context of viral infection shows pan-cellular
distribution (Figure 4.5C). The tagged Vif protein was detected in both the
cytoplasm and nucleus without preference of accumulation in a particular
subcellular compartment. The subcellular localization of Vif has been addressed
previously (Goncalves et al., 1994; Karczewski and Strebel, 1996; Simon et al.,
1997). These studies either investigated the expression patterns by transient
transfection of a Vif expression vector or visualized at very low resolution during
infection using a Vif monoclonal antibody during infection. Ectopic over
expression of Vif was reported to be at the cellular membrane or within the
cytoplasmic compartment. Our immunocytochemistry experiments visualize the
punctate subcellular localization of Vif at high resolution in virus-producing cells.
However, it is worth noting that since a Vif-permissive cell line was used in our
study, the subcellular localization of Vif might vary based on infection of a Vifpermissive or restricted cell type. For our future study, we will investigate the Vif
immunocytochemistry during infection of non-permissive cells.
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A. R7/3-IN-3xFLAG

B. R7/3-Env-3xFLAG

C. R7/3-Vif-3xFLAG

Figure 4.5 Immunocytochemical staining of HeLa P4R5 cells after infection with
3xFLAG tagged viruses. Cells were fixed and probed with anti-FLAG monoclonal
antibody followed by Alexa-Fluor 594 anti-mouse as secondary antibody. The
cells were counterstained for nuclear DNA (blue).
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In an attempt to study the routing of the viral proteins in the viral life cycle, a time
course

with

each

of

the

tagged

viruses was

performed

in

infected

GHOST(3)X4R5 cells. Since GFP expression in the GHOST(3)X4R5 cell line is
conditional upon viral infection, these reporter cells were used to determine
which of the cells in the population were infected. GFP can first be detected 18
hours after infection. As shown in Figure 4.6, we observed anti-FLAG staining for
the IN, Env or Vif 3xFLAG tagged viruses at 18, 27 and 36 hours post infection.
However, we did not notice any obvious redistribution of the tagged viral proteins.
This may not be too surprising since by 18 hours most of the viral life cycle
(approximately 24 hours) has been completed. At 36 hours post infection,
syncytia formation, shown as large fused cells with multiple nuclei, was observed
in all three infections. Further experiments with these viruses at shorter times
after infection may be necessary for teasing out the intracellular movement of
these proteins over time.
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18 hrs

27 hrs

36 hrs

R7/3-IN-3xFLAG

R7/3-Env-3xFLAG

R7/3-VIF-3xFLAG

Figure 4.6 Immunocytochemical time course study of the location of 3xFLAG
tagged proteins during infection in Ghost cells at 18, 27 and 36 hour time points.
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4.2.4 3xFLAG Tagged Viral Proteins Can be Quantitatively Recovered
During HIV-1 Infection
In pilot experiments, we assessed the ability of the 3xFLAG-tag to be an
accessible substrate for the quantitative purification/recovery of the tagged viral
protein during infection. Using the potent immunoaffinity characteristics afforded
by the 3xFLAG-tag, whole cell lysates from infected cultures were incubated with
α-FLAG(M2)-conjugated magnetic beads. To determine the extent of recovery,
the eluted proteins from the beads were immunoblotted with the same FLAG
antibody. We show that 3xFLAG tagged viral proteins were expressed efficiently
in total cell lysates, (Figure 4.7A) and can easily be detected in their batch elution
profiles (Figure 4.7B). Thus, all three viral proteins initially targeted for 3xFLAGtagging were successfully recovered from progressive infectious cultures. All
immunosignals were specific to each tagged viral protein and absent from the
wild type control infection. Predictably, two major species of tagged proteins were
recovered from the IN-3xFLAG infection—one the mature, fully-processed
integrase protein (38 kDa), the other, the much larger proteins of molecular
weights approximating 100 and 180 kDa. These proteins likely reflect the
presence of the 3xFLAG tagged Gag-Pol polyprotein and related molecules,
since integrase is part of this polyprotein before viral protease cleavage that
occurs during viral egress from a producer cell. Under the conditions used in the
pilot experiments, the recovered tagged protein in R7/3-Env-3xFLAG infections
was at approximately 160 kDa, representing the gp160 precursor of the envelope
glycoprotein instead of the mature 120 kDa gp120 glycoprotein species. Since
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the mature form of gp120 is fully glycosylated and forms a homotrimer, the
3xFLAG epitope and α-FLAG binding might be less accessible in this form
compared to the gp160 precursor (see discussion above).

Small-scale immunoprecipitation was performed using cells infected with single
1xFLAG tagged virus, R7/3-1xIN-FLAG, or the biotin acceptor tag, R7/31xSNAGG, the latter infected in cells expressing a biotin ligase. Importantly,
although these viruses are more infectious than R7/3-3xIN-FLAG, to our surprise,
the M2 α-FLAG mAb was unable to effectively isolate tagged IN or the Gag-Pol
polyprotein from the infected culture even though the stable existence of the tag
was confirmed by Western blot detection in the total cell lysate. Similar findings
are observed for the biotin tag biochemical affinity purifications. It is quite
possible that these smaller tags are buried in the folded viral integrase and not
accessible for antibody binding.
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A. Total lysates

B. Elutions
IN

IN Env WT

kDa

IN WT Vif Env

191

ENV-3F

Poly proteins

97

ENV-3F

64
51

IN-3F

IN-3F

39

28

VIF-3F

19

Figure 4.7 Immunoprecipitation of 3xFLAG tagged viral proteins during infection
using α-FLAG. Western blots were probed with 1 µg/mL α-FLAG. Expression of
the 3xFLAG in (A) the total lysate and (B) the eluted material is shown.
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4.3 Discussion
The replication phenotypes of the viruses targeted for insertion were investigated
quantitatively by growth curves and/or one-step growth analyses. Although the
growth curves need to be reproduced in replicate experiments to include those of
viruses with only the 5 amino acid PmeI site insertion as well as the replication
defective viruses to be used as negative controls, these assays show that the
growth kinetics of the viruses with 3xFLAG insertions is similar to wild-type R7/3,
but with a slightly delay in viral production (Figure 4.1). As described in the
previous chapter, the presence of the 3xFLAG-tag within IN, Env or Vif is stable
and persists across many cycles of infection, modified viruses exhibiting wild type
levels of viral protein expression and processing. Taken together, these results
confirm the generation of replication competent viruses with long-term expression
of a potent epitope tag. One-step infectivity assays for IN-tagged viruses
(1xSNAGG, 1xFLAG, 3xFLAG) are consistent with regard to the results obtained
over the course of a viral growth curve. In a genetic assay used to compare the
integration frequency of viruses with various tag insertions, the 3xFLAG tagged
virus shows an integration frequency in a range compatible with sustained viral
replication in susceptible cells (Figure 4.3). Its lower integration frequency,
perhaps indicative of slight perturbations in the efficiency of one or more
functions carried out by integrase that are manifested when it is fused to a 30
amino acid exogenous and highly charged protein determinant. In general, it is
not surprising that smaller tags result in less functional defects and are of less
consequence to viral replication kinetics [illustrated by the behavior of the PmeI,

121

1xFLAG and the 1xSNAGG biotin acceptor viruses (Figure 4.2)]. However,
although insertion of a larger tag into the same location might be expected to
have more disruptive effects on the structure (or function) of the tagged protein
and result in a reduction infectious viral titer, our results indicate that no insertion
was dramatically more disruptive than any another at position 280 in integrase.
This is not always the case. For example, the simple insertion of five amino acids
(PmeI) at position Env 140 is replication-competent but when the 3xFLAG-tag is
inserted at the identical position within this protein, the virus is severely
compromised.

The relative replication fitness of various tagged viruses can be investigated by
competition assay with wild type. This type of study could reveal which virus
predominates when directly challenged in the same culture with the other viral
species. In these experiments, cell would be infected with a 1:1 ratio of the
tagged virus to the wild type virus. Proviral DNA can be extracted from infected
cells and then amplified by PCR using primers flanking the relevant viral coding
region. The ratio of the wild type to tagged virus, an indication of relative fitness,
can be monitored daily by determining the ratio of intact to once cut (by PmeI or
BlpI) in PCR fragment restriction digestion. An even more sensitive assay that
can be used to estimate the relative fitness is based on growth competition
experiments that use quantitative real-time PCR analysis (Weber et al., 2003). To
quantify the proportion of both HIV-1 variants in the mixture, primers and probes
can be designed specifically recognize and amplify the tag insertion or a specific

122

the viral coding region. The final ratio of the two viruses produced from each dual
infection/growth competition experiment can be determined by real-time PCR
and compared to production in monoinfections (Quinones-Mateu et al., 2000). A
relative fitness value for each virus in the competition can then be estimated by
the production of each individual HIV-1 strain in the dual infection.

Our data provide quantitative evidence for the overall rationale of our
methodology – the biological selection of tags that exhibit relative inertness with
respect to infectivity kinetics. The replication competency of the tagged viruses is
a prerequisite of our strategy of host factor recovery and identification. Because
of the amplification afforded by robust viral replication, the tagged viral protein
represents a substantial proportion of the intracellular protein mass and thus is
an enriched source for the discovery of binding events between viral and host
proteins in the natural environments.

The HIV-1 gp120 variable regions are known to tolerate substantial changes in
length, amino acid composition and glycosylation without compromising envelope
function (Kuiken et al., 2003). We generated an infectious viral clone with a
3xFLAG tag at the base of the V2 loop region of gp120, an area thought to be
unimportant for viral entry (Burton et al., 2004; Kwong et al., 1998). Thus, it is
reasonable to ask if the 3xFLAG epitope is accessible for FLAG antibody binding
and viral neutralization. In our experiments, the M2 monoclonal FLAG antibody
could only partially neutralize the V2-3xFLAG virus. Although highly speculative,
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the fact that the HIV-1 envelope can tolerate a large alteration in the V2 region
indicates that this region likely plays a negligible role in the viral entry process.
Since the overall structure of the envelope is maintained in this viral mutant, it
remains susceptible to neutralization by conventional antibody targeting of the V3
loop. Therefore, the potential for neutralizing activity of the FLAG antibody is
unlikely to result from disruption of a function intrinsic to gp120-receptor binding.
Given the considerable size of an antibody molecule in comparison to that of the
HIV-1 envelope trimer (Labrijn et al., 2003), steric hindrance may account for the
reduced efficiency with which virus attachment and/or membrane fusion events
occur in the presence of the bound antibody. Therefore, the neutralization activity
of FLAG antibody might result from the binding and continued presence of the
bulky antibody during the attempted entry process. It would also interesting to
see if the antigen binding fragment (Fab) or the single-chain fragment V (scFv) of
M2 FLAG antibody has the ability to neutralize the Env 3xFLAG tagged virus,
given the fact that they are much smaller in size than the full-length antibody and
may be more likely to avoid steric hindrance effects. There has been much
debate on whether antibody binding to HIV-1 envelope glycoprotein necessarily
leads to neutralization (Cavacini and Posner, 2004). Our study supports the
notion that antibody binding with high affinity to Env exhibits some degree of
neutralizing activity as a consequence of steric hindrance (Parren et al., 1998).

A fraction of the 3xFLAG tagged viruses could not be neutralized by α-FLAG
mAb even at very high concentrations. At least two possible scenarios can be

124

envisioned: (1) The mature gp120 protein is highly glycosylated (Wei et al.,
2003). Since the potency of neutralization by steric hindrance is expected to be
largely determined by the accessibility of the epitope (Greenspan, 2001), the
3xFLAG epitope in a subset of viruses might be shielded by heavy glycosylation
limiting antibody binding to its epitope. This hypothesis can be tested by
introducing point mutations to remove glycan from Env and then studying the
effect of this modification on neutralization. (2) Alternatively, although more
unlikely than the scenario presented in (1), if binding between the 3xFLAG
epitope and the antibody is reversible, a fraction of the virus may be able to bind
to the cell membrane and elaborate fusion before the rebinding to the antibody.
However, most of the evidence from our study seems to support the first
possibility. The immunofluorescent staining of Env-3xFLAG infected cells only
detects the cytoplasmic distribution of the mutant viral envelope instead of that
found for its natural counterpart, where it is both cytoplasmic and accumulated at
the plasma membrane, in position where the mature, fully glycosylated Env can
be multimerized and incorporated into the virion. Furthermore, the majority of the
envelope protein isolated during infection with the α-FLAG mAb is in the form of
unprocessed gp160 (Figure 4.7). This indicates that the 3xFLAG insertion might
be partially buried in the highly glycosylated mature gp120 or gp120 trimer, but
accessible for FLAG antibody binding in the form of gp160, the unprocessed
precursor of gp120. Although Env forms trimer on the surface of the viral particle,
it is not clear if the epitope in each gp120 monomer need to be accessible for
complete neutralization. Taken together, the reason for partial neutralization by
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FLAG antibody is most likely due to the inaccessibility of 3xFLAG epitope in the
mature oligomerized gp120 by its physical shielding either structurally or by posttranslational glycosylation of the envelope protein.

Our study here shows that exogenous peptide tags can be introduced into the
gp120 V2 region without affecting the recognition/fusiogenic function and
conventional neutralization sensitivity of the HIV-1 glycoprotein. This is consistent
with a previous report on the neutralization of a virus with 1xFLAG insertion in the
V4 loop (Ren et al., 2005). Findings like this can be used for the establishment of
an experimental system to study antibody-mediated neutralization, in which
exogenous epitopes can be manipulated without interfering with normal structure
and function of the carrier envelope glycoprotein. Such studies may provide
further insights into mechanistics of HIV-1 neutralization by antibodies and other
molecules.

Saturation mutagenesis of the HIV-1 envelope gene would possibly result in
replication competent viral clones with 3xFLAG insertions at different locations.
Neutralization of the viral infection by α-FLAG would be an indication that the
particular 3xFLAG insertion is very likely in a surface exposed region of the
gp120 trimer. Another application of the 3xFLAG tagged infectious clone in
envelope is to investigate the effect of glycosylation on antibody neutralization. A
proposed 'glycan shield' mechanism of neutralization escape whereby selected
changes in glycan packing prevent neutralizing antibody binding has been
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reported (Wei et al., 2003). It represents a new mechanism contributing to HIV-1
persistence in the face of an evolving antibody repertoire. By substitution
mutagenesis on residues adjacent to the insertion, a virus with 3xFLAG tag
insertion in Env that can be neutralized by α-FLAG can be used to establish that
neutralizing antibody-selected alterations in glycosylation can confer escape from
an epitope-specific monoclonal antibody.

We describe replication-competent HIV-1 that carry a potent 3xFLAG tag, which
can, in practice, serve as a powerful tool to visualize any HIV-1 protein during
infection. This strategy allows visualization of a functional viral protein species
during viral infection in living cells, imaging providing a route to more fully
understand the dynamics of viral host cell interactions. The HIV-1 viral protein R
(Vpr) has been tagged with GFP to permit the first observation of intracellular
HIV-1 complexes in living cells (McDonald et al., 2002). Recently, virus with a
tetra-cysteine tag at the extreme C-terminus of IN was labeled with the bisarsenical fluorescein derivative, FlAsH, for real-time imaging during infection
(Arhel et al., 2006). Here, the location of the IN, Env or Vif proteins during
infection was visualized by indirect immunocytochemistry. Since we have chosen
to use the FLAG epitope for our recombinant viruses, we can rely on the
commercial availability of a wide panel of anti-FLAG reagents (Sigma). For
example, infections with our viruses can now be used for even more sensitive
applications such as direct immunocytochemistry (fluorescent-conjugated) or
electron microscopy (immunogold-conjugated) α-FLAG antibodies.
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Our studies using indirect immunofluorescence reveal the subcellular localization
of three tagged viral proteins during infection (or in some cases their immediate
polyprotein precursor). We expected to see accumulation of the stained Env at
cell membrane, where the viral budding occurs. As discussed earlier, the
exclusive cytoplasmic staining pattern that we observed for the Env-tagged virus
might represent the intracellular location of an early immature form of the gp160
precursor instead of the mature, fully-glycosylated form of gp120.

Although integrase is predominantly nuclear when expressed in the absence of
other viral proteins, it elaborates a different staining pattern in cells producing the
virus. It is both cytoplasmic and concentrated at the surrounding the plasma
membrane (Figure 4.5A). Immunoprecipitation from a continuous infection with
the IN-3xFLAG virus resulted in the overwhelming isolation of the Gag-Pol
polyprotein. Since IN is present at the C-terminus of Gag-Pol, we suspect that
the continuously infected cells from which immunoisolations were originally
performed represent viral producer cells as a majority. As a result, the Gag-Pol
polyprotein is preferentially recovered. On the other hand, the mature 38kDa IN
proteins produced only after viral budding and in cells undergoing incoming
infection , represent a minority of the total infected population in continuous,
unsynchronized culture. However, when fresh uninfected target cells are added
to the infected culture before harvesting (16-24 hours prior), there is considerably
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more mature, 32 kDa IN immunoprecipitated than the Gag-Pol polyprotein
precursor (see Chapter 5).

We show here the characterization of HIV-1 with tag inserted in in, env and vif
gene products using various techniques such as infectivity and, neutralization
assay and immunocytochemically. Our study is a starting point that may lead to
versatile application of the modified viruses in an effort to understand HIV
biology. Most importantly, the replication competent status and the accessibility
of the tag in the infected culture provide a foundation for the use of our mutants
to isolate viral protein and their cellular interactors directly from infection. This
method is described in the next chapter.
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Chapter 5: Identification of Cellular Proteins That
Interact

with

Tagged

Viral

Proteins

During

Infection

5.1 Introduction
To efficiently precipitate HIV-1 viral proteins from infected cells and subsequently
identify the cellular protein(s) they interact with, we isolated three infectious HIV1 clones each carrying a 3xFLAG tag in IN, Env gp120 or Vif. These clones
replicate efficiently in target cells when compared to the parental virus, R7/3.
Because of the amplification afforded by viral replication, the tagged viral proteins
represent a substantial proportion of the intracellular protein mass. Therefore, as
cells infected with an individually tagged virus are expanded in culture they
become an enriched reservoir for the recovery of viral-host proteins in complex.
Cellular proteins that are associated with a particular viral protein under
physiological conditions during HIV-1 replication can be recovered by
immunoprecipitation via the strong avidity mediated by the 3xFLAG epitope tag.
The purified protein complexes can then be identified by mass spectrometry (MS)
and confirmed by a variety of techniques including tandem MS analysis, reverse
targeting and I-DIRT (Tackett et al., 2005).

Strategies are needed to identify cellular proteins and their complexes that play a
required role in HIV-1 biology. As discussed earlier, the multiple functions of HIV130

1 IN seemingly make this protein the most attractive target for our current study.
However, this ‘multi-tasking’ ability strongly complicates the study of this protein.
Several types of mutation in integrase are known have pleiotropic effects on
disparate steps of virus replication and thus sometimes generate data that are
difficult to interpret. For example, Q168A has been characterized as an IN single
point mutation that blocks replication of the virus at the step of integration and
thought to have direct effect on integrase catalytic activity. However, later study
has shown that instead of affecting integration directly, IN Q168A actually
disrupts the interaction of IN with the host factor LEDGF/p75, which tethers IN to
chromatin prior to integration (Emiliani et al., 2005). In spite of recent efforts to
elucidate the nuclear import pathway of the human immunodeficiency virus type
1 (HIV-1), the exact route(s) that the IN protein takes (as well as the domains that
mediate its import) are still not understood (Armon-Omer et al., 2004; BouyacBertoia et al., 2001; Yamashita and Emerman, 2005). Since IN is found in
several different intracellular locations depending on the point of the viral life
cycle, an additional problem in studying integrase may be that specific functions
of the protein are determined by particular complexes formed with cellular
proteins only in certain subcellular compartments (Van Maele et al., 2006).

Regardless of these complications, any study geared toward the identification of
the components of host complexes associated with a particular viral protein will
require their purification using a technique with high specificity and affinity. Here,
3xFLAG-tagged viruses were used to isolate host proteins complexes from
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cultures infected with tagged, yet replication-competent mutants. We examined
protein complexes involving tagged viral proteins produced during the infection of
human T cells. In addition to some host proteins previously identified, mass
spectrometry analyses of proteins recovered from tagged viral infections have
revealed a larger number of interacting cellular proteins not previously described.
These results provide the basis for a new way to understand of basic retroviral
processes common to all retroviruses (i.e., proviral integration, envelope
maturation) as well as those specific to the lentiviral family (i.e., nuclear
localization) in which HIV-1 is the most studied member.

5.2 Results
5.2.1 Large Scale Immunoaffinity Isolation of 3xFLAG Tagged Viral
Proteins From Infected Culture
Our strategy is illustrated in Figure 5.1. To follow interactions specific to the
targeted HIV-1 protein, we used replication-competent viruses that could
incorporate a 3xFLAG tag within the body of the IN, Env or Vif protein. As shown
in Chapter 4, viruses expressing the 3xFLAG epitope are infectious with only
slight delays in replication when compared to the wild type virus. As a negative
control, immunoisolations were also performed with untagged wild type virally
infected cultures to test for the presence of any nonspecific protein interactions
that occur between the whole cell lysate and the specific antibody-bead
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conjugate used in the recoveries. Infections by R7/3-IN-3xFLAG and R7/3-Env3xFLAG in CEM target cells also served as ideal control for each other.

Infected CEM or Vif-restricted HUT78 T cells were rapidly frozen and
cryogenically lysed to preserve protein complexes, as previously described
(Cristea et al., 2006). The cell lysates were subsequently used for immunoaffinity
purifications on magnetic beads coated with monoclonal α-FLAG M2 antibody,
the purified proteins (and their complexes) identified by mass spectrometry after
their purification by one- dimensional SDS-polyacrylamide electrophoresis.

Under optimized conditions, we have obtained efficient recoveries of the 3xFLAG
tagged viral proteins from the infected cultures as shown by Coomassie Blue
staining (Figure 5.2). The molecular weights correlate with the predicted sizes of
the tagged proteins: 36 kDa for IN-3xFLAG, 163 kDa for the tagged, full-length
Gag-Pol polyprotein, and 163 kDa for the glycosylated Env gp160 protein. The
identities of the tagged proteins at these molecular weights were confirmed by
MS analysis and Western blot. In this particular set of elutions, no band
corresponding to Vif-3xFLAG (26 kDa) was detected by Coomassie blue staining.
However, MS and Western blot analysis detected the presence of this protein.
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3xFLAG Tagged Virus
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Figure 5.1 Scheme of the immunoaffinity isolation of tagged viral proteins and
their complexes from infected cell culture.
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Figure 5.2 A preparative Coomassie blue-stained SDS-PAGE gel (4 to 20% BisTris) of co-immunoprecipitated cellular proteins with either 3xFLAG tagged IN,
Env or Vif. The bands confirmed as the tagged viral protein is indicated. The
positions of molecular weight markers are indicated at the left.
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The efficiency of immunoisolation was assessed by Western blot using the αFLAG mAb. The eluted samples were compared to the fraction of the tagged
protein in the total lysate and in the column flow-through. As shown in Figure 5.3,
the expression of all 3xFLAG tagged viral proteins in infected culture were
detected in the respective total cell lysate. In this experiment, the Env-3xFLAG
protein appeared to be much more abundant than the IN-3xFLAG protein.
However, based on detection of the tagged proteins in the elution lanes, most of
the 3xFLAG tagged IN in the infected cultures was recovered and absent or
diminished

in

the

flow-through

fractions.

The

additional bands

in

IN

immunoisolation are indicative of the Gag-Pol or Pol polyproteins, or possibly a
species of post-translationally modified integrase. Env protein was highly
abundant in total lysate and saturated the magnetic beads for binding as
indicated by the strong signal given in Western blot in the flow-through fractions
(Figure 5.3). The tagged viral proteins were successfully eluted from the
antibody-conjugated magnetic beads as evidenced by the absence of the tagged
protein post-elution. In all of the eluted samples, the 3xFLAG-tagged proteins
were present, their strong signal intensities on Western blot indicative of the high
levels of tagged protein recovered after elution and correlating well with the
results obtained from the preparative Coomassie blue staining of these samples.
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Figure 5.3 Immunoblot developed with α-FLAG to assess immunoprecipitation
efficiencies. In the lanes for total lysates (TL) and flow-through (FT),
approximately 0.1% of the sample volume was loaded; for elutions and beads
recoveries, 1% of the sample was used.
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5.2.2

Proteomic

Characterizations

of

Proteins

Recovered

by

Immunoaffinity Isolation During HIV-1 Infection
To identify the host proteins involved in HIV-1 infection, elution samples of each
tagged

HIV-1

immunoisolation

was

resolved

by

SDS-PAGE.

Prior

to

electrophoresis, the cysteinyl residues within the samples were reduced and
alkylated to yield carboxyamidemethyl derivatives and to avoid spontaneous
intermolecular disulfide bond formation during the run. The eluted samples
contained a large number of bands with a wide range of sizes (Figure 5.2). To
analyze the proteins in the gel, each lane was sectioned into 24-26 contiguous
slices. Each fraction was then digested individually with trypsin and the resulting
peptides eluted from the gel by extraction. Peptide material extracted from each
gel slice was first analyzed by MALDI-TOF MS, followed by MS/MS. The MALDITOF MS data confirmed that the digested samples contained peptides that could
be assigned to cellular or viral protein. Searches of available databases indicate
that the IN-3xFLAG and Env-3xFLAG samples contain statistically significant
protein identifications. Thus, unique proteins presented in each of the
immunoaffinity isolations appear to be from specific 3xFLAG tagged viral protein
complexes and not from contaminating non-specific proteins. Some of the
proteins identified in the IN-3xFLAG immunoprecipitation are divided into subsets
of either cellular (Table 4) or viral proteins (Table 5). The genInfo identifier (gi)
number, a unique integer that identifies a particular sequence, is included for
each identified protein. Since IN and Env are most likely involved in different
aspects of viral life cycle, cellular proteins that appeared in both IN and Env
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samples probably represent nonspecific interactions. Some of them were
eliminated as candidates for interaction since they are routinely recovered during
immunoprecipitation and identified by mass spectrometry analysis from human
cells (Cristea et al., 2006). The proteins that are commonly isolated through nonspecific interactions are shown in Table 6.

Proteins recovered from the Env-3xFLAG infected cultures are displayed in
Figure 5.5. Among the proteins recovered from the R7/3-Env-3xFLAG infection,
the CD4 receptor was identified with a high level of confidence. Further
confirmation of peptide sequences recovered from immunoprecipitation samples
are in the process of being analyzed by tandem MS analysis. So far, we have
confirmed MS identification by comparison of parallel mobility fractions in which
wild type infected but untagged control cultures were contrasted with IN or Env
protein recoveries.
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IN
DNA-PK
Nup358

KDa

250
150

Gag-Pol
Pol

100
75

Ku80
INI1
MCM7
Rsf-1

Reverse
transcriptase

50
NARF
37

Integrase

25
20
15

Figure

5.4

The

mobilities

of

proteins recovered

from

the

IN-tagged

immunoprecipitation. In this figure, viral proteins are shown on the left of the gel
lane, the recovered cellular proteins are on the right.
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Table 4. Cellular proteins identified from the IN-3xFLAG immunoprecipitation.
Function Involved

Protein Name

GI Number

Nuclear Import

Nup358

gi|83305554

RanGAP1

gi|4506411

TPR

gi|114155142

POM210

gi|97180292

HECT E3 Ub ligase

gi|51094760

AN1

gi|28376664

NARF

gi|12653339

DNA-PK

gi|113430845

ATP-dependant DNA

gi|10863945

Ubiquitination

DNA Repair

Helicase II (Ku80)
Chromatin Remodeling

SWI2/SNF2

gi|15529034

MN1

gi|94730396

SNF5 (INI1)

gi|27545326

Hsp70

gi|62896815

MCM7

gi|755746

Rsf-1

gi|388788333
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Table 5. Viral proteins immunoprecipitated with 3xFLAG-tagged IN during viral
infection. The expected molecular masses were within the range of their
observed masses.
Protein Name

gi number

Molecular Weight (kDa)

Gag-Pol

gi|94732061

160

Pol

gi|38491490

90

Gag

gi|82568630

55

RT

gi|49574314

66, 51

Nef

gi|47779058

27

Env

gi|46882803

120 (size of gp120)

Vif

gi|32399659

23

p24 (CA)

gi|3183828

24

Protease

gi|24021494

22
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Table 6. Proteins (Homo sapiens) that are obtained in all lanes and
considered as common contaminants in all three immunoisolations.
Protein name

gi number

Myosin VC

gi|9055284

Tubulin beta polypeptide

gi|5729813

Vimentin

gi|340234

Dynein heavy chain domain 3

gi|75677365

Beta actin

gi|16924319

Plectin

gi|41322910

Keratin

gi|7717238
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Env
Golgi proteins
gi|1236759

KDa
250
150

Env
gi|119433

100
75

BiP
gi|6470150

Gag
50 gi|36365464

CD4
gi|2392606

gp41
gi|19172954

T-cell receptor beta chain
gi|22711863

37

CD3E
gi|4502671

25
20
15

Figure 5.5 The identity and mobility of the proteins recovered from the Env
3xFLAG tagged immunoprecipitation. In this figure viral proteins are shown on
the left of the gel lane, the recovered cellular proteins are on the right,
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5.2.3 Immunoblot Analysis of Virus-host Interactions
A series of pilot experiments were initially carried out to test or confirm whether
specific cellular proteins could be co-immunoprecipitated with 3xFLAG-tagged
viral proteins during infection. Immunopurified samples were examined by
Western blot analysis using specific antibodies against the cellular proteins.
Previous small scale immunoaffinity purification experiments of virus with the IN3xFLAG tag did not detect the presence of some cellular proteins documented
with various certainties to interact specifically with integrase such as LEDGF
(Cherepanov et al., 2003), p300 (Cereseto et al., 2005) or Gemin2 (Hamamoto et
al., 2006) by immunoblotting.. However, as shown in Figure 5.6, specific
interaction between the envelope protein and its CD4 receptor was revealed in a
small-scale immunoprecipitation, in which 10 mL continuously infected culture
was used under a lysis condition of 50 mM Tris-HCl, 150 mM NaCl and 1%
Triton. Elution from wild type infected culture was used as control. It should be
noted that these pilot experiments did not entail the cryogenic lysis procedure as
outlined. In addition buffer system was used in these recoveries.
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kDa

Env

WT

64

51

Figure 5.6 Immunoblotting of the Env-tagged HIV-1 immunoisolation using the
wild type infection in parallel as the negative control. Sample identity is indicated.
This blot is probed with the α-CD4 mAb, OKT-4.
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5.3 Discussion
The study of cellular proteins involved in the HIV-1 life cycle has been
complicated by the lack of antibodies with high binding affinities and specificities
against the proteins of HIV-1. Here, we describe the development of a robust
strategy that uses modified infectious virus harboring a potent antigenic tag
within a target viral protein to significantly enrich the recovery of the tagged
protein along with

its associated host protein complexes. Importantly, most

contaminants from the infected culture lysates are removed quickly in a single
step that precedes their rapid identification. The immunoisolation method we use
is based on the studies of our collaborators that use GFP as their proteomic
probe (Cristea et al., 2006; Cristea et al., 2005). The rapid freezing and cryogenic
grinding procedures outlined in these papers uniquely preserve protein
complexes close to their original state in the cell. The buffer conditions used here
have been previously optimized for the immunoprecipitation study of Sindbis
infection. We show here that this proteomic recovery system can be adapted to
more size-restricted genomes like HIV-1 if a high affinity epitope tag is used to
facilitate rapid single-step immunoaffinity isolations. In turn, this procedure
minimizes nonspecific binding while maximizing the recovery of even transiently
interacting cellular partners.

To capture the viral-cellular complexes encountered during infection, the 3xFLAG
tagged IN, Env, Vif, as well as wild type infected target cells were prepared from
large, one-liter cultures of susceptible cells. The yield of the Vif immunoisolation
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was low probably due to the targeted cell type used. The Vif-restricted cell type
HUT78, which does not form syncytia during infection, was used for the
immunoisolation experiment. Since the infection could not be monitored by
following syncytia formation, it was possible that only a small portion of the cells
were infected. The IN-3xFLAG and Env-3xFLAG can serve as controls for each
other since they are completely different proteins but both tagged with the
3xFLAG peptide. In fact, even though the tagged viral proteins normally reside in
different subcellular compartments during infection, the cryogenic methodology
used here is capable of complete mixing of the freeze-fractured compartments
prior to thawing in lysis buffer. Thus, the opportunity for possible non-specific
contamination of the α-FLAG-conjugated beads should be nearly identical
regardless of the tagged viral protein. This makes comparison between proteins
isolated from the IN or Env tagged viral protein purifications discriminatory with
respect to their specific interaction—nonspecific interactions considered to be
present in both elution samples. Many highly abundant cytoskeletal proteins were
observed in both immunoisolations, such as microtubulin and actin. They are
often encountered during mammalian lysate isolations as nonspecific binding
proteins (Cristea et al., 2006), although we cannot rule out the possibility that
these proteins are involved in the directional intracellular transport of viral
contents (Fackler and Krausslich, 2006). On the other hand, a study using an
anti-idiotypic antibody to the V3 domain of gp120 has indicated that vimentin may
participate in the early steps of HIV-1 replication (Thomas et al., 1996). We noted
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that several proteins like vimentin and myosin are present in both samples
raising questions as to the specificity of the reported interactions.

The proteomic analysis of HIV-1 immunoprecipitation from the tagged viral
infections reveals many candidates that have not previously been described to
interact with these viral proteins. The host proteins identified in our preliminary
experiments are components of a wide variety of cellular systems encompassing
a wide spectrum of intracellular pathways. Since the limited genomic complexity
of viruses in particular dictate their substantial reliance on a vast array of different
cellular systems for their survival, the identified cellular proteins, after verification
for specific interaction, should provide potential clues for their role in viral biology.
Table 4 provides a list of the proteins identified to interact specifically with tagged
integrase during infection. Of the unique proteins identified here, some have
been previously been reported to associate with HIV-1 integrase. SNF5, also
known as integrase interactor 1 (INI1), was the first cellular protein shown to
directly interact with integrase (Kalpana et al., 1994). The ATP-dependent DNA
helicase II, also known as Ku80, has been reported to associate with the viral
preintegration complexes containing HIV-1 IN (Li et al., 2001). DNA-dependent
protein kinase (DNA-PK) was also identified in our search. The requirement of
the DNA-PK for IN-interaction activities is controversial. It has been proposed
that, DNA-PK, along with Ku70 and Ku80, play a role in retroviral DNA integration
and protect cells against toxicity induced by HIV-1 Integrase or the integration
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process itself (Daniel et al., 1999). However, other studies have suggested that
DNA-PK is not required for efficient lentiviral integration (Baekelandt et al., 2000).

The primary integral plasma membrane protein required for HIV-1 entry (CD4
receptor) was among the cellular proteins found to interact with Env-3xFLAG
during infection. This indicates that Env 3xFLAG maintains its ability to bind to
this cellular receptor and is consistent with a requirement of this cellular factor for
the growth and expansion of the Env-tagged virus in culture.

The identification of known interactions supports the rationale of our approach.
Traditional methods for the isolation of protein complexes are usually based on
expressing the protein of interest as tagged by N- or C-terminal fusion in the
absence of other viral proteins. This strategy, however, does not always
represent the natural situation for interaction. For HIV-1, the more biologically
relevant way to express a viral protein is to produce it in the context of viral
infection. However, in this case, the location of tag insertion becomes critical.
Although 1xFLAG tag insertion at the C-terminal end of IN and insertion of 1xHA
tag at the C-terminus of Vif has resulted in replication-competent virus (Petit et
al., 1999; Yu et al., 2003), one cannot expect this outcome for all viral proteins.
The cloning of a tag at the N- or C-terminus might affect polyprotein processing.
In addition, over the past 8 years since the initial publication of the 1xFLAG-IN
virus, no reports using this virus for proteomic studies have appeared in the
literature. The reason for lack of its use may be reflected in data from our
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laboratory using a related 1xFLAG tagged virus at the identical position (IN 280)
as in our valuable 3xFLAG-IN virus. Using this 1xFLAG-tagged virus, we have
been unable to quantitatively recover IN from infected cells (see above).

We developed the transposon-based insertion strategy to select at random,
those sites in the targeted viral protein that can tolerate an insertion. This
procedure is without human bias and allows the virus itself to self-select the most
inert position for insertion. We feel that the strategy employed here is an efficient
and potentially powerful approach that is generally applicable to the study of
other viral proteins.

As shown in table 4, proteins eluted from 3xFLAG-IN viral infections contain
many proteins from several important cellular systems, including the nuclear pore
complex, the ubiquitin/proteasome system, the DNA repair and the chromatin
remodeling assemblages. In addition, we have also identified membraneassociated proteins, an RNA export factor and ADP/ATP carrier. However, at
present, the relevance of these proteins to viral biology is unclear. While most of
these proteins provide important possibilities for influencing viral function, the
present observations only represent a starting point for further extensive
analyses. MS/MS and I-DIRT will be used to confirm the peptide sequences and
verify the presence of the cellular proteins in the immunoisolations. Further
studies such as co-localization, reciprocal immunoprecipitation and RNAi will be
needed to determine the relevance of these host proteins to viral life cycle.
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The I-DIRT technique can be used to determine whether a given interaction is
specific (Tackett et al., 2005). Briefly, cells infected with the replicationcompetent virus expressing an affinity-tagged viral protein are grown in light
isotopic medium while wild-type cells or cells infected with wild type HIV-1 are
grown in heavy isotopic medium such as DL-lysine-4,4,5,5-d4 2HCl (d4-lysine).
(The molecular weight difference between the two isotopes is 4 Daltons.) Equal
amounts of the two preparations are then mixed and the isotopically light affinitytagged protein is immunoisolated. Both specific and nonspecific interacting
proteins will be recovered with the affinity-tagged protein. Interactions that are
specific will form with the tagged protein prior to cell lysis, and will be exclusively
light labeled. In contrast, nonspecific proteins, which form their association with
the tagged protein after thawing of the lysed mixture of light and heavy cells, will
be both isotopically heavy and light labeled. After isolation of the affinity-tagged
protein complex and trypsin digestion of the co-enriching proteins, specifically
interacting proteins are identified by mass spectrometry as isotopically light, while
nonspecifically interacting proteins appear as a mixture of light and heavy
isotopes.

We believe that abundant and high affinity binding cellular proteins are more
likely to be immunoisolated with the tagged viral proteins from infection. The
buffer conditions used for our large-scale immunoprecipitation (20 mM K-HEPES,
pH 7.4, 110 mM KOAc, 2 mM MgCl2, 0.1% Tween 20, 1% Triton, 0.5%
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deoxycholate, 0.3 M NaCl, and 25 U/mL DNase) were originally optimized for
Sindbis immunoprecipitation (Cristea et al., 2006). Buffer conditions are critical
having effects on the subset of cellular proteins co-immunoprecipitated with the
tagged viral proteins. For example, binding of IN to LEDGF has been assayed in
vitro in 25 mM Tris-HCl, 0.1% NP-40, 20 mM imidazole containing 150 to 400
mM NaCl in the presence of 1 mM MgCl2 (Busschots et al., 2005), a much milder
set of conditions than the ones used in our study here. A panel of detergents as
well as different salt concentrations can be used to optimize the 3xFLAG tagged
viral protein immunoprecipitation from the HIV-1 infected cells. It is possible that
under certain modified buffer conditions, additional interacting cellular factors
including other known integrase binding partners such as LEDGF and Rad18
may be revealed.

Meanwhile, infection of different cell types might result in an overlapping but
distinct set of cellular proteins recovered during immunoisolation. For example,
infection of primary macrophage cells or other non-dividing cell types may reveal
factors involved in active nuclear import of the virus, perhaps being more
abundant in these cells.

In our study, only one 3xFLAG clone has been selected for each of the original
target proteins. It is quite possible that viruses with tags positioned at different
locations within a viral protein would also be infectious. Recovery of the same set
of host factors from tags placed at different locations within a target protein would
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provide compelling evidence for authenticity of the interactions. Conversely, while
most of the set of recovered host proteins would be expected to be the same, it is
also possible that a few cellular proteins might be recovered with only one of the
tagged proteins. Genomic fingerprinting can assist in the identification of new
sites in the targeted protein most amenable for further insertional modification.

There are several caveats to be considered when interpreting the data. First, the
tagged viral proteins were recovered from continuously infected culture, which is
a mixture of all stages of the viral life cycle after seven days of continuous
propagation. Therefore, particular host protein recovered might only represent a
negligible portion of the whole infected culture. Second, the expression level and
variety of cellular proteins can change during the course of infection. Interaction
observed at a certain point of the viral life cycle might result from differences in
the expression levels of cellular proteins. Another consideration is that while the
MS analysis used here identified many proteins, some known cellular partners
were not detected. For example, the lens epithelium-derived growth factor
(LEDGF/p75), a factor known to interact with HIV-1 integrase (Cherepanov et al.,
2003; Maertens et al., 2003), was not detected in the IN elution. Failure to
identify a particular protein by MS does not necessarily indicate that the protein is
not present in the analyzed sample, since the absence of identifiable peptides
can be due to several technical factors. In this case, because the samples were
treated with integrase inhibitor prior to lysis, some protein interactions might be
partially blocked in the presence of this compound. This reflects the intrinsic
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difficulty in identifying proteins present in relatively small amounts within complex
mixtures, even after large-scale purification. Alternatively, since the IN-LEDGF
interaction was detected only upon physical cross-linking and in the context of an
IN domain yeast two-hybrid search, the LEDGF-IN interaction may not be of
sufficient strength to be detected here.

There are a few limitations of this strategy if it is applied to other HIV-1 genes.
HIV-1 has several overlapping reading frames, for example, pol overlaps with vif,
env overlaps with rev and tat. Insertions into the overlapping region of one
protein would necessarily result in the mutagenesis of the other. In the case of
integrase, this problem was alleviated by using Vif-permissive target cells.
However, to circumvent this problem in general, cells that constitutively express
one of the viral proteins can be used as the target cells for infection or expressed
in cells assembling the virus in either case to preserve the function of the
particular viral protein.

Our MS analysis has identified cellular proteins potentially involved in various
aspects of virus replication, but also identified proteins whose presence is difficult
to interpret based on current knowledge. Several explanations are possible. First,
the cellular proteins have unknown functions, or multiple pertinent functions other
than which they are best known (Jeffery, 2003). Second, some of the proteins
identified here also could be simply adhered to the viral protein nonspecifically
and are not functionally relevant. However, this proteomic analysis represents
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important data because it provides the basis for further studies aimed at the
involvement of cellular proteins and their pathways in the HIV-1 replication cycle.
Such studies will provide additional information about the various pathways used
by HIV-1 in infected cells, raise interesting questions about the possible
contributions of these viral assisting molecules in HIV-1 pathogenesis, and may
eventually point to potential cellular targets for novel approaches to therapeutic
intervention of HIV-1 infection.

The electrophoretic mobility of many of the observed proteins from the
preparative gel corresponds to their expected size as deduced from their amino
acid sequences.

For example, Ku80 was found in the gel fractions

corresponding to 80 kDa. However, some of the proteins were identified outside
of the normal molecular weight range. For example, IN was found in range 20
kDa to 50 kDa. However, this might represent a special case because IN is also
a component of the large (183 kDa) Gag-Pol protein and other of its intermediate
proteolytic intermediates that are larger than the mature IN molecule. Posttranslational

modifications,

such

as

phosphorylation,

ubiquitination

or

glycosylation may cause proteins to migrate more slowly than expected and to be
found in higher molecular mass bands on the SDS gels. On the other hand,
some proteins migrated at a faster rate, reflecting a lower molecular mass than
expected for the full-length proteins. The presence of truncated forms of cellular
proteins might be due to their degradation, alternative splicing of their mRNA or
post-translational cleavage by non-specific cellular proteases.
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MS also detected several viral proteins from the IN-3xFLAG immunoprecipitation.
This list includes Gag-Pol, matrix (MA), capsid (CA), p51 and p66 reverse
transcriptase (RT), protease (PR), Nef, Vif and p24 (Table 5). As described in the
previous paragraph, the biological significance is potentially masked by the fact
that during its maturation, IN is expressed as in integral portion of the Gag-Pol
polyprotein, only cleaved by HIV-1 PR after egression of the virion from the
producer cell (Vogt, 1996). On the other hand, Gag processed products (MA and
CA), RT and IN are thought to be part of the RTC/PIC. Therefore, it is not
possible to distinguish between these two possibilities in the current experimental
setting. Immunoprecipitation experiments at different time points synchronized
after infection can be used in the future to address this question.

During the development of our strategy, various tags were tested including Strep,
1x- and 3x-FLAG and a biotin receptor tag (SNAGG) where biotin can be added
co-translationally by co-expression of the bacterial bir-a gene in cells. The
1xFLAG tag is considerably smaller than the 3xFLAG tag and its addition results
in viruses that are less compromised for replication. However, the binding affinity
of the M2 α-FLAG mAb for 1xFLAG is at least 1-2 orders of magnitude weaker
than it is for 3xFLAG. The strep-tag and the SNAGG-tag utilize the extremely
strong binding between biotin and streptavidin (Wilchek and Bayer, 1990). They
have the advantage of being relatively uncharged, neutral and smaller compared
to the acidic 3xFLAG tag, and therefore, perhaps more likely to be less

157

structurally disruptive. Surprisingly, these tags were both less efficient and less
specific during immunoaffinity isolation. It is possible that the shorter tag is
hidden, buried or unavailable for antibody or binding partner accession. It has
also been documented that some engineered biotinylated molecules often bind to
streptavidin with affinities that are reduced by several orders of magnitude,
compared to the extremely high affinity of native biotin for streptavidin (Chilkoti et
al., 1995).
The abundance and the affinity of the strength of the binding are both critical
parameters for successful immunoprecipitation results. Infections of cell types
other than T cell lines were examined for tagged protein recovery. For example,
GHOST(3)X4R5 and HeLa P4R5 cells were used because these adherent cell
types can be efficiently infected and used to detect the intracellular trafficking of
the tagged viral protein after infection. We also tried a cross-linking treatment
were performed with the tagged viruses to probe weak or temporary interactions.
The VSV-G envelope was used to pseudotype tagged virus as it is more
infectious than either the X4- or R5-tropic HIV-1 Env and allows entry into almost
all mammalian cell types at high m.o.i. However, the VSV-G pseudotype strategy
can only be used for a single round of viral infection. In the end, the best system
for proteomic studies is the infection of T cell lines with a 3xFLAG tagged virus
specifying the natural X4-tropic HIV-1 Env protein. This approach clearly results
in the most available substrate for immunoprecipitation by virtue of the
amplification and expansion of the virus over a several day period. Thus, the
conditions to obtain the most prodigious viral expansion during T cell infection
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‘scale-up’ have been optimized to obtain the largest amount of the targeted viral
protein for our studies.

The keys to the success of our approach include the random introduction of a
potent, yet relatively small, tag within a specific HIV-1 viral coding region, the
incorporation of a stringent selection for the viruses that can accommodate the
tag yet remain infectious in culture and the use of state-of-the-art tools to identify
host proteins associated with viral proteins after their recovery from infected
cells. Our study of proteins that interact with HIV-1 IN, Env and Vif during natural
infection represents a “breakthrough” technology that can be further developed to
identify cellular factors that associate with other viral proteins. The work
presented here only represents a first step in the comprehensive description and
characterization of the intricate interactome that must exist at the interface of
virus and host. As an extension of this approach, animal models can be studied
using a similar approach to investigate virus replication, spread, and
pathogenesis in vivo. Of course this represents a higher degree of difficulty since
success in an animal system not only depends on the ability to insert a tag within
a protein without disrupting its function but most importantly, long-term stability of
the recombinant tag.

A similar strategy has been reported to study Sindbis virus in vitro using
replication-competent GFP-tagged viruses (Atasheva et al., 2007; Cristea et al.,
2006; Navaratnarajah and Kuhn, 2007). We have considered use GFP protein as
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a possible insertion since the GFP tagged viral protein can be visualized by the
green fluorescence during infection. However, the 27 kDa GFP is a relatively
large insertion compared to the compact genome of HIV-1. An attempt to insert
GFP into the PmeI site within the HIV-1 V1-V3 region of envelope was not
successful. Independently developed, our system is the first one for the study of
HIV-1 proteins and overcomes the major hurdle of intergenic recombination.
Therefore, we predict that the presently described technique will be broadly
applicable to many viral systems and will greatly facilitate our understanding of
the molecular details of the complex interplay between the virus and the host
during pathogen establishment and persistence.
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Implications of Current Study and Prospect for
the Future
We have successfully developed a system to molecularly engineer HIV-1 in such
a way that the incorporation of a foreign immunological tag does not appreciably
affect sustained viral replication in culture. Using independently tagged
replication-competent derivatives we have recovered host proteins that interact
specifically with the tagged viral protein from continuous infection. Mass
spectrometry has generated a list of potential interacting partners for each viral
protein. In addition to reproduce the large-scale immunoprecipitation from
infected material and the mass spectrometry analysis, several methods will be
used to validate the identified host factors. Immunocytochemistry of the
interaction will be studied. A coherent pattern of subcellular localization between
the viral and host proteins may suggest the association of the proteins in the
intracellular environment. For immunofluorescence studies, cells will be cotransfected with an epitope-tagged cellular protein and its putative viral ligand.
Alternatively, the host protein subcellular localization will be investigated in the
context of viral infection using the epitope tagged virus. The location of each
protein alone will be first examined. It is conceivable that co-expression of the
viral and host proteins might result in the relocalization of the host protein to a
new intracellular compartment. This would be consistent with the interpretation
that the two proteins interacted either immediately before or during intracellular
relocalization. Fluorescence resonance energy transfer (FRET), which exploits
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the fact that energy can be transferred from a fluorophore donor in the excited
state to a fluorophore acceptor when it is in close proximity (<100 Angstroms),
can be adopted to investigate the direct association between two intracellular
molecules. (Jares-Erijman and Jovin, 2006). Reciprocal immunoprecipitation will
be employed to validate specific interactions. In addition, RNAi/siRNA can be
used to inquire about the importance of a suspected interaction to viral
replication, as exemplified by the study of Tsg101 depletion (Garrus et al., 2001).
Tsg101 complete ‘knockdown’ was achieved and resulted in a significant
reduction of viral particle release and infectivity, which could in turn, be rescued
by re-introduction of the Tsg101 gene. Furthermore, immunoprecipitation using
various truncated forms of the viral and cellular proteins can be employed to map
the binding domains or sites in both proteins, which can also be confirmed by
immunofluorescence microscopy. Finally, trans-dominant mutants might be
generated for suspected host interacting factors and used much as RNAi/siRNA
is to abrogate the function of the cognate wild type factor during the process of
infection or in virion-producing cells.

It is possible that a single viral protein can bind to different cellular proteins at
different times and/or locations during various steps of the HIV-1 infectious cycle,
especially for a protein like HIV-1 integrase that is proposed to be multifunctional. To be more comprehensive in our study, our approach can be used to
investigate interactions at particular stage during viral life cycle by synchronizing
infections. We believe our approach will allow us to observe rare, transient
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interactions that would only become apparent in synchronized HIV-infected
cultures at various points of viral replication or stages of the cell cycle. A
synchronized infection can be achieved by infecting target cells with a replication
competent tagged virus for 0.5 hours at 15oC. The cells will then be washed
extensively to remove extra viruses attached to the cells or in the medium and
placed at 37oC to initiate infection. Therefore, viruses will enter the cells at
approximately the same time point starting the replication cycle. Synchronously
infected cells will be harvested and assayed at selected time points (i.e. 2, 8, 12
or 24 hours) post-infection. The tagged viral protein(s) recovered at various time
points within a single-cycle infection has the potential to retrieve entire
complexes at particular stages. These types of studies will not only reveal the
dynamic extent of HIV-1 replication and its cellular cofactors, but also may
increase the chance of detecting any transient integrase-cellular complexes
normally existing at low concentration since all of the viruses will be at the same
step at the same time.

In addition to identifying regions within the proteins that can tolerate insertions
without adverse effects on viral growth, the transposon linker scanning libraries
can also be used for structure/function characterization of HIV-1 viral proteins. If
the protein of interest is saturated with a library of random insertions, the
distribution of the insertions can reveal important information with regard to
different regions of the protein. For example, regions of a viral protein less
amenable to linker insertion (i.e., regions in which few viable tagged derivatives
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can be obtained) indicates that this region of the protein is critical to protein
structure or function, while insertional “hot spots” suggests that those regions are
highly flexible sequences or possibly surface accessible. Predictably, organisms
with small genomes and regions of overlapping reading frames will have very
stringent requirements with regard to insertional tolerance. Consistent with this
interpretation, only one or two places within the three HIV-1 proteins we initially
targeted could accommodate a five amino-acid insertion. However, this survey
although comprehensive for the presence of diverse insertional points within the
specific viral protein, was not exhaustive with respect to the independent and
reiterative selections for viable tagged mutant viruses. It is not inconceivable that
if

this

system

was pushed further, new insights about viral protein

structure/function relationships might emerge.

Epilogue
Studies presented here provide an innovative strategy to elucidate of the
complex interactions between cellular and viral proteins during HIV infection, and
can be extended to other areas of research. It should be a great asset not only
for providing insight in HIV biology but also for discovery of unexpected targets
for its antiviral intervention.

The strategy developed here can be used to generate replication competent
viruses with an epitope tag insertion in any viral coding region. As a result, it is a
powerful molecular tool that can lead to the identification of a variety of host
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factors (and their complexes) interacting specifically with the tagged viral proteins
during an infectious viral cycle. This systematic approach could possibly identify
networks of cellular proteins that are involved in viral replication. The utility of
tagged viruses extends beyond the scope of cellular protein interaction studies.
For instance, the viruses with specific biochemical or immunologic tags can be
used to examine the intracellular localization of viral proteins with much greater
sensitivity than in the past. This will allow the visualization of tagged viral proteins
during infection. Indeed, HIV-1 IN has been labeled with a small tetracysteine
tag, which preserved infectivity of the virus while allowing it to be labeled with the
bis-arsenical fluorescein derivative, FlAsH. This labeling allowed image
processing of both intracytoplasmic and intranuclear HIV-1 complexes in three
dimensions over time (Arhel et al., 2006). Insertion of a tag for visualization will
provide new insights into the various movements of HIV-1 complexes within
infected cells and provides the basis for the study of the dynamic virus-host cell
interactions that occur during infection.
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Appendix 1: HIV-1 Integrase Interacts with RNA
Helicase A in vitro

A 1.1 Introduction
HIV-1 integrase (IN) is a viral protein that displays pivotal roles in virus replication
and pathogenesis. It is the key player in viral cDNA integration into the host
chromosome (Coffin et al., 1997). In addition, this viral protein has also been
shown to contribute to other steps during the early stages of viral replication,
including reverse transcription (Wu et al., 1999) and viral DNA nuclear import (Ao
et al., 2007). Several cellular binding partners for IN have been reported,
including SNF5/INI1 (Kalpana et al., 1994), LEDGF (Cherepanov et al., 2003;
Kalpana et al., 1994), and p300 (Cereseto et al., 2005). The identification of
these cellular factors has provided valuable insights into IN function.

In an attempt to search for cellular factors that interact with HIV-1 IN, we used in
vitro affinity purification coupled with mass spectrometry. We show that IN can
specifically recover RNA Helicase A (RHA) in various cells using a variety of INderived probes. In addition, the subcellular localization of both proteins was
investigated.

RNA helicase A (RHA, gi|100913206) is a member of the DEXH-box (where X
can be any amino acid) family of proteins. It is also termed nuclear DNA helicase
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II (NDHII) or DHX9 (Rocak and Linder, 2004). RHA contains a helicase core
domain consisting of seven motifs that are conserved in all RNA helicases and
two copies of a double-stranded RNA binding domain in the N-terminal region
(Zhang and Grosse, 1997). RHA is a nuclear protein that shuttles between the
nucleus and the cytoplasm with the assistance of a bidirectional nuclear transport
domain consisting of 110 amino acids within the C-terminus (Tang et al., 1999).
Its function is subject to regulation by arginine methylation, a modification
catalyzed by protein-arginine methyltransferase 1 (PRMT1) (Smith et al., 2004).
RHA is able to unwind double-stranded RNA or DNA with the energy derived
from the hydrolysis of NTPs by virtue of its NTPase activity (Lee and Hurwitz,
1992). This property enables RHA to participate in multiple cellular processes
from RNA transcription to RNA processing to RNA nuclear export.

In light of its multiple functions in cellular RNA metabolism, it is reasonable to
question if RNA helicases, or RHA in particular, regulates the activity of HIV-1
RNA. Indeed, RHA has shown to stimulate transcription of HIV-1 RNA (Fujii et
al., 2001). The underlying mechanism appears to involve the binding of RHA to
the transactivation response element (TAR) located at the very 5' end of all HIV-1
RNAs. This interaction is mediated by the double-stranded RNA binding domains
within the N-terminus of RHA and is reminiscent of the interaction between TAR
and the TAR-binding protein (Gatignol et al., 1991). It is perceived that, by virtue
of its ability to bind TAR, RHA either modulates the transactivation activity of Tat
or can indirectly influence RNA polymerase II in initiation/elongation from the viral
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long terminal repeat (LTR). In addition, RHA also seems to enhance the Rev-Rev
response element (RRE) control of late viral gene expression (Li et al., 1999).
Since RHA itself exhibits weak interaction with the RRE and is thus unlikely to
play a direct role in the export of the genomic viral RNA, RHA may promote the
release of these unspliced RNAs from spliceosome.

In addition to its involvement in HIV-1 gene expression, a recent finding has
revealed that RHA contributes to HIV-1 particle assembly and reverse
transcription. RHA is shown to associate with constituents of the HIV-1 Gag
protein and is packaged into virions in an RNA-dependent manner (Roy et al.,
2006). It is demonstrated that siRNA mediated RHA-knockdown produces
significantly less infectious viral particles. Thus it is conceivable that RHA gains
access to the viral assembly machinery simply by binding to HIV-1 RNA.
Interestingly, defective particles with no or diminished levels of RHA also showed
reduced virion-associated endogenous reverse transcriptase activity. In this
respect, RHA might assist HIV-1 reverse transcriptase to more efficiently copy
viral genomic RNA by unwinding its secondary structure or promoting the
interaction of this RNA with the nucleocapsid protein in order to assemble into an
active reverse transcription complex.
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A 1.2 Results
A 1.2.1 Precipitation of RHA from Various Immunoprecipitations with
Integrase or Its SH3 Domain
To investigate cellular factors that interact with IN, various DNA constructs were
created to fuse integrase or its C-terminal SH3 domain (amino acids 220-270) to
high affinity tags such as the 3xFLAG epitope or EGFP-MBP. The 3xFLAG tag
was inserted at IN residue 280 instead of the N- or C-terminal end. Since
3xFLAG tag insertion at this particular position results in a replication competent
virus (see above), it is likely that ectopic expression of IN with the 3xFLAG-tag
incorporated

at

residue

280

maintains

proper

IN

structural/functional

relationships and as such, is likely an excellent substrate to probe natural host
interactions encountered by this protein in the cell. The 3xFLAG-tagged IN was
expressed transiently in transfected 293T cells. Following immunoaffinity
purification, SDS/PAGE and Coomassie blue staining was used to visualize
recovered proteins. Individual protein bands were excised and subjected to mass
spectrometry analysis, as shown in Figure A1.1. RHA was identified in the band
corresponding to the molecular weight RHA of 140 kDa (Nakajima et al., 1997).
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Figure A1.1 Immunoaffinity purification of protein complexes using 3xFLAGtagged IN and visualized by Coomassie staining. RHA and IN, boxed and
indicated with arrows were identified by mass spectrometry. Control (C) was
transfected with pcDNA3.1.
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Previous reports have shown that the integrase C-terminal domain (IN CTD) is
important for various functions of integrase (Lu et al., 2005; Lutzke and Plasterk,
1998). Research in our lab has focused on the nuclear localization property
associated with the IN-CTD, which has been mapped to about 45-50 amino acids
that in three dimension elaborates an SH3 domain (220-270). We have shown
that when IN-CTD is fused with EGFP-MBP (67 kDa) it resides in the nucleus,
while a triple Lys-to-Ala substitution mutation at positions 262, 263 and 266
results in its cytoplasmic localization. To search for cellular proteins that bind to
this particular region, EGFP-MBP was fused to the IN-SH3 subdomain. The triple
mutant fusion protein EGFP-MBP-IN(SH3K(262/3/6)A) was constructed as well and
used as a control. Figure A1.2 shows the immunoisolation of the fusion protein
using α-GFP antibody. Transfection efficiency was determined by the green
fluorescence associated with EGFP expression. In this experiment more than
50% of the 293T cells express the EGFP fusion protein. The majority of the INSH3 fusion was observed in the nucleus while the triple mutant fusion was
restricted to the cytoplasmic compartment (Figure A1.2). Endogenous RHA was
identified by mass spectrometry in the sample isolated from the wild type IN SH3
domain fusion protein in the region of 150 kDa. The entire sample and control
lanes were subjected to MS analysis. RHA was absent in control lane of EGFPMBP-IN(SH3K(262/3/6)A).
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Figure A1.2 Immunoaffinity purification of EGFP-MBP-IN(SH3) and its
associated proteins. The expression of green fluorescence and the subcellular
localization are shown on the left. RHA and IN, boxed and indicated with arrows
were identified by mass spectrometry. (in collaboration with Dr. Ileana Cristea in
the Laboratory of Dr. Brian Chait).
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Similarly, RHA was specifically immunoprecipitated from a CEM cell lysate using
amylose magnetic beads bound to recombinant MBP-IN(SH3) fusion protein
expressed and purified from bacteria (Figure A1.3). Here, an unrelated SH3
domain, Sso7d (Baumann et al., 1994), was fused with MBP to create MBP-Sso7
and used as a structurally-similar control. Unfused MBP was also used as a
negative control. RHA was not identified from control bands cut from the gel in
the region of interest. This system differs from the one described above for
transfected mammalian cells because the fusion protein was first produced in E.
coli and then bound to amylose magnetic resins before its incubation with a
target T cell lysate and therefore provides evidence that IN may interact with
RHA in an unmodified form.

A 1.2.2 Validation of the RHA-IN Interaction by Immunoblotting
To verify the interaction between RHA and IN, N-terminal 3xHA-tagged RHA and
3xFLAG-tagged IN280 were co-transfected in 293T cells. As controls, cells were
transfected with 3xHA-RHA or IN-3xFLAG alone. Immunoprecipitation was
performed with α-FLAG. As shown in Figure A1.4, the presence of 3xHA-RHA in
the affinity purification was detected when the membrane was probed with α-HA.
There were no signals corresponding to 3xHA-RHA in the control lanes where
tagged RHA or IN was separately expressed. These results indicate that 3xHARHA can be specifically immunoprecipitated with IN-3xFLAG. However,
reciprocal precipitation using α-HA conjugated beads failed to pull out 3xFLAG
tagged integrase under the conditions used.
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Figure A1.3 Immunoaffinity purification of MBP-IN(SH3) and its associated
proteins using a bacteria-mammalian system as described in the text. RHA and
MBP-IN(SH3) were confirmed by MS analysis and indicated with arrows. (in
collaboration with Dr. Ileana Cristea in the Laboratory of Dr. Brian Chait).
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Figure A1.4 Immunoprecipitation of 3xRHA with IN-3xFLAG. Cells were
incubated with α-FLAG and probed with α-HA. Elution lanes are on the right. (1)
3xHA-RHA alone, (2) IN-3xFLAG alone, (3) 3xHA-RHA + IN-3xFLAG. A portion
of the input total lysates is probed on the left.
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A 1.2.3 Subcellular Localization of RHA and Integrase
RHA is a nuclear protein and shuttles between the nucleus and the cytoplasm
(Tang et al., 1999). Expression of HIV-1 integrase in mammalian cells is mainly
localized to the nucleus. To investigate to what extent RHA and IN co-localize
within cells such that they can interact, 293T cells were co-transfected with
EGFP fused to the N-terminal of IN (EGFP-IN) and 3xFLAG tagged RHA
(3xFLAG-RHA). Indirect immunofluorescent staining was performed using αFLAG. As shown in Figure A1.5, 3xFLAG-RHA was mostly observed in the
nucleus with a small, but detectable amount in the cytoplasm. Interestingly, RHA
was observed to be slightly more concentrated at the nuclear envelope (Figure
A1.5 B and C). This is consistent with the report that RHA is present in a highly
enriched NPC fraction (Gatfield et al., 2001). Similar to RHA, both EGFP-IN and
EGFP-MBP-IN(SH3) were mainly localized in the nucleus with trace amounts in
the cytoplasm. When the fluorescent signals for RHA and EGFP-IN (or EGFPMBP-INSH3) were merged, we observed that wild type integrase and RHA were
both localized to the nucleus but at this level of discrimination, no evidence for
co-subnuclear localization could be established. On the other hand, the nuclear
localization triple mutant fusion protein EGFP-INK(262/3/6)A was excluded from the
nucleus. It did not change the distribution of RHA, consistent with our finding that
the IN triple substitution mutant does not interact with RHA.
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Figure A1.5 Subcellular localization of 3xFLAG-RHA and various EGFP-IN
fusions in 293T cells.
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A 1.3 Discussion
In this study, we provide evidence that RHA associates with HIV-1 integrase.
Integrase is an important viral enzyme and a component of the machinery that
provides nuclear localization, integration and coordinates DNA repair for the
virus. Taking the results obtained from other laboratories into consideration, we
speculate that RHA might be involved in multiple steps of viral life cycle through
its interaction with IN. It might exert an effect through modeling the secondary
structures of viral RNA or rearranging RNA-protein interactions. Considering the
sophisticated protein-protein and protein-RNA interactions that take place during
generation of virus particles, it is not surprising that the virus utilizes the RNA
binding ability of an RNA helicase, like RHA, to regulate these complex molecular
events.

RHA is one of the few RNA helicases that have been reported to play a role in
HIV-1 replication. It has been found to be incorporated into the HIV-1 virion and
may participate in HIV-1 reverse transcription as well as particle assembly (Roy
et al., 2006). It has also been reported to impact HIV-1 transcription through its
interaction with TAR (Fujii et al., 2001). HIV-1 particles that do not contain RHA
show reduced virion endogenous RT activity (Lu et al., 2005; Wu et al., 1999). It
is possible that RHA may directly assist viral RT in the coping of vRNA into cDNA
through unwinding RNA secondary structures or regulation of the interactions RT
makes with other factors to form a functional reverse transcription complex.
Coincidentally, IN has been documented to affect RT activity as well. It would be
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interesting to determine if RHA play a direct role in reverse transcription or
indirectly influences RT activity through its interaction with IN. A summary of
possible RHA and HIV-1 interaction nodes is summarized in Figure A1.6.

The function of RHA might be related to HIV-1 replication in other ways. The
regulatory activity of RHA in RNA transcription is implicated by its presence
within the RNA polymerase II holoenzyme complex. For example, RHA has been
shown to bridge the interactions made between RNA polymerase II and
transcription co-activators such as CREB-binding protein and BRAC1 (breast
cancer-specific tumor suppressor protein 1) (Nakajima et al., 1997). RHA also
directly interacts with the p65 subunit of NF-B and stimulates NF-B-mediated
reporter gene expression (Tetsuka et al., 2004). With regard to RNA nuclear
export, RHA directly binds to the constitutive transport element (CTE) RNA of
type D retroviruses. In addition, together with the cellular factors Tap (Tipassociated protein) and HAP95 (helicase A-binding protein 95), RHA promotes
the export of CTE-containing RNA molecules (Tang et al., 1997). Finally, RHA
has been shown to interact with Ubc9 and leads to the SUMO-1 conjugation of
RHA both in vitro and in vivo (Argasinska et al., 2004).
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Figure A1.6 A Schematic representation of the possible involvement of RHA at
the steps of reverse transcription, proviral transcription and in downstream posttranscriptional events of HIV-1.
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Research in our lab has shown that HIV-1 IN interacts with the DNA repair
protein Rad18 (Mulder et al., 2002) and part of the Rad6 DNA repair pathway is
associated with modification of PCNA by ubiquitin (Hoege et al., 2002).
Furthermore, Rad18 forms a tight complex with Rad6 both in yeast and
vertebrate cells (Bailly et al., 1997; Tateishi et al., 2000) and it has been shown
to be mono- and poly-ubiquitinated in a Rad6-dependent manner (Miyase et al.,
2005). Rad6 is a member of the E2 Ub-ligase family (also named UBC2). Rad18,
like many other E3 enzymes, contains a RING finger domain. In both yeast and
vertebrate cells, Rad18 also contains the RING domain within its NH2-terminal
region. This may suggest that Rad18 functions as an E3 recognin. It was
subsequently found that Rad18 is involved in the monoubiquitination of PCNA in
cells treated with DNA-damaging agents – PCNA monoubiquitination critical for
polymerase switching in trans-lesion DNA synthesis (Hoege et al., 2002;
Kannouche et al., 2004; Stelter and Ulrich, 2003). It would be interesting to see
whether RHA is ubiquitinated and functions through the same or a similar
pathway during HIV-1 infection via its interaction with IN.

It has been suggested that RHA initiates its interaction with HIV-1 genomic RNA
within the nucleus and that this interaction persists throughout the subsequent
events that occurs until the genomic RNA is incorporated into viral particles (Roy
et al., 2006). To resolve whether there is direct interaction between IN and RHA
or whether it is RNA dependent, the effects of RNase treatment to RHA
immunoprecipitation with IN is being studied. Preliminary results showed that the
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addition of RNase did not eliminate the interaction between RHA and IN.
However, further experiments such as addition of an RNase inhibitor, RNA
detection or binding experiment using purified proteins are necessary to confirm
this observation.

Our experiments using IN SH3 domain fusion proteins shows that the SH3 is
sufficient for the binding of IN to RHA. Although RHA was recovered with fulllength IN, we have so far been unable to show reciprocal immunoprecipitation
using N-terminal-tagged RHA. It is possible that the N-terminal tagging in RHA
interferes with the putative RHA-IN interaction. Immunoprecipitation using Cterminal tagged RHA will help address this potential problem. Although
subcellular localization studies demonstrate that both proteins are predominantly
within the nucleus, we are unable to reach a conclusion concerning the potential
co-localization between RHA and IN within this cellular compartment.
Fluorescent resonance energy transfer (FRET) analysis might help to address
this question. Detailed MS or MS/MS analysis of immunoaffinity isolation of IN3xFLAG tagged viral infection is underway to investigate if RHA is present in the
elution. This would be a further indication of an RHA-IN association that is active
during active viral infection.

In summary, our study demonstrates the association of RHA with ectopicallyexpressed

HIV-1

IN by

immunoprecipitation.

mass

Further

spectrometry
experiments,
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analysis

and

including

verified

by

reciprocal

immunoprecipitation, FRET microscopy and mapping of the binding domain are
necessary to authenticate this interaction.
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Appendix 2: Investigation of HIV-1 Integrase PostTranslational Modifications

A 2.1 Introduction
Post-translational modifications (PTMs) are covalent modifications that change
the properties of a protein by proteolytic cleavage or by addition of a modifying
group to one or more amino acids. They modulate the activity of most eukaryote
proteins by defining its active state, localization, turnover and interactions with
other proteins. Examples of the biological effects of protein modifications include
phosphorylation in signal transduction pathways (Cohen, 2000), ubiquitinationdependent proteolysis (Tyers and Jorgensen, 2000), transcriptional activation via
acetylation (Wang et al., 2005), attachment of fatty acids for membrane
anchoring and association (Resh, 2006) and glycosylation can affect protein halflife (Sinclair and Elliott, 2005). Analysis of these modifications presents
formidable challenges but their determination can generate indispensable insight
into biological function. To map modification sites in molecular detail, biochemical
characterization (Gesellchen et al., 2006), site directed mutagenesis (Ragolia et
al., 2007) and novel mass spectrometric peptide sequencing and analytic
technologies have been successfully applied (Larsen et al., 2006; Mann and
Jensen, 2003).
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Post-translational modification is of great interest for the study of viruses.
Pathogens have coevolved with their hosts and acquired the ability to optimize
their replication by taking advantage of cellular signaling networks (Manes et al.,
2003). This strategy of survival becomes extremely important for small parasites
such as viruses. The post-translational state of many viral proteins might have
evolved to intercept, disrupt, mimic or usurp numerous signaling pathways in
their hosts (Kahn et al., 2002).

HIV-1 IN has been shown to undergo post-translational modification by
acetylation (Cereseto et al., 2005). HIV-1 IN is a substrate for histone
acetyltransferase (HAT)-mediated, p300 posttranslational acetylation both in vitro
and in vivo. Interestingly, p300 modification targets lysine residues within the Cterminal domain of integrase (IN-CTD). The IN-CTD is known to possess intrinsic
DNA binding activity in vitro (Engelman et al., 1994; Gao et al., 2001; Lutzke and
Plasterk, 1998). The ability of many proteins to bind DNA is affected by p300
acetylation (Gu and Roeder, 1997; Wang et al., 2005). It is of great interest to
see if posttranslational acetylation by p300 in some way regulates the function(s)
of HIV-1 integrase. To confirm the above observations and to characterize the
reported acetylation mutant, we mutagenized an R7/3 proviral clone at the IN
codons for lysine (K) residues 264, 266 and 273. In this mutant (3R) the lysines,
previously identified as the primary targets for acetylation, are substituted with
arginine (R), In the Cereseto report, this particular K>R triple substitution mutant
is defective for replication (Cereseto et al., 2005). However, when these specific
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substitutions were incorporated into R7/3, our standard HIV-1 wild type proviral
clone, the R7/3 3R mutant virus replicated with kinetics similar to wild type. This
discrepancy might be explained by the Cereseto group’s use of an acidic epitope
tag (1xFLAG) placed at the extreme C-terminus of integrase (position 288/288)
near the sites targeted for acetylation. We showed that while the combination of
the epitope tag with the RRR substitution results in a replication-defective
phenotype , both the 3R mutant and 1xFLAG viruses are viable when in single
combination..

Phosphorylation of integrase has been reported for the integration protein of
Rous sarcoma virus (RSV), an avian retrovirus (Horton et al., 1991). A
phosphorylation site has been identified in the C-terminus of RSV IN and is
thought to regulate correct proteolytic processing of RSV IN in the producer cell.
Research in our lab has also shown that HIV-1 IN can also be phosphorylated in
vitro by Casein Kinase II (CKII). CKII is a protein Ser/Thr kinase complex that
forms a heterotetramer consisting of two catalytic (α and/or α') subunits and two
noncatalytic (β) subunits (Litchfield, 2003). CKII is essential for viability in yeast
(Glover, 1998; Kikkawa et al., 1992), which may, in part, protect cellular proteins
from caspase proteolysis. There is also mounting evidence indicating that CK2 is
a component of regulatory protein kinase networks involved in various aspects of
transformation and cancer (Fraser et al., 2000; Landesman-Bollag et al., 2001).
CKII has also been implicated in viral biology. In one study, a CKII site has been
found to flank the nuclear targeting signal of Human cytomegalovirus (HCMV)
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and enhance nuclear import of the HCMV ppUL44 protein (Alvisi et al., 2005).
With regard to HIV-1, CKII has been shown to phosphorylate HIV-1 MA (Swingler
et al., 1997), Rev (Meggio et al., 2001) and Vpu (Friborg et al., 1995).

Although four conserved CKII consensus target sites exist in HIV-1 IN, our study
here identifies residue S283 as the key site of CKII phosphorylation in vitro. This
result was obtained from the analyses of mutants containing either serine-toalanine

(SA)

or

threonine-to-alanine

(TA)

at

the

consensus

CKII

phosphorylation sites within IN. Single or combinatorial mutants were
characterized by biochemical assay or mass spectrometry analysis. Among the
predicted sites, the serine at residue 283 within the IN CTD is the primary residue
targeted

for

CKII phosphorylation in

vitro.

Characterization of

viruses

incorporating the S283A mutation is described below.

Ubiquitination covalently attaches a single ubiquitin molecule or multi-ubiquitin
chain to target proteins, giving rise to mono- or poly-ubiquitinated proteins,
respectively. Most polyubiquitinated proteins are subjected to proteolysis by the
proteasome.

In

contrast,

monoubiquitination

has

been

associated

with

proteasome-independent cellular functions including endocytosis, virus budding,
chromatin remodeling and nuclear protein export to the cytoplasm (Hicke, 2001;
Li et al., 2003). During the process of ubiquitination, the ubiquitin molecule is
activated through its linkage with the ubiquitin-activating enzyme (E1). Activated
ubiquitin is then transferred to one of the ubiquitin-conjugating enzymes (E2s).
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Ubiquitin is finally conjugated directly to the target protein usually with the help of
an ubiquitin ligase (E3) (Bonifacino and Weissman, 1998; Hershko and
Ciechanover, 1998; Pickart, 2001).

HIV-1 IN is a substrate for the N-end rule (Mulder and Muesing, 2000)—a distinct
ubiquitin-proteasome pathway that defines the half-life of target proteins
according to the identity of their N-terminal residue (Varshavsky, 1996). Authentic
IN is the proteolytic product of the Gag-Pol polyprotein and specifies an Nterminal phenylalanine (Phe or F), which renders it particularly prone to rapid
destruction by N-end rule proteasomal degradation when it is expressed in the
absence of other viral proteins. In general, degradation of proteins by the
proteasome occurs after the substrate has been covalently modified by linkage of
a multi-ubiquitin chain, marking the protein for destruction. Rad18, a DNA
repairing protein and an E3 ubiquitin ligase (Tasaki et al., 2005) and has been
identified as an interacting partner of HIV-1 IN (Mulder et al., 2002).
Paradoxically, however, the overexpression of Rad18 results in a corresponding
increase in the stabilization of F-IN (Mulder et al., 2002). Here, we sought to
biochemically and biophysically characterize IN ubiquitination in vivo (especially
mono-ubiquitination

of

IN)

by

immunoprecipitation

analysis

and

mass

spectrometry. Using a panel of mutant Ub clones, our results indicate that IN is
both monoubiquitinated and polyubiquitinated in cells.
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A 2.2 Results
A 2.2.1 Characterization of an HIV-1 IN Acetylation Mutant
The previously reported (Cereseto et al., 2005) acetylation mutant with Lys to Arg
substitution at residues 264, 266 and 273 (3R) was constructed in the context of
the proviral clone Bru, a proviral clone with a genetic pedigree convergent to that
of R7/3 (Wain-Hobson et al., 1991). To be consistent with the original finding, the
3R mutant was constructed in both Bru and R7/3 backgrounds. The different
proviral constructs used in our experiments are illustrated in Figure A2.1.
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Replication-Competent
R7/3 WT
R7/3 3R
264 266 273

R7/3 FLAG

R7/3 Bru WT

R7/3 Bru 3R
264 266 273

R7/3 Bru FLAG

Replication-Defective

R7/3 3R FLAG
264 266 273

R7/3 Bru 3R FLAG
264 266 273

Figure A2.1 Summary of the integrase genotypes of the mutant viruses and their
replication statuses in CEM cells. Viral infections were followed over the course
of 12 days and scored for replication by syncytia formation and p24 or RT
production.
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Using viral growth curves generated in a manner similar to the original report,
viral titers were determined by the activity of exogenous reverse transcriptase in
the culture. As shown in Figure A2.2(A), the presence or absence of the
integrase 1xFLAG tag is critical in the context of the mutations described. Thus,
while the tagged and untagged wild type viruses are replication competent,
addition of the 1xFLAG tag to the 3R substitution mutant results in viruses
incapable of growth in culture. In contrast, an untagged 3R mutant replicates
well. In an independent viral growth assay measuring the p24 content, similar
viral growth curves were produced [Figure A2.2(B)]. Again, the IN 3R mutant
tagged at IN-288 with 1xFLAG was defective. Similar results were obtained in the
indicator cell lines, M5.25 and HeLa P4R5 as shown in Figure A2.3. Finally,
when we compared the relevant variables in all possible combination (wild type
vs. 3R mutant, 1xFLAG-tagged vs. untagged and IN R7/3 vs. IN Bru) our
observations were further strengthened (Figure A2.1). It is clear that a replication
defect occurs when the epitope tag is present in combination with the closely
spaced 3R mutation, regardless of the particular IN used, as the 3R mutation by
itself, does not preclude viral replication through several cycles of infection in
culture.
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Figure A2.2 Replication potential of the WT and 3R mutant viruses in CEM cells.
(A) Growth curves by RT assay. D116A is a catalytically inactive mutant and
used as a replication-defective control. (B) Growth curves determined by p24
accumulation.
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R7/3

R7/3 Bru

R7/3 3R

R7/3 Bru 3R

Figure A2.3 Comparison of the infection status of wild type and the
K(264/266/273)R (3R mutant viruses) in HeLa P4R5 cells. The in gene from the
Bru virus was cloned into R7/3 to produce the R7/3 Bru virus and its
corresponding 3R mutant. Infected cells, shown in dark blue, were stained for βgalactosidase activity 2 days after infection.
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A genetic assay using a dominant selectable marker, blastocidin D (bsd) was
employed to measure the respective integration frequencies of the WT and 3R
mutant viruses. Integration frequencies of greater than 15 to 20% of that of the
wild type are required for sustained viral replication in CEM T cell culture
(Wiskerchen and Muesing, 1995a, b). The untagged R7/3 3R mutant integrated
with a frequency nearly equivalent to WT, whereas the 1xFLAG tagged mutant
(R7/3 Bru 3R-1xFLAG) integrated with a frequency of about 12% compared to
the tagged, wild type virus (R7/3 Bru-1xFLAG). This effect is not specific to the
tagged Bru IN sequence per se, since the 1xFLAG-tagged mutant R7/3 (R7/3
3R-1xFLAG) when compared to R7/3-1xFLAG behaves in identical fashion.

To investigate replication dynamics of the 3R mutant in primary cell culture,
especially after macrophage infection, an R5-tropic virus was used, R7/3:YU-2 in
which the Env gene of YU-2 is recombined into R7/3 by replacement of the X4tropic env gene. R7/3:YU-2 WT and its 3R mutant show no difference in their
ability to infect macrophages. To see whether the 3R mutant preferentially
utilizes a particular class of co-receptor, infections of WT and 3R in R7/3 (X4,
CXCR4) or R7/3:YU2 (R5, CCR5) were studied in HeLa P4R5 cells. The results
show that the 3R mutant is as infectious as WT (in some cases registering better
in this assay) regardless of the co-receptor used for viral entry.

In attempt to verify the direct interaction between p300 and integrase in vivo
(Cereseto et al., 2005), p300 tagged at its C-terminus (p300-HA) and a p300
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expression clone with a 33 amino acid deletion mutant at its catalytic site (p300HATminus) were generated and used for coimmunoprecipitation studies. Under the
conditions used in our experiments, we failed to selectively immunoprecipitate
endogenous p300, transfected p300-HA or p300-HATminus when 3xFLAG tagged
IN was used as “bait”. Reciprocal immunoprecipitations using p300-HA to probe
potential p300 interactions with IN when examined in reverse also failed to
recover 3xFLAG-tagged IN280 or an untagged full-length integrase after
cotransfection with their respective expression plasmid.

A 2.2.2 Integrase is Phosphorylated by Casein Kinase II in vitro
Research in our laboratory has shown that recombinant IN is phosphorylated
specifically by CKII among a panel of kinases tested in vitro. The consensus site
for CKII-targeted phosphorylation is S/T-X-X-(E/D). As shown in Figure A2.4,
there are four potential CKII phosphorylation sites conserved within the HIV-1 IN
amino acid sequence: T66, T93, S195, S283. In vitro phosphorylation assays of
recombinant His-tagged IN was performed using commercially obtained purified
CKII (New England Biolabs) in the presence of

32

P-γ-labeled ATP. A titration

experiment was performed to determine the linear range of kinase activity on its
substrate in vitro.

CKII was serially diluted and shown to phosphorylate the

recombinant HIV-1 IN substrate using as little as 0.02 U/mL of CKII. Therefore, in
comparison to other CKII substrates, IN is very active for modification by this
kinase in vitro (Figure A2.5). To identify the primary site(s) of CKII modification,
various Ser/The to Ala point mutations were constructed as shown in Table 7.
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Wild-type recombinant His-tagged IN and its cognate mutants were purified and
normalized for their protein content. Kinase reactions were performed using
recombinant CKII. As shown in Figure A2.6, many of the mutations did not
significantly reduce the level of IN phosphorylation. However, mutants of
integrase that included the S283A substitution mutation were compromised for
CKII phosphorylation. The S283A single mutant gave the weakest signal for
phosphorylation due to slight less integrase in the particular sample. This
indicates that the primary site for phosphorylation in vitro is at serine residue 283.
Mutational analysis shows that phosphorylation can be reduced to 10% that of
WT when alanine is substituted for serine at residue 283; the other potential
phosphorylation sites in integrase are less reactive to this kinase.
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288

Carboxyl
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Zn finger domain (1-49)
FLDGIDKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQ
LKGEA

Catalytic core (50-212)
MHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIEAEVIPAETG
QETAYFLLKLAGRWPVKTIHTDNGSNFTSATVKAACWWAGIKQ
EFGIPYNPQSQGVVESMNKELKKIIGQVRDQAEHLKTAVQMAVFI
HNFKRKGGIGGYSAGERIVDIIATDIQTKE

Carboxyl terminus (213-288)
LQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKGEGAVVIQDNSDI
KVVPRRKAKIIRDYGKQMAGDDCVASRQDED

Figure A2.4 Consensus CKII phosphorylation sites within HIV-1 IN (T66, T93,
S195, S283) shown in italicized bold red. The relative placement and sizes of the
IN domains are indicated at the top of the figure.
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Figure A2.5 Titration of CKII activity on purified integrase. The CKII kinase
reaction was performed using recombinant WT integrase in the presence of γ32

P-ATP. CKII was serially diluted 1:3 starting from 50 U/mL (50mU/µL) and the

extent of reaction visualized by autoradiography.
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Table 7. His-tagged integrase alanine-substitution mutants altered at the
targeted serine or threonine residues within consensus CKII sites.
Single Mutants Double Mutants Triple Mutants

Quadruple Mutant

T66A

T66/T93A

T66/T93/S195A

T66/T93/S195/S283A

T93A

T66/S195A

T66/T93/S283A

S195A

T66/S283A

T66/S195/S283A

S283A

T93/S195A

T93A/S195/S283A

T93/S283A
S195/S283A
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93/195

195/283

Wt 66/93 66/195

66/93/195/283

Vector

93/283

66/283

93/195/283

66/195/283

66 93 195 283

66/93/283

Wt

66/93/195

Silver Stain

BSA
IN

Kinase Reaction
Assay

IN
wt

* ***

wt

* * *

Figure A2.6 His-tagged mutants of integrase are compromised for CKII
phosphorylation in S283A mutants (*). Samples were normalized for protein
concentration. The silver stain of the same gel prior to autoradiography is shown
at the top.
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To map the IN domain responsible for CKII phosphorylation, IN and various
truncated forms were fused with GST. A schematic illustration of the constructs
and the Coomassie staining of the purified fusion proteins after normalization for
their respective protein content are shown in Figures A2.7A and B. As a control,
GST was used alone. Kinase reaction using CKII was performed on these GST
fusion proteins as shown in Figure A2.7C. The full length IN(1-288) gave the
strongest signal for phosphorylation when compared to IN(1-50) and IN(1-212)
both of which were weakly phosphorylated. The IN-CTD (residues 212-288) is
phosphorylated to a level comparable to that of the full-length IN(1-288). When
the S283A mutation is incorporated into IN(1-288), the signal for phosphorylation
is dramatically reduced. A similar result was obtained when the S283A mutation
was recombined into the IN-CTD(212-288) fusion protein. Taken together, these
results corroborate the earlier observations from the mutagenic survey of all
potential CKII phosphorylation sites and indicate that in a variety of assays the
serine residue at position 283 is the primary target of CKII activity, the IN-CTD
being the main domain targeted for phosphorylation.
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Figure A2.7 Mapping the integrase domain targeted for CKII phosphorylation
using recombinant GST-IN, GST-IN(S283A) and GST-IN truncation fusion
proteins as test substrates for CKII. (A) A schematic illustration of the GST
constructs used. (B) Coomassie blue stain of the purified GST-IN fusion proteins
used in the CKII reaction. (C) Autoradiography of the same gel in B. C1: GST
alone. C2: no protein substrate.
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In the viral context, when each of the four potential phosphorylation sites were
mutated from S or T to alanine, T93A, S195A and S283A remained replication
competent by syncytia formation. R7/3 T66A was found to be the only singlysubstituted mutant virus that was defective as revealed by the lack of syncytia
formation or detectable accumulation of p24. In contrast, the double or triple
mutants that include S283A are observed to be viable. The subcellular
localization of various phosphorylation mutants was also studied in the context of
an EGFP-IN fusion. Most single and double mutations were nuclear localized
except mutants that involve T66A, which are excluded from the nucleus.

Immunoprecipitation experiments were performed in the hope of probing a direct
interaction between IN and CKII. Various strategies were used including
reciprocal immunoprecipitation attempts using α-IN or α-CKII. Myc-CKIIβ and
HA-CKIIα (or α’), 3xFLAG-IN and the 3xFLAG-IN(S283A) mutant were also tried
using α-Myc, α-HA, or α-FLAG mAb immunoprecipitation. So far, we have been
unable to detect any association between IN and CKII or any of its subunits in
cells.

Since residual phosphorylation was observed with S283A mutant, MS/MS
analysis was used in an attempt to identify other weakly kinased CKII sites in
integrase. Wild-type recombinant integrase was purified and reacted in vitro with
purified CKII. The band corresponding to IN was excised and submitted for MS
analysis. Data analysis was based on a shift in mass (+80 Dalton) at the residue
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targeted for phosphorylation. MS/MS analysis was able to show that S283 was
indeed phosphorylated in vitro. However, the trypsin digestion failed to recover a
stretch of peptide sequence from residue 50-120, where two of the potential sites
T66 and S195 were located. The threonine residue at position 93, (T93)
remained unphosphorylated in this experiment.

A 2.2.3 Integrase Ubiquitination
The first amino acid of authentic HIV-1 integrase produced during infection is
phenylalanine (Phe), in contrast to recombinant HIV-1 IN that contains an Nterminal Methionine (Met) residue. To study authentic integrase in the absence of
viral infection in human cells, an ubiquitin fusion strategy was employed to
produce any desired residue at the N terminus of the IN protein. (Mulder and
Muesing, 2000). The coding sequence of human ubiquitin (Ub) was fused with
that of authentic IN to generate Ub-Phe-IN, specifying Phe as the N-terminal
amino acid. Integrase fused to Ub were co-translationally cleaved at the Ub-IN
junction to produce the Phe-initiated IN. A 3xFLAG-tag was inserted at IN residue
280 (Figure A2.8) to produce tagged Ub-Phe-IN. A corresponding tagged Met
initiated IN expression plasmid (Ub-Met-IN-3xFLAG) was also constructed.
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IN
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Figure A2.8 Schematic illustration of the HIV-1 integrase expression vector UbPheIN-3xFLAG. The arrow denotes the location of the post-translational
cleavage between ubiquitin (Ub) and phenylalanine (Phe)-integrase. Ub-Met-IN3xFLAG was similarly constructed.
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Figure A2.9 Immunoisolation and detection of ubiquitination of the 3xFLAGtagged (Phe)IN protein in 293T cells. The immunoblot were probed with either
(A) α-FLAG or (B) α-Ub. The smears indicate high molecular weight
ubiquitinated products and are bracketed.
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Since integrase is degraded by the N-end rule pathway and it interacts with
Rad18 in cells, is likely to be ubiquitinated. To test this, Ub-PheIN-3xFLAG was
expressed in mammalian cells and immunoprecipitated with α-FLAG. When
probed with α-FLAG IN-3xFLAG related products were observed (Figure A2.9A).
When probed with α-Ub, the lane with Ub-PheIN-3xFLAG gave a smear at high
molecular weight range between 65kDa to 190 kDa, indicating the presence of
ubiquitinated (Phe)IN-3xFLAG (Figure A2.9B). We have sought to determine
which lysine residue(s) of Ub is preferentially utilized for ubiquitination and the
sites within IN targeted for ubiquitin addition. A set of mutant Ub expression
vectors were obtained in which all but one Lys residue (at Ub positions: 6, 11, 27,
29, 33, 48 or 63) have been. substituted with Arg (Nishikawa et al., 2004). Each
construct was co-transfected with Ub-Phe-IN-3xFLAG and immunoisolated using
α-FLAG. Surprisingly, co-transfection of IN-3xFLAG with HA-Ub29K resulted in a
band that was about 10 kDa larger than intact IN-3xFLAG (36 kDa) and
considerably more intense than any other Ub linkage (Figure A2.10A). When
probed with α-HA for the presence of single Lys Ub linked products, the lane with
HA-Ub29K gave a different pattern than others. IN-3xFLAG was mainly monoubiquitinated rather than poly-ubiquitinated when expressed with Ub29K (Figure
A2.10B). There was significant preference for Ub29K to form a mono-ubiquitinated
product. In contrast, significantly less mono-ubiquitinated IN and increased level
of poly-Ub IN were detected when Phe-IN was expressed as single Lys-to-Arg
Ub mutant at position 29 (Ub29R) compared with all other single Lys to Arg
mutants (Figure A2.11, lane 4). In addition, this experiment reveals that when the
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Ub K48R expression construct is used, a mono-ubiquitinated IN-derived product
and reduced the poly-Ub of IN is observed (Figure A2.11, lane 5). Therefore, Ub
linkage through residues 48K may result in poly-ubiquitination while Lys-29K
preferentially produces a mono-ubiquitinated integrase species.

In attempts to identify ubiquitination sites in integrase, (Phe)IN-3xFLAG was cotransfected with HA-Ub29K since this combination gave the most abundant
ubiquitinated product(s). IN-3xFLAG was immunoprecipitated by virtue of the
3xFLAG tag within the IN CTD. The band on SDS-PAGE gel (Figure A2.12) at a
molecular weight of 46 kDa was excised and then subjected to MS and MS/MS
analysis. Ubiquitin and IN-3xFLAG peptides were identified in the 46 kDa band
with by MS. The masses for possible branched Ub fragment, consisting of the
acceptor Ub tryptic fragment linked to amino acid GG (or LRGG) from the Cterminus of the donor Ub as well as IN peptide sequences with possible linkage
with GG (or LRGG) were calculated and experiment data were searched for
matches. However, the site(s) in integrase where ubiquitin is linked to IN was
unfortunately inconclusive by MS/MS analysis.
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Figure A2.10 Phe-IN-3xFLAG coexpressed with a mutant Ub specifying only a
single Lys residue. Ub-Phe-IN-3xFLAG was transfected with the respective HAtagged Ub mutant expression vector and immunoaffinity purified using α-FLAG.
1: HA-Ub WT; 2: HA-Ub6K; 3: HA-Ub11K; 4: HA-Ub29K; 5: HA-Ub48K; 6: HA-Ub63K;
7: pcDNA3.1. The Western blot was probed with either (A) α-FLAG or (B) α-HA.
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Figure A2.11 Phe-IN-3xFLAG expression with Ub single Lys to Arg substitution
mutants. Ub-Phe-IN-3xFLAG was transfected with various HA-Ub mutants and
immunoaffinity purified with α-FLAG. 1: Ub wt; 2: Ub6R; 3: Ub11R; 4: Ub29R; 5:
Ub48R; 6: Ub63R. The Western blot was probed with α-FLAG.
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Figure A2.12 Immunoaffinity isolation of ubiquitinated protein complexes using
α-FLAG. Ub-Phe-IN-3xFLAG was co-transfected with the HA-Ub29K expression
vector. The band representing the mono-ubiquitinated (Phe)IN-3xFLAG species
(indicated with *) was excised and processed for MS and MS/MS.
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A 2.3 Discussion
A 2.3.1 HAT Acetylation
It is clear from the results that a replication defect occurs only when the 3xFLAG
epitope tag is present in conjugation with the K(264/266/273)R (or 3R) mutation,
that in primary amino acid sequence, is nearby. The 3R mutation itself does not
preclude sustained viral replication in culture. When compared to the WT virus, a
genetic assay shows that the integration frequency of the untagged 3R mutant
was sufficient to allow replication in culture. Experiments by others in the lab
confirm that the IN CTD is an efficient target for HAT-mediated acetylation by
p300 in vitro (Topper et al., 2006). In addition, the steady-state level of late RT
products synthesized during 3R mutant infection compared to WT closely
paralleled the results we obtained using other assays designed to detect any
observable defects associated with the 3R mutation. Taken together, these
determinations cast doubt on the significance of acetylation (or other posttranslational modification) at these specific lysine residues (264, 266, 273) in the
immortalized cell types examined. However, the three lysines targeted for
acetylation are conserved across all clades of HIV-1 and therefore suggest that
their preservation is important for some aspect of viral replication. For example,
the specific lysine at position 273 might be important for maintaining the integrity
of the Vif coding frame since the 273 codon is within the pol-vif overlap region
(Topper et al., 2006). Despite this, all three residues can be conservatively
replaced with arginine in single, double or triple combinations while remaining
proficient for IN function and viral replication. This suggests that acetylation is not
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essential for IN function during infection of immortalized cells. Thus, we cannot
confirm the original observation of the Cereseto group that post-translational
acetylation by p300 is essential for viral integration and replication. The
discrepancy between our work and that of the Cereseto and coworkers may be
explained by their use of an acidic epitope tag placed at the extreme carboxyl
terminus of integrase, near the target site for acetylation and mutation (Topper et
al., 2006). Indeed, the combination of this epitope tag with the 3R substitution
results in a replication-defective phenotype while the untagged 3R mutant is a
replication competent virus. These observations provide evidence for an
unanticipated experimental caveat and highlight the need for caution when
interpreting data generated from tagged viruses and their mutant derivatives.

A2.3.2 Casein Kinase II
CKII is shown here to phosphorylate HIV-1 integrase in vitro. We have
characterized the domain and phosphorylation sites responsible for reactivity with
the CKII kinase. Study using IN truncations mapped the IN-CTD (212-288) to be
the major participating substrate for CKII phosphorylation. The serine at residue
283 is the major target of CKII-mediated phosphorylation in vitro. Substitution of
this serine (S283A) diminished, but did not abolish, CKII phosphorylation. This
indicates that other sites in IN are utilized for CKII phosphorylation, although
perhaps through promiscuous activity of this kinase. In attempts to map all the
CKII sites in IN, mass spectrometry confirmed that Ser 283 is indeed
phosphorylated. However, MS/MS analysis of other potential phosphorylation
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sites was inconclusive due to poor recovery of the IN peptide segment at
residues 50-120.

Although S283 reacts with CKII in vitro, the biological relevance of this
observation remains to be clarified. IN S283A does not show significant change
in subcellular localization when compared to nuclear localized WT IN. Ser to Ala
single mutation at IN residue 283 had no major effect on viral replication. It is
possible that multiple sites within IN participate in phosphorylation events, and
the effect of a single mutation is masked by the function of others. Furthermore,
we are unable to demonstrate any interaction between IN and CKII in vivo using
immunoprecipitation protocols under any of the conditions examined. Although
physical association might not be necessary for CKII phosphorylation,
optimization of the lysis conditions could be critical.

A2.3.3 Ubiquitination
HIV-1 IN is the substrate of N-end rule pathway and it interacts with Rad18, an
E3 Ub ligase (Mulder et al., 2002; Mulder and Muesing, 2000; Tasaki et al.,
2005). However, the temporal and specific requirement of IN ubiquitination in the
context of viral infection has yet to be characterized. The studies reported here
examine IN ubiquitination when IN is expressed in cells in the absence of other
viral proteins. In these experiments, IN is ubiquitinated in mammalian cells. We
identify covalent lysine linkage of both mono- and poly-Ub species to IN. Our
results show that the pattern of IN ubiquitination changes dramatically depending
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upon the use of Ub-Lys-29K or Ub-Lys-48R. IN preferentially utilizes Ub29K to
produce a mono-ubiquitinated product in vivo (Figure A2.10), and mutation at UbK29R severely reduces the level of a mono-Ub-IN product (Figure A2.11). This
may indicate that mono-Ub of IN is catalyzed using the Ub-Lys-29 residue.
Another possibility is that other Lys linkages, especially 48K, results in the polyUb of IN. Indeed, K48R mutation in Ub reduces poly-Ub products with
concomitant increases in the mono-Ub form of IN. When a Ub mutant in which
the only available Lys is at position 48 is used, it yields predominantly polyubiquitinated products, indicating that IN may preferentially utilize Ub48K for polyubiquitination. The significance of possible mono-Ub formation using Ub29K is not
clear at present, although mono-ubiquitination has been shown to prevent
intramolecular interactions of the modified protein with other ubiquitinated targets
(Hoeller et al., 2006). On the other hand, the most common poly-Ub chain is
linked through Lys-48 of Ub and serves as a signal for rapid degradation of
substrates (Chau et al., 1989).

For many proteins, mass spectrometry analysis has been of great utility to
identify Ub linkage(s) required for mono- or poly-ubiquitination. Here, using MS,
monomeric Ub was shown to be covalently linked to IN. However, the results of
MS/MS for details regarding the preferred and precise sites within IN targeted for
Ub modification were inconclusive because of the low level of the isolated Ub-IN.
It would be invaluable if we can recovery integrase peptide(s) that linked with Ub
(addition of G-G after trypsin digestion) or Lys-48-linked Ub fragment from poly-
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Ub IN.

In summary, our studies on integrase post-translational modifications (PTMs)
including acetylation, phosphorylation and ubiquitination have identified potential
PTM sites. For some of the presumptive sites targeted for modification, the
behavior of the relevant mutants of the IN protein expressed in isolation or within
the context of viral replication have been characterized. Further experiments are
warranted to decipher the possible implications of IN modification to HIV-1
replication in the more clinically relevant cell types.
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